2369 genotypes with 3883 annotations displayed
of selected term and subterms
|
Searched Term: abnormal immune system development
|
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93488
|
\Abattm1c(EUCOMM)Hmgu/\Abattm1c(EUCOMM)Hmgu \Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:333883
|
abnormal T-helper 1 cell differentiation
|
J:333883
|
abnormal T-helper 17 cell differentiation
|
J:333883
|
\Abcb1atm1Bor/\Abcb1atm1Bor \Abcb1btm1Bor/\Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
increased double-positive T cell number
|
J:102640
|
\Abcg1tm1Dgen/\Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal monocyte differentiation
|
J:132952
|
\Abl1m1/\Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
abnormal B cell differentiation
|
J:14644
|
decreased immature B cell number
|
J:14644
|
decreased pro-B cell number
|
J:14644
|
\Abl1m1/\Abl1m1
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:28795
|
decreased pro-B cell number
|
J:28795
|
\Abl1m1/\Abl1m1
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphopoiesis
|
J:148105
|
decreased pro-B cell number
|
J:148105
|
\Ackr4tm1.1Rjbn/\Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal T-helper 17 cell differentiation
|
J:166490
|
\Adatm1Mw/\Adatm1Mw \Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:73418
|
increased double-negative T cell number
|
J:73418
|
\Adam10tm1.1Dhc/\Adam10tm1.1Dhc \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal B cell differentiation
|
J:158127
|
decreased transitional stage T2 B cell number
|
J:158127
|
increased transitional stage T1 B cell number
|
J:158127
|
\Adam10tm1.1Khr/\Adam10tm1.1Khr \Csf3rtm1Link/\Csf3rtm1Link \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6N)
|
abnormal granulocyte differentiation
|
J:179060
|
myeloid hyperplasia
|
J:179060
|
\Adam10tm1.1Khr/\Adam10tm1.1Khr \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
abnormal granulocyte differentiation
|
J:179060
|
abnormal T cell differentiation
|
J:179060
|
decreased double-positive T cell number
|
J:179060
|
myeloid hyperplasia
|
J:179060
|
\Adam10tm1Zhu/\Adam10tm1.1Zhu \Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
decreased double-positive T cell number
|
J:139042
|
\Adam10tm1Zhu/\Adam10tm1Zhu \Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
decreased double-positive T cell number
|
J:139042
|
\Adam17tm1a(EUCOMM)Wtsi/\Adam17+
(involves: C57BL/6 * C57BL/6N)
|
myeloid hyperplasia
|
J:213427
|
\Adgrg3tm1Zgwg/\Adgrg3tm1Zgwg
(involves: 129 * C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:222670
|
increased transitional stage T2 B cell number
|
J:222670
|
\Admtm1Unc/\Admtm1Unc
(129S6/SvEvTac-Admtm1Unc)
|
abnormal lymph organ development
|
J:130930
|
\Aff1Rob/\Aff1+
(involves: BALB/cAnNCrl * C3H/HeN)
|
abnormal double-negative T cell morphology
|
J:82265
|
\Aff1tm1Cim/\Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell differentiation
|
J:63253
|
decreased double-positive T cell number
|
J:63253
|
\Agtpbp1atms/\Agtpbp1atms
(MRL/Mp-Agtpbp1atms)
|
abnormal T cell differentiation
|
J:103944
|
\Aicdaem1Jaych/\Aicdaem1Jaych
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:305843
|
\Aicdatm1.1Fwa/\Aicdatm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:209271
|
abnormal somatic hypermutation frequency
|
J:209271
|
\Aicdatm1Hon/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:136224,
J:141427
|
abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm1Hon/\Aicdatm1.1Fwa
(involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal class switch recombination
|
J:209271
|
\Aicdatm1Hon/\Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427,
J:73659,
J:120658
|
abnormal somatic hypermutation frequency
|
J:136224,
J:141427
|
\Aicdatm1Hon/\Aicdatm1Hon \Bcl6tm1.1Jwan/\Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal somatic hypermutation frequency
|
J:190534
|
\Aicdatm1Hon/\Aicdatm1Hon \Exo1tm1Wed/\Exo1tm1Wed \Ightm4.1Mnz/\Igh+
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon \Exo1tm1Wed/\Exo1tm1Wed \Ightm4.1Mnz/\Igh+ \Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon \Ightm3Mnz/\Ightm4.1Mnz \Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:159173
|
\Aicdatm1Hon/\Aicdatm1Hon \Ightm4.1Mnz/\Igh+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon \Ightm4.1Mnz/\Igh+ \Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm3Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm1Hon/\Aicdatm4Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm2.1Hon/\Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
abnormal somatic hypermutation frequency
|
J:169227
|
\Aicdatm3.1Mnz/\Aicdatm3.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
abnormal somatic hypermutation frequency
|
J:147109
|
\Aicdatm3Mnz/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm4.1Mnz/\Aicdatm4.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
abnormal somatic hypermutation frequency
|
J:147109
|
\Aicdatm4Mnz/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
abnormal somatic hypermutation frequency
|
J:141427
|
\Airetm1.1Doi/\Airetm1.1Doi \Tg(Ins2-TFRC/OVA)296Wehi/0 \Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
\Airetm1Mand/\Aire+ \Tg(Ins2-TFRC/OVA)296Wehi/0 \Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
\Airetm1Pltn/\Airetm1Pltn
(B6.129S4-Airetm1Pltn)
|
abnormal myelopoiesis
|
J:115076
|
\Akap13tm1Segj/\Akap13+
(involves: 129)
|
decreased transitional stage T2 B cell number
|
J:181088
|
increased transitional stage T1 B cell number
|
J:181088
|
\Akt1tm1Pnt/\Akt1tm1Pnt \Akt2tm1.1Mbb/\Akt2tm1.1Mbb \Akt3tm1Mbb/\Akt3tm1Mbb \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
decreased double-positive T cell number
|
J:135903
|
increased double-negative T cell number
|
J:135903
|
\Akt1tm1Pnt/\Akt1tm1Pnt \Akt2tm1.1Mbb/\Akt2tm1.1Mbb \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
decreased double-positive T cell number
|
J:135903
|
increased double-negative T cell number
|
J:135903
|
\Akt1tm1Pnt/\Akt1tm1Pnt \Akt3tm1Mbb/\Akt3tm1Mbb \Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-positive T cell number
|
J:135903
|
\Aldh2tm1a(EUCOMM)Wtsi/\Aldh2tm1a(EUCOMM)Wtsi \Fancd2tm1Hou/\Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal lymphopoiesis
|
J:193232
|
increased double-positive T cell number
|
J:193232
|
\Alox15tm1Fun/\Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J)
|
abnormal myelopoiesis
|
J:119405
|
\Ank1M1Wlst/\Ank1M1Wlst
(involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)
|
abnormal myelopoiesis
|
J:170562
|
\Ank1nb/\Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))
|
abnormal thymus development
|
J:30699
|
\Apctm1Kk/\Apctm1Kk \Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:100461
|
arrested T cell differentiation
|
J:100461
|
increased double-negative T cell number
|
J:100461
|
\AplfGt(RRF189)Byg/\AplfGt(RRF189)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:168260
|
\Aptxtm1Pmc/\Aptxtm1Pmc \Atmtm2.1Mfgc/\Atmtm2.1Mfgc
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:316365
|
\ArTfm/Y
(involves: STOCK EdaTa Atp7aMo-blo)
|
increased immature B cell number
|
J:110923
|
\Arhgap17tm1b(EUCOMM)Wtsi/\Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
increased transitional stage T1 B cell number
|
J:211773
|
\Arhgap45em1Ciphe/\Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased DN1 thymic pro-T cell number
|
J:309971
|
\Arhgdiatm1Ytk/\Arhgdiatm1Ytk \Arhgdibtm1Miyo/\Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:140671
|
decreased immature B cell number
|
J:140671
|
decreased transitional stage B cell number
|
J:140671
|
\Arid3atm1Pwt/\Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:169178
|
abnormal class switch recombination
|
J:169178
|
decreased pro-B cell number
|
J:169178
|
decreased transitional stage B cell number
|
J:169178
|
decreased transitional stage T1 B cell number
|
J:169178
|
decreased transitional stage T2 B cell number
|
J:169178
|
\Arid3btm1c(KOMP)Wtsi/\Arid3btm1c(KOMP)Wtsi \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * SJL)
|
abnormal B cell differentiation
|
J:236980
|
decreased immature B cell number
|
J:236980
|
decreased pre-pro B cell number
|
J:236980
|
decreased pro-B cell number
|
J:236980
|
decreased transitional stage B cell number
|
J:236980
|
\Arid4atm1Alb/\Arid4atm1Alb
(involves: 129S7/SvEvBrd)
|
abnormal mononuclear cell differentiation
|
J:141004
|
\Arid4atm1Alb/\Arid4atm1Alb \Arid4btm1Alb/\Arid4b+
(involves: 129S7/SvEvBrd)
|
abnormal leukopoiesis
|
J:141004
|
\Arid5btm1Pjh/\Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c)
|
abnormal lymphopoiesis
|
J:70658
|
decreased double-positive T cell number
|
J:70658
|
decreased pro-B cell number
|
J:70658
|
\Arpc1btm1a(EUCOMM)Wtsi/\Arpc1btm1a(EUCOMM)Wtsi
(C57BL/6N-Arpc1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased transitional stage T2 B cell number
|
J:211773
|
\Asah1tm1.2Geno/\Asah1tm1.2Geno
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:285931
|
\Asxl1tm1.1Iaai/\Asxl1tm1.1Iaai \Tet2tm1.1Iaai/\Tet2tm1.1Iaai \Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:208092
|
\Asxl1tm1.1Iaai/\Asxl1tm1.1Iaai \Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:208092
|
\Asxl1tm1.1Iaai/\Asxl1tm1.1Iaai \Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal myelopoiesis
|
J:208092
|
\Asxl1tm1.1Mjxu/\Asxl1+
(involves: 129 * C57BL/6)
|
abnormal myelopoiesis
|
J:208085
|
\Asxl1tm1.1Mjxu/\Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6)
|
myeloid hyperplasia
|
J:208085
|
\Asxl1tm1Bc/\Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:155898
|
increased double-negative T cell number
|
J:155898
|
\AtmM4Btlr/\AtmM4Btlr
(C57BL/6J-AtmM4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272821
|
\Atmm6Btlr/\Atmm6Btlr
(C57BL/6J-Atmm6Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274964
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274964
|
abnormal T cell differentiation
|
J:274964
|
\Atmtm1Awb/\Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
decreased double-positive T cell number
|
J:34193
|
increased double-positive T cell number
|
J:34193
|
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150435
|
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J)
|
increased double-positive T cell number
|
J:226414
|
\Atmtm1Awb/\Atmtm1Awb \Paxxem1Spj/\Paxxem1Spj
(involves: A/J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:236776
|
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6)
|
decreased immature B cell number
|
J:61201
|
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:191288
|
\Atmtm1Led/\Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal T cell differentiation
|
J:36561
|
increased double-positive T cell number
|
J:36561
|
\Atmtm1Mfl/\Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal T cell differentiation
|
J:69726
|
increased double-negative T cell number
|
J:69726
|
\Atmtm1Shzh/\Atmtm2.1Fwa \Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:191288
|
\Atmtm2.1Mfgc/\Atmtm2.1Mfgc
(C57BL/6-Atmtm2.1Mfgc)
|
abnormal T cell differentiation
|
J:316365
|
\Atmintm1.1Jhh/\Atmintm1.1Jhh \Cd79atm1(cre)Reth/\Cd79a+
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh)
|
decreased immature B cell number
|
J:230105
|
\Atmintm1.1Jhh/\Atmintm1.1Jhh \Cd79atm1(cre)Reth/\Cd79a+ \Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh \Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased immature B cell number
|
J:191832
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:191832
|
decreased immature B cell number
|
J:191832
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh \Trp53tm1Brn/\Trp53tm1Brn \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased immature B cell number
|
J:191832
|
\Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
abnormal B cell differentiation
|
J:171924
|
decreased immature B cell number
|
J:171924
|
decreased pro-B cell number
|
J:171924
|
\Atp11cambr/Y \Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
decreased pro-B cell number
|
J:171924
|
\Atp11cambr/Y \Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
\Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:171925
|
decreased immature B cell number
|
J:171925
|
decreased transitional stage B cell number
|
J:171925
|
decreased transitional stage T1 B cell number
|
J:171925
|
decreased transitional stage T2 B cell number
|
J:171925
|
decreased transitional stage T3 B cell number
|
J:171925
|
\Avpr1atm1Sbhu/\Avpr1atm1Sbhu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:105892
|
\Azi2tm1Aki/\Azi2tm1Aki
(Not Specified)
|
abnormal dendritic cell differentiation
|
J:204786
|
\B2mtm1Jae/\B2mtm1Jae \Rr94tm3.2Litt/\Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
\B2mtm1Jae/\B2mtm1Jae \Rr96tm1.1Yzo/\Rr96tm1.1Yzo
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
\B2mtm1Jae/\B2mtm1Jae \Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:151075
|
\B2mtm1Jae/\B2mtm1Jae \Zbtb7btm1Litt/\Zbtb7btm1.2Litt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
abnormal double-positive T cell morphology
|
J:141144
|
\B2mtm1Unc/\B2mtm1Unc \Il2tm1Hor/\Il2tm1Hor
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:39981
|
\B2mtm1Unc/\B2mtm1Unc \Prkdcscid/\Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
arrested B cell differentiation
|
J:102141
|
arrested T cell differentiation
|
J:102141
|
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv \Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:123547
|
abnormal T-helper 17 cell differentiation
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv \Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\B9d2+ \Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\B9d2+ \Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
\Bach2m1Ccg/\Bach2m1Ccg
(C57BL/6-Bach2m1Ccg)
|
myeloid hyperplasia
|
J:94077
|
\Bach2m2Anu/\Bach2m2Anu
(C57BL/6NCrlAnu-Bach2m2Anu)
|
increased immature B cell number
|
J:104190
|
\Bach2tm1a(EUCOMM)Wtsi/\Bach2tm1a(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased immature B cell number
|
J:211773
|
\Bach2tm1b(EUCOMM)Wtsi/\Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased transitional stage B cell number
|
J:211773
|
\Bach2tm1Igar/\Bach2tm1Igar
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:91110
|
abnormal class switch recombination
|
J:91110
|
abnormal somatic hypermutation frequency
|
J:91110
|
\Badtm1Meg/\Badtm1Meg
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:88139
|
abnormal T cell differentiation
|
J:88139
|
decreased pro-B cell number
|
J:88139
|
\Bak1tm1Thsn/\Bak1tm1Thsn \Baxtm1Sjk/\Baxtm2Sjk \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased pro-B cell number
|
J:100463
|
increased transitional stage B cell number
|
J:100463
|
\Bak1tm1Thsn/\Bak1tm1Thsn \Baxtm1Sjk/\Baxtm2Sjk \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:100463
|
\Bap1tm1.1Geno/\Bap1tm1.1Geno \Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal myelopoiesis
|
J:187380
|
myeloid hyperplasia
|
J:187380
|
\Batf3tm1Kmm/\Batf3tm1Kmm
(involves: 129S6/SvEvTac * BALB/cJ)
|
abnormal dendritic cell differentiation
|
J:141064
|
\Batftm1.1Ejt/\Batftm1.1Ejt
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:160935
|
abnormal T-helper 2 cell differentiation
|
J:160935
|
\Batftm1.1Kmm/\Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm)
|
abnormal CD4-positive T cell differentiation
|
J:150643
|
\Bcl2tm1Dlo/\Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:73660
|
\Bcl2tm1Dlo/\Bcl2tm1Dlo
(B6.129P2-Bcl2tm1Dlo)
|
abnormal leukopoiesis
|
J:73316
|
\Bcl2tm1Dlo/\Bcl2tm1Dlo \Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast)
|
abnormal leukopoiesis
|
J:73316
|
\Bcl2tm1Lbox/\Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell differentiation
|
J:114637
|
decreased immature B cell number
|
J:114637
|
\Bcl2tm1Sjk/\Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-positive T cell number
|
J:15224
|
increased double-negative T cell number
|
J:15224
|
\Bcl2tm2.1Lbox/\Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased immature B cell number
|
J:175730
|
\Bcl2tm2.1Lbox/\Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased immature B cell number
|
J:175730
|
\Bcl2l1tm1Ywh/\Bcl2l1tm1Ywh \Mcl1tm1Ywh/\Mcl1tm1Ywh \Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:137400
|
\Bcl2l1tm1Ywh/\Bcl2l1tm1Ywh \Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:99012
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:58641
|
increased double-negative T cell number
|
J:58641
|
increased immature B cell number
|
J:132217
|
increased transitional stage B cell number
|
J:132217
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal leukopoiesis
|
J:73316
|
increased immature B cell number
|
J:133084
|
increased transitional stage B cell number
|
J:133084
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast \Biktm1Ast/\Biktm1Ast
(B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast)
|
abnormal B cell differentiation
|
J:103605
|
abnormal T cell differentiation
|
J:103605
|
decreased immature B cell number
|
J:103605
|
decreased pro-B cell number
|
J:103605
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast \Faslpr/\Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
increased immature B cell number
|
J:132217
|
increased transitional stage B cell number
|
J:132217
|
\Bcl2l11tm1Ast/\Bcl2l11tm1Ast \Dicer1tm1Bdh/\Dicer1tm1Bdh \Aicdatm1(cre)Njen/\Aicda+
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:181782
|
\Bcl2l11tm1Sjk/\Bcl2l11tm1Sjk
(involves: 129X1/SvJ)
|
increased transitional stage B cell number
|
J:100463
|
\Bcl3tm1Sbn/\Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:39747
|
abnormal class switch recombination
|
J:39747
|
\Bcl3tm1Sbn/\Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
decreased transitional stage T1 B cell number
|
J:207111
|
decreased transitional stage T2 B cell number
|
J:207111
|
\Bcl6tm1.1Dent/\Bcl6tm1.1Dent \Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T follicular helper cell differentiation
|
J:202372
|
\Bcl6tm1.1Jwan/\Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac)
|
abnormal somatic hypermutation frequency
|
J:190534
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * C57BL/6JJcl)
|
abnormal somatic hypermutation frequency
|
J:190943
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2)
|
abnormal somatic hypermutation frequency
|
J:190943
|
\Bcl10tm1Mak/\Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:67297
|
decreased double-positive T cell number
|
J:67297
|
increased double-negative T cell number
|
J:67297
|
\Bcl10tm1Swm/\Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:85147
|
\Bcl11atm1Ngc/\Bcl11a+
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
decreased DN2 thymocyte number
|
J:194616
|
\Bcl11atm1Ngc/\Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal dendritic cell differentiation
|
J:207383
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:83646
|
increased double-negative T cell number
|
J:83646
|
\Bcl11atm1Pwt/\Bcl11atm1Pwt \Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+ \Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal dendritic cell differentiation
|
J:207383
|
\Bcl11atm2.1Peli/\Bcl11atm2.1Peli \Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
decreased DN2 thymocyte number
|
J:194616
|
decreased immature B cell number
|
J:194616
|
decreased pro-B cell number
|
J:194616
|
\Bcl11btm1Avram/\Bcl11btm1Avram \Tcratm1Mom/\Tcratm1Mom \Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
decreased double-positive T cell number
|
J:128515
|
\Bcl11btm1Avram/\Bcl11btm1Avram \Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
decreased double-negative T cell number
|
J:128515
|
decreased double-positive T cell number
|
J:128515
|
\Bcl11btm1Avram/\Bcl11btm1Avram \Tg(Cd4-cre)1Cwi/? \Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
decreased double-positive T cell number
|
J:128515
|
\Bcl11btm1Jpk/\Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:83651
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:83651
|
decreased double-positive T cell number
|
J:83651
|
increased double-negative T cell number
|
J:83651
|
\Bcl11btm1Peli/\Bcl11btm1Peli \Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)
|
abnormal NK cell differentiation
|
J:161373
|
\Bcl11btm2.1Jpk/\Bcl11b+ \Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:210122
|
increased double-negative T cell number
|
J:210122
|
\Bhlhe40tm1Tan/\Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal CD4-positive T cell differentiation
|
J:72651
|
decreased double-positive T cell number
|
J:72651
|
increased double-negative T cell number
|
J:72651
|
\Bhlhe41tm1.2Cdon/\Bhlhe41tm1.2Cdon
(B6.129S6-Bhlhe41tm1.2Cdon)
|
abnormal T-helper 2 cell differentiation
|
J:157740
|
\Birc3tm1Jda/\Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
decreased immature B cell number
|
J:166899
|
\Birc5tm1Mak/\Birc5tm1Mak \Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
decreased double-negative T cell number
|
J:90892
|
\Birc5tm1Wnt/\Birc5tm1Emc \Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:87435
|
\Birc5tm1Wnt/\Birc5tm1Emc \Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:87435
|
increased double-negative T cell number
|
J:87435
|
\Blktm1Tara/\Blktm1Tara \Fyntm1Sor/\Fyntm1Sor \Lyntm1Ard/\Lyntm1Ard
(either: B6.129-Lyntm1Ard Fyntm1Sor Blktm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))
|
abnormal B cell differentiation
|
J:115080
|
abnormal pro-B cell differentiation
|
J:115080
|
arrested B cell differentiation
|
J:115080
|
decreased immature B cell number
|
J:115080
|
\Blmtm4Ches/\Blmtm4Ches \Trp53bp1tm1Jc/\Trp53bp1tm1Jc \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:194603
|
\Blnkm1Btlr/\Blnkm1Btlr
(C57BL/6J-Blnkm1Btlr)
|
arrested B cell differentiation
|
J:159439
|
\Blnkm1Btlr/\Blnkm1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
\Blnktm1Achn/\Blnktm1Achn
(involves: 129X1/SvJ)
|
abnormal B cell differentiation
|
J:58805
|
arrested B cell differentiation
|
J:58805
|
increased pro-B cell number
|
J:58805
|
\Blnktm1Dkit/\Blnktm1Dkit
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:84040
|
abnormal immature B cell morphology
|
J:94297
|
abnormal plasma cell differentiation
|
J:143854
|
arrested B cell differentiation
|
J:143854
|
decreased immature B cell number
|
J:84040
|
decreased transitional stage B cell number
|
J:143854
|
\Blnktm1Dkit/\Blnktm1Dkit \Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
absent immature B cells
|
J:84040
|
arrested B cell differentiation
|
J:84040
|
\Blnktm1Dkit/\Blnktm1Dkit \Igh-Jtm1(3H9-VDJ)Mwg/\Igh-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
\Blnktm1Dkit/\Blnktm1Dkit \Igh-Jtm1(3H9-VDJ)Mwg/\Igh-J+ \Igk-Jtm1Mwg/\Igk-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
\Blnktm1Dkit/\Blnktm1Dkit \Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal plasma cell differentiation
|
J:143854
|
arrested B cell differentiation
|
J:143854
|
\Blnktm1Kplm/\Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:61130,
J:131161
|
decreased immature B cell number
|
J:61130
|
increased pro-B cell number
|
J:61130,
J:131161
|
\Blnktm1Kplm/\Blnktm1Kplm \Ightm4Cgn/\Igh+ \Igktm1Rsky/\Igk+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:120460
|
increased transitional stage B cell number
|
J:120460
|
\Blnktm1Pjln/\Blnktm1Pjln
(involves: BALB/c)
|
arrested B cell differentiation
|
J:58740
|
\Blnktm1Pjln/\Blnktm1Pjln \Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:94768
|
decreased immature B cell number
|
J:94768
|
\Blnktm1Pjln/\Blnktm1Pjln \Btktm1Gsv/Y \Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB)
|
abnormal B cell differentiation
|
J:94768
|
\Blnktm1Pjln/\Blnktm1Pjln \Btktm1Wk/\Btktm1Wk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:70406
|
\Bmal1tm1Bra/\Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:118522
|
decreased transitional stage B cell number
|
J:118522
|
\Bmftm1.1Ast/\Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
increased immature B cell number
|
J:133084
|
increased transitional stage B cell number
|
J:133084
|
\Bmi1tm1Brn/\Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
abnormal double-negative T cell morphology
|
J:17712
|
decreased immature B cell number
|
J:17712
|
\Bmi1tm1Brn/\Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:134271
|
\Bmi1tm1Brn/\Bmi1tm1Brn \E2f6tm1Lees/\E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:134271
|
\Bmp2tm1Cjt/\Bmp2tm1Cjt \Bmp4tm1Jfm/\Bmp4tm1Jfm \Tg(Prrx1-cre)1Cjt/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal bone marrow development
|
J:118257
|
\Bnip3ltm1.1Gwd/\Bnip3ltm1.1Gwd
(involves: 129 * C57BL/6)
|
abnormal thrombopoiesis
|
J:141583
|
\Bod1lem1Bltn/\Bod1lem1Bltn \Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:337726
|
\Braftm1Tumg/\Braf+ \Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA)
|
abnormal lymph organ development
|
J:216228
|
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd \Shld1em1Nus/\Shld1em1Nus
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd \Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:307190
|
\Brca1tm2Mak/\Brca1tm2Mak \Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:63282
|
increased double-negative T cell number
|
J:63282
|
\Brca1tm2Mak/\Brca1tm2Mak \Tg(Lck-cre)548Jxm/? \Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:63282
|
increased double-negative T cell number
|
J:63282
|
\Bsgtm1.1Znc/\Bsgtm1.1Znc \Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased double-positive T cell number
|
J:207886
|
\Bst1tm1Thir/\Bst1tm1Thir
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:111424
|
\Btkm2Anu/\Btkm2Anu
(C57BL/6NCrlAnu-Btkm2Anu)
|
increased immature B cell number
|
J:104190
|
\Btktm1Gsv/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:35769
|
decreased immature B cell number
|
J:35769
|
\Btktm1Wk/\Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:28968
|
increased pro-B cell number
|
J:28968
|
\Btktm1Wk/\Btktm1Wk \Tectm1Welm/\Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:66080
|
\Btkxid/\Btkxid
(CBA/CaHN-Btkxid/J)
|
impaired myelopoiesis
|
J:92639
|
\Btkxid/\Btkxid
(CBA/HN-Btkxid)
|
abnormal lymphopoiesis
|
J:7981
|
\Btkxid/\Btkxid
(B6.CBA-Btkxid)
|
decreased transitional stage B cell number
|
J:145687
|
\C1galt1ptl1/\C1galt1ptl1
(C57BL/6-C1galt1ptl1)
|
abnormal thrombopoiesis
|
J:115272
|
\C1qtnf4em1Smoc/\C1qtnf4em1Smoc
(C57BL/6JSmoc-C1qtnf4em1Smoc/Smoc)
|
abnormal macrophage differentiation
|
J:302282
|
\C3ar1tm1Raw/\C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
abnormal T-helper 2 cell differentiation
|
J:80071
|
\Cacnb4lh/\Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
decreased double-positive T cell number
|
J:115345
|
\Cadm1Gt(Ayu21-W34)Imeg/\Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
abnormal T cell differentiation
|
J:178612
|
abnormal T cell receptor V(D)J recombination
|
J:178612
|
increased double-positive T cell number
|
J:178612
|
\Calcrltm1Kmca/\Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca)
|
abnormal lymph organ development
|
J:130930
|
\Camltm1Rjb/\Camltm2Rjb \Tg(Lck-cre)1Cwi/0 \Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:100536
|
abnormal positive T cell selection
|
J:100536
|
\Card11em1Welu/\Card11+
(involves: C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:292926
|
decreased transitional stage T3 B cell number
|
J:292926
|
increased transitional stage T2 B cell number
|
J:292926
|
\Card11em1Welu/\Card11em1Welu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:292926
|
abnormal plasma cell differentiation
|
J:292926
|
decreased transitional stage T1 B cell number
|
J:292926
|
decreased transitional stage T3 B cell number
|
J:292926
|
increased transitional stage T2 B cell number
|
J:292926
|
\Card11em2Welu/\Card11em2Welu
(involves: C57BL/6)
|
abnormal plasma cell differentiation
|
J:292926
|
increased transitional stage T2 B cell number
|
J:292926
|
\Card11m1Btlr/\Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
abnormal double-negative T cell morphology
|
J:149767,
J:139069
|
\Card11M7Btlr/\Card11M7Btlr
(C57BL/6J-Card11M7Btlr)
|
abnormal T cell differentiation
|
J:274762
|
\Card11m8Btlr/\Card11m8Btlr
(C57BL/6J-Card11m8Btlr)
|
abnormal B cell differentiation
|
J:274940
|
\Card11tm1Litt/\Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal double-negative T cell morphology
|
J:89322
|
abnormal T cell differentiation
|
J:89322
|
\Card11tm1Pngr/\Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:84036
|
\Card11tm1Vmd/\Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
absent immature B cells
|
J:95800
|
\Card11tm1Xav/\Card11tm1Xav
(involves: 129 * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:132226
|
\Card11unm/\Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
abnormal B cell differentiation
|
J:84042
|
\Carm1tm1Mtb/\Carm1tm1Mtb
(involves: 129S6/SvEvTac)
|
arrested T cell differentiation
|
J:159958
|
\Carm1tm2.1Mtb/\Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
|
arrested T cell differentiation
|
J:159958
|
\Casp3tm1Flv/\Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal bone marrow development
|
J:94703
|
\Casp8tm1Wll/\Casp8tm1.1Yuan \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
abnormal macrophage differentiation
|
J:92722
|
\Cbfa2t3tm1.1Swh/\Cbfa2t3tm1.1Swh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal myelopoiesis
|
J:140967
|
decreased immature B cell number
|
J:140967
|
\Cbfbtm1Itan/\Cbfbtm1Itan \Rr94tm3.1Litt/\Rr94tm3.1Litt \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
decreased double-positive T cell number
|
J:158962
|
increased double-positive T cell number
|
J:158962
|
\Cbfbtm1Itan/\Cbfbtm1Itan \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125953
|
abnormal T-helper 1 cell differentiation
|
J:125953
|
increased double-positive T cell number
|
J:158962
|
\Cbfbtm1Itan/\Cbfbtm1Itan \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive T cell differentiation
|
J:125953
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
abnormal double-positive T cell morphology
|
J:125953
|
abnormal T-helper 1 cell differentiation
|
J:125953
|
\Cbfbtm1Itan/\Cbfbtm1Itan \Zbtb7btm2Litt/\Zbtb7b+ \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
\Cbfbtm1Itan/\Cbfbtm1Itan \Zbtb7btm2Litt/\Zbtb7btm1.2Litt \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
\Cbfbtm1Lhc/\Cbfbtm1Lhc \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:105040
|
\Cbfbtm1Spe/\Cbfbtm1Spe \Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
|
abnormal myelopoiesis
|
J:80670
|
\Cbfbtm1Spe/\Cbfbtm1Spe \Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
|
abnormal myelopoiesis
|
J:80670
|
\Cbfbtm1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
decreased double-positive T cell number
|
J:124224
|
\Cbfbtm2.1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
decreased double-positive T cell number
|
J:124224
|
\Cbfbtm2Itan/\Cbfbtm2Itan
(Not Specified)
|
abnormal lymph organ development
|
J:168918
|
\Cbfbtm5Ppl/\Cbfb+
(Not Specified)
|
abnormal mononuclear cell differentiation
|
J:193140
|
myeloid hyperplasia
|
J:193140
|
\Cbltm1.1Hua/\Cbltm1.1Hua \Lattm1Les/\Lattm1Les
(involves: 129P2/OlaHsd)
|
abnormal thymus development
|
J:91369
|
\Cbltm1.1Hua/\Cbltm1.1Hua \Lcp2tm1Gak/\Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
\Cbltm1.1Hua/\Cbltm1.1Hua \Lcp2tm1Gak/\Lcp2tm1Gak \Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
\Cbltm1Ddlb/\Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:103366
|
abnormal T cell differentiation
|
J:103366
|
\Cbltm1Wlan/\Cbltm1Wlan
(involves: 129S1/Sv * C57BL/6)
|
myeloid hyperplasia
|
J:81965
|
\Cblbtm1Pngr/\Cblbtm1Pngr \Itktm1Litt/\Itktm1Litt
(B6.129-Itktm1Litt Cblbtm1Pngr)
|
abnormal T-helper 2 cell differentiation
|
J:141390
|
\Cbx2tm1Cim/\Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:38487
|
\Cbx4tm1.1Gxu/\Cbx4tm1.2Gxu \Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal lymphopoiesis
|
J:194053
|
abnormal thymus development
|
J:194053
|
decreased double-positive T cell number
|
J:194053
|
\Cbx4tm1.2Gxu/\Cbx4tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thymus development
|
J:194053
|
\Ccl21atm1Yout/\Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal negative T cell selection
|
J:244640
|
\Ccnb2tm1Thnt/\Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:47430
|
\Ccnd1tm1Dsn/\Ccnd1tm1Dsn \Ccnd2tm1Wbg/\Ccnd2tm1Wbg \Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:92563
|
\Ccnd3tm1.1(Ccnd2)Iaai/\Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased double-positive T cell number
|
J:192031
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(Not Specified)
|
decreased double-positive T cell number
|
J:88120,
J:192031
|
increased double-negative T cell number
|
J:88120
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc \Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased double-positive T cell number
|
J:192031
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc \Rb1tm2Brn/\Rb1tm2Brn \Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192031
|
\Ccnd3tm2.1Pisc/\Ccnd3tm2.1Pisc \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192032
|
\Ccne1tm1Pisc/\Ccne1tm1Pisc \Ccne2tm1Pisc/\Ccne2tm1Pisc
(involves: 129S2/SvPas)
|
abnormal thrombopoiesis
|
J:85224
|
\Ccr6tm1Lira/\Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:76461
|
\Ccr7tm1Rfor/\Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal class switch recombination
|
J:57976
|
\Ccr9tm1.1Mal/\Ccr9tm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:72386
|
decreased double-positive T cell number
|
J:72386
|
decreased pro-B cell number
|
J:72386
|
\Ccr9tm1Ccb/\Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:94596
|
\Cd1d1tm1.2Aben/\Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
abnormal CD4-positive T cell differentiation
|
J:177038
|
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested T cell differentiation
|
J:125679
|
\Cd3dtm1Kap/\Cd3dtm1Kap
(C57BL/6-Cd3dtm1Kap)
|
arrested T cell differentiation
|
J:39925
|
\Cd3em1Btlr/\Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
arrested T cell differentiation
|
J:132486
|
\Cd3em1Btlr/\Cd3em1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd3em2Btlr/\Cd3em2Btlr
(C57BL/6J-Cd3em2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274934
|
abnormal T cell differentiation
|
J:274934
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:192604
|
abnormal T cell differentiation
|
J:192604
|
increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:192604
|
abnormal positive T cell selection
|
J:192604
|
increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno \Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive T cell differentiation
|
J:192604
|
abnormal positive T cell selection
|
J:192604
|
increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno \Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:192604
|
abnormal T cell differentiation
|
J:192604
|
decreased double-positive T cell number
|
J:192604
|
increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Lov/\Cd3etm1.1Lov
(Not Specified)
|
arrested T cell differentiation
|
J:72144
|
decreased double-positive T cell number
|
J:72144
|
increased double-negative T cell number
|
J:72144
|
\Cd3etm1.1Lov/\Cd3etm1.1Lov \Trdctm1Mal/\Trdctm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
\Cd3etm1Cpt/\Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:54756
|
\Cd3etm1Cpt/\Cd3etm1Cpt \Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:54756
|
\Cd3etm1Lov/\Cd3etm1Lov
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:72144
|
decreased double-positive T cell number
|
J:72144
|
increased double-negative T cell number
|
J:72144
|
\Cd3etm1Mal/\Cd3etm1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:77098
|
\Cd3etm1Mal/\Cd3etm1Mal
(C57BL/6-Cd3etm1Mal)
|
abnormal double-negative T cell morphology
|
J:81133
|
arrested T cell differentiation
|
J:81133
|
\Cd3etm1Mal/\Cd3etm1Mal \Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:77098
|
\Cd3gtm1Amk/\Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77504
|
\Cd4maat/\Cd4maat
(C57BL/6JAnu-Cd4maat/Apb)
|
abnormal double-positive T cell morphology
|
J:104190
|
\Cd4sesh/\Cd4sesh
(C57BL/6JAnu-Cd4sesh/AnuApb)
|
abnormal double-positive T cell morphology
|
J:104190
|
\Cd4tm1(cre/ERT2)Thbu/\Cd4+ \Gfm1tm1c(EUCOMM)Wtsi/\Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal T-helper 17 cell differentiation
|
J:302272
|
\Cd4tm1Doi/\Cd4tm1Doi \Lag3tm1Doi/\Lag3tm1Doi
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
\Cd4tm1Doi/\Cd4tm1Litt \Lag3tm1Doi/\Lag3+
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
\Cd4tm1Jrp/\Cd4tm1Jrp
(either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp)
|
abnormal T cell differentiation
|
J:45168
|
decreased double-positive T cell number
|
J:45168
|
\Cd4tm1Mak/\Cd4tm1Mak \Cd8atm1Mak/\Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal double-negative T cell morphology
|
J:12572
|
abnormal T cell differentiation
|
J:12572
|
decreased double-positive T cell number
|
J:12572
|
\Cd5tm1.1Chra/\Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
decreased double-positive T cell number
|
J:189919
|
increased double-negative T cell number
|
J:189919
|
\Cd5ltm1Nto/\Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:52195
|
\Cd7tm1Bfh/\Cd7tm1Bfh
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:48758
|
\Cd7tm1Bfh/\Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
increased double-positive T cell number
|
J:48758
|
\Cd8am1Btlr/\Cd8am1Btlr
(C57BL/6J-Cd8am1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221492
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221492
|
\Cd8atm1.1Kio/\Cd8atm1.1Kio
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive T cell differentiation
|
J:76799
|
\Cd8atm1Asin/\Cd8atm1Asin
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal double-positive T cell morphology
|
J:126026
|
\Cd8atm1Asin/\Cd8atm1Asin \Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
\Cd8atm1Asin/\Cd8atm1Mak
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
\Cd8b1m2Btlr/\Cd8b1m2Btlr
(C57BL/6J-Cd8b1m2Btlr)
|
abnormal B cell differentiation
|
J:274761
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274761
|
\Cd8b1tm1Litt/\Cd8b1+ \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased double-positive T cell number
|
J:112551
|
\Cd8b1tm1Litt/\Cd8b1tm1Litt \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal negative T cell selection
|
J:112551
|
abnormal positive T cell selection
|
J:112551
|
\Cd8b1tm1Wpfl/\Cd8b1tm1Wpfl
(involves: 129S2/SvPas)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:19928
|
\Cd19tm1(cre)Cgn/? \Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sortm1(HBEGF)Awai
(involves: 129P2/OlaHsd * C57BL/6)
|
absent immature B cells
|
J:131076
|
\Cd19tm1(cre)Cgn/\Cd19+ \Ell2tm1.1Cmil/\Ell2tm1.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:234692
|
decreased transitional stage T2 B cell number
|
J:234692
|
decreased transitional stage T3 B cell number
|
J:234692
|
increased immature B cell number
|
J:234692
|
increased pro-B cell number
|
J:234692
|
\Cd19tm1(cre)Cgn/\Cd19+ \Ep300tm2Reck/\Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:147840
|
abnormal transitional stage B cell morphology
|
J:147840
|
\Cd19tm1(cre)Cgn/\Cd19+ \Faslpr/\Fastm1Cgn \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
\Cd19tm1(cre)Cgn/\Cd19+ \Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:74619
|
\Cd19tm1(cre)Cgn/\Cd19+ \Ikbkbtm1Cgn/\Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:79132
|
\Cd19tm1(cre)Cgn/\Cd19+ \Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:79132
|
\Cd19tm1(cre)Cgn/\Cd19+ \Irf8tm1.1Hm/\Irf8tm1.1Hm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased transitional stage B cell number
|
J:168923
|
\Cd19tm1(cre)Cgn/\Cd19+ \Klhl6tm2Sato/\Klhl6tm2Sato
(either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal B cell differentiation
|
J:101363
|
\Cd19tm1(cre)Cgn/\Cd19+ \Mcl1tm2Sjk/\Mcl1tm3Sjk
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:86906
|
absent early pro-B cells
|
J:86906
|
absent late pro-B cells
|
J:86906
|
arrested B cell differentiation
|
J:86906
|
\Cd19tm1(cre)Cgn/\Cd19+ \Notch2tm2Hhi/\Notch2tm1.1Hhi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased transitional stage B cell number
|
J:83476
|
\Cd19tm1(cre)Cgn/\Cd19+ \Pax5tm1Mbu/\Pax5tm3Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal B cell differentiation
|
J:75504
|
abnormal class switch recombination
|
J:75504
|
decreased immature B cell number
|
J:75504
|
\Cd19tm1(cre)Cgn/\Cd19+ \Prdm1tm1Clme/\Prdm1tm1Clme
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:101890
|
abnormal plasma cell differentiation
|
J:101890
|
\Cd19tm1(cre)Cgn/\Cd19+ \Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell negative selection
|
J:155314
|
abnormal class switch recombination
|
J:114881
|
\Cd19tm1(cre)Cgn/\Cd19+ \Rac1tm1Tyb/\Rac1tm1Tyb \Rac2tm1Mddw/\Rac2tm1Mddw
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:86765
|
decreased transitional stage B cell number
|
J:86765
|
\Cd19tm1(cre)Cgn/\Cd19+ \Rbpjtm1Hon/\Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76240
|
\Cd19tm1(cre)Cgn/\Cd19+ \Slc3a2tm1.1Mgin/\Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:148000
|
abnormal plasma cell differentiation
|
J:148000
|
\Cd19tm1(cre)Cgn/\Cd19+ \Tbl1xr1tm1c(EUCOMM)Hmgu/\Tbl1xr1tm1c(EUCOMM)Hmgu \Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
abnormal B cell differentiation
|
J:292118
|
\Cd19tm1(cre)Cgn/\Cd19+ \Tcf3tm1Mbu/\Tcf3tm1.2Mbu
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased immature B cell number
|
J:137719
|
decreased pro-B cell number
|
J:137719
|
decreased transitional stage B cell number
|
J:137719
|
\Cd19tm1(cre)Cgn/\Cd19+ \Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:172843
|
\Cd19tm1(cre)Cgn/\Cd19+ \Wacem2Cya/\Wacem2Cya
(B6.Cg-Cd19tm1(cre)Cgn Wacem2Cya)
|
abnormal plasma cell differentiation
|
J:345327
|
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:27463
|
\Cd22m1Anu/\Cd22m1Anu
(C57BL/6JAnu-Cd22m1Anu/AnuApb)
|
arrested B cell differentiation
|
J:104190
|
\Cd22m1Btlr/\Cd22m1Btlr
(C57BL/6J-Cd22m1Btlr)
|
abnormal B cell differentiation
|
J:173079
|
\Cd22m1Btlr/\Cd22m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
\Cd22m2Btlr/\Cd22m2Btlr
(C57BL/6J-Cd22m2Btlr)
|
abnormal B cell differentiation
|
J:215821
|
\Cd22tm1.1(CD22)Lnit/\Cd22tm1.1(CD22)Lnit
(involves: 129S4/SvJae)
|
decreased transitional stage T1 B cell number
|
J:189017
|
decreased transitional stage T2 B cell number
|
J:189017
|
\Cd22tm1Eac/\Cd22+ \Lyntm1Ard/\Lyn+ \Ptpn6me-v/\Ptpn6+ \Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
\Cd22tm1Eac/\Cd22+ \Lyntm1Ard/\Lyn+ \Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
\Cd22tm1Eac/\Cd22+ \Ptpn6me-v/\Ptpn6+ \Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
\Cd22tm1Eac/\Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal transitional stage B cell morphology
|
J:132991
|
\Cd22tm1Lam/\Cd22tm1Lam \Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd22tm3Lnit/\Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased transitional stage B cell number
|
J:198790
|
\Cd24atm1Pjln/\Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
abnormal B cell differentiation
|
J:76695
|
decreased immature B cell number
|
J:76695
|
\Cd27tm1Jbo/\Cd27tm1Jbo
(B6.129P2-Cd27tm1Jbo)
|
abnormal leukopoiesis
|
J:97606
|
\Cd28tm1Jmg/\Cd28tm1Jmg
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
\Cd28tm1Jmg/\Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
\Cd28tm1Mak/\Cd28+ \Cd5tm1Cgn/\Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal class switch recombination
|
J:14194
|
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:123989
|
\Cd28tm1Mak/\Cd28tm1Mak \Cd5tm1Cgn/\Cd5+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak \Cd5tm1Cgn/\Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak \Tg(H2-K-Cd86)7All/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:112266
|
\Cd28tm1Pjl/\Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:83722
|
\Cd28tm1Pjl/\Cd28tm1Pjl \Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
abnormal class switch recombination
|
J:83722
|
\Cd36tm1Mfe/\Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal plasma cell differentiation
|
J:130897
|
increased transitional stage B cell number
|
J:130897
|
\Cd37tm1Hor/\Cd37tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:63315
|
\Cd40tm1Kik/\Cd40tm1Kik \Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
\Cd40tm1Kik/\Cd40tm1Kik \Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(involves: 129 * 129P2/OlaHsd * BALB/c)
|
increased transitional stage B cell number
|
J:138560
|
\Cd40lgm1Btlr/Y
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd40lgm1Btlr/\Cd40lgm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:25010
|
abnormal T cell differentiation
|
J:25010
|
decreased double-positive T cell number
|
J:25010
|
\Cd40lgtm1Imx/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:21137
|
\Cd40lgtm1Imx/\Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6J * BALB/c)
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
increased double-positive T cell number
|
J:123582
|
\Cd69tm1Fsm/\Cd69tm1Fsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:61329
|
increased immature B cell number
|
J:61329
|
\Cd72tm1Jrp/\Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal B cell differentiation
|
J:76990
|
increased immature B cell number
|
J:76990
|
increased pro-B cell number
|
J:76990
|
\Cd72tm1Jrp/\Cd72tm1Jrp \Tg(BCL2)22Wehi/0
(either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))
|
increased immature B cell number
|
J:76990
|
\Cd74tm1Eae/\Cd74tm1Eae
(B6.129S2-Cd74tm1Eae)
|
arrested B cell differentiation
|
J:112084
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * BALB/cAn)
|
abnormal B cell differentiation
|
J:110927
|
increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal B cell differentiation
|
J:110927
|
increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal B cell differentiation
|
J:110927
|
increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv)
|
abnormal positive T cell selection
|
J:125548
|
\Cd79am1Btlr/\Cd79am1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd79atm1(cre)Reth/\Cd79a+ \Ctnnbl1tm1.1Crad/\Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:232010
|
\Cd79atm1(cre)Reth/\Cd79a+ \Dynll1tm1.1Jhh/\Dynll1tm1.1Jhh
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth)
|
decreased immature B cell number
|
J:230105
|
\Cd79atm1(cre)Reth/\Cd79a+ \Dynll1tm1.1Jhh/\Dynll1tm1.1Jhh \Tg(IghMyc)22Bri/0
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
\Cd79atm1(cre)Reth/\Cd79a+ \Eif4a1tm1.1Bea/\Eif4a1tm1.1Bea
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased pro-B cell number
|
J:344730
|
\Cd79atm1(cre)Reth/\Cd79a+ \Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
abnormal B cell differentiation
|
J:181705
|
abnormal class switch recombination
|
J:181705
|
decreased transitional stage B cell number
|
J:181705
|
\Cd79atm1(cre)Reth/\Cd79a+ \Huwe1tm1.1Mak/Y \Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:181705
|
\Cd79atm1(cre)Reth/\Cd79a+ \Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:209928
|
increased pro-B cell number
|
J:209928
|
\Cd79atm1(cre)Reth/\Cd79a+ \Phf5atm1.1Oux/\Phf5atm1.1Oux
(involves: BALB/c * C57BL/6J)
|
abnormal B cell receptor editing
|
J:345807
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:345807
|
decreased early pro-B cell number
|
J:345807
|
decreased immature B cell number
|
J:345807
|
decreased late pro-B cell number
|
J:345807
|
increased pre-pro B cell number
|
J:345807
|
\Cd79atm1(cre)Reth/\Cd79a+ \Slc39a10tm1.1Tfk/\Slc39a10tm1.1Tfk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
decreased pro-B cell number
|
J:213935
|
\Cd79atm1(cre)Reth/\Cd79atm1(cre)Reth \Mzb1tm1.1Rug/\Mzb1tm1.1Rug
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
increased late pro-B cell number
|
J:211639
|
increased pro-B cell number
|
J:211639
|
\Cd79atm1.1Cgn/\Cd79a+ \Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn \Cd79btm1Gzmn/\Cd79b+
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn \Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:124400
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn \Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:179254
|
increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn \Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:71100
|
\Cd79atm1.1Rsky/\Cd79atm1.1Rsky
(involves: C57BL/6)
|
increased immature B cell number
|
J:179254
|
increased transitional stage B cell number
|
J:179254
|
increased transitional stage T1 B cell number
|
J:179254
|
increased transitional stage T2 B cell number
|
J:179254
|
increased transitional stage T3 B cell number
|
J:179254
|
\Cd79atm2(cre/Esr1*)Reth/\Cd79a+ \Rag1tm1.1Sadu/\Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
\Cd79atm2Cgn/\Cd79atm2Cgn
(involves: C57BL/6)
|
increased pro-B cell number
|
J:66840
|
\Cd79atm2Cgn/\Cd79atm2Cgn \Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
decreased transitional stage B cell number
|
J:66840
|
\Cd79atm2Pld/\Cd79atm2Pld
(BALB/c-Cd79atm2Pld)
|
abnormal B cell differentiation
|
J:87492
|
abnormal T cell differentiation
|
J:87492
|
decreased double-positive T cell number
|
J:87492
|
\Cd79atm4.1Cgn/\Cd79atm4.1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
\Cd79atm4.1Cgn/\Cd79atm4.1Cgn \Ightm1.2Rsky/\Igh+
(involves: BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:125719
|
\Cd79atm4Cgn/\Cd79atm4.1Cgn \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
arrested B cell differentiation
|
J:91091
|
\Cd79atm5.1Cgn/\Cd79a+ \Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
(involves: 129 * C57BL/6)
|
decreased immature B cell number
|
J:125719
|
increased pro-B cell number
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn \Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn \Ightm1.2Rsky/\Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
decreased immature B cell number
|
J:125719
|
increased pro-B cell number
|
J:125719
|
\Cd79atm5Cgn/\Cd79atm5.1Cgn \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
arrested B cell differentiation
|
J:91091
|
\Cd79atm6Cgn/\Cd79atm6Cgn
(involves: C57BL/6)
|
increased transitional stage B cell number
|
J:113407
|
\Cd79bm1Ghost/\Cd79bm1Ghost
(B10.Cg-Ptprca Cd79bm1Ghost H2a)
|
abnormal B cell differentiation
|
J:157450
|
arrested B cell differentiation
|
J:157450
|
\Cd79btm1Mnz/\Cd79btm1Mnz
(involves: 129S1/Sv)
|
abnormal pro-B cell differentiation
|
J:78601
|
abnormal pro-B cell morphology
|
J:78601
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz \Tg(BCL2)22Wehi/0 \Tg(IghelMD4)4Ccg/0 \Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz \Tg(BCL2)22Wehi/0 \Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz \Tg(IghelMD4)4Ccg/0 \Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:78601
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz \Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
decreased transitional stage B cell number
|
J:66840
|
increased pro-B cell number
|
J:66840
|
\Cd79btm3Mnz/\Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:128768
|
decreased immature B cell number
|
J:128768
|
increased pro-B cell number
|
J:128768
|
\Cd80tm1Shr/\Cd80tm1Shr \Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae * BALB/c)
|
decreased double-positive T cell number
|
J:112266
|
\Cd81tm1Tmiy/\Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:41830
|
\Cd82tm1Kjbr/\Cd82tm1Kjbr
(Not Specified)
|
abnormal macrophage differentiation
|
J:326451
|
\Cd83lcd4/\Cd83lcd4
(involves: C57BL/6J)
|
abnormal CD4-positive T cell differentiation
|
J:92721
|
\Cd83tm1Tft/\Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75700
|
arrested T cell differentiation
|
J:75700
|
\Cd180tm1Kmiy/\Cd180tm1Kmiy \Faslpr/\Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
increased double-negative T cell number
|
J:137066
|
\Cd247tm1Lov/\Cd247tm1Lov
(involves: 129S4/SvJae)
|
decreased double-positive T cell number
|
J:14170
|
\Cd247tm1Mal/\Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6))
|
abnormal T cell differentiation
|
J:15272
|
decreased double-positive T cell number
|
J:15272
|
increased double-negative T cell number
|
J:15272
|
\Cd247tm1Mal/\Cd247tm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112990,
J:110847
|
abnormal T cell differentiation
|
J:112990
|
decreased double-positive T cell number
|
J:110847
|
\Cd247tm1Mal/\Cd247tm1Mal \Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:110847
|
abnormal T cell differentiation
|
J:110847
|
decreased double-positive T cell number
|
J:110847
|
\Cd247tm1Mhu/\Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:15579
|
decreased double-positive T cell number
|
J:15579
|
increased double-negative T cell number
|
J:15579
|
\Cd247tm1Tks/\Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:15271
|
\Cd247tm2.1Lov/\Cd247tm2.1Lov
(Not Specified)
|
abnormal gamma-delta T cell differentiation
|
J:192915
|
abnormal T cell differentiation
|
J:192915
|
abnormal T-helper 1 cell differentiation
|
J:192915
|
\Cd247tm2.1Lov/\Cd247tm2.1Lov \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:192915
|
\Cd274tm1Lpc/\Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:162539
|
\Cdh17tm1Ohn/\Cdh17tm1Ohn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pro-B cell number
|
J:96738
|
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal lymphopoiesis
|
J:144975
|
abnormal T cell differentiation
|
J:144975
|
decreased double-negative T cell number
|
J:144975
|
decreased double-positive T cell number
|
J:144975
|
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
decreased double-positive T cell number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
\Cdk6tm1Phin/\Cdk6tm1Phin \Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:144975
|
\Cdk6tm2.1Phin/\Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
decreased DN4 thymocyte number
|
J:174697
|
decreased double-positive T cell number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
increased double-negative T cell number
|
J:174697
|
\Cdk6tm3.1Phin/\Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
increased DN1 thymic pro-T cell number
|
J:174697
|
\Cdk6tm4.1Phin/\Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
decreased DN4 thymocyte number
|
J:174697
|
decreased double-positive T cell number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
\Cdkn1atm1Led/\Cdkn1atm1Led \Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
\Cdkn1atm1Led/\Cdkn1atm1Led \Zbtb17tm1Cksn/\Zbtb17tm1Cksn \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zbtb17tm1Cksn Cdkn1atm1Led Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased double-positive T cell number
|
J:71394
|
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd \Pbx1tm1Koss/\Pbx1tm1Koss \Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal spleen mesenchyme morphology
|
J:184521
|
\Cdkn2btm1Wff/\Cdkn2btm1Wff \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
myeloid hyperplasia
|
J:163498
|
\Cebpatm1Dgt/\Cebpatm1Dgt \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:94682
|
failure of myelopoiesis
|
J:94682
|
\Cebpatm1Gjd/\Cebpatm1Gjd
(B6.129S7-Cebpatm1Gjd)
|
failure of myelopoiesis
|
J:94682
|
\Cebpatm2Btp/\Cebpatm2Btp
(B6.129P2-Cebpatm2Btp)
|
abnormal myelopoiesis
|
J:187834
|
\Cebpetm1Kgx/\Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal eosinophil differentiation
|
J:76024
|
abnormal granulocyte differentiation
|
J:76024
|
abnormal myelopoiesis
|
J:76024
|
abnormal neutrophil differentiation
|
J:76024
|
impaired myelopoiesis
|
J:76024
|
\Cebpetm1Kgx/\Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
abnormal eosinophil differentiation
|
J:76024
|
abnormal granulocyte differentiation
|
J:76024
|
abnormal myelopoiesis
|
J:76024
|
abnormal neutrophil differentiation
|
J:76024
|
impaired myelopoiesis
|
J:76024
|
\Cflartm1.1Pope/\Cflartm1.2Pope \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal myelopoiesis
|
J:167430
|
\Chd4tm1.1Kge/\Chd4tm1.1Kge \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
arrested T cell differentiation
|
J:109547
|
decreased double-positive T cell number
|
J:109547
|
\Chd4tm1.2Kge/\Chd4tm1.2Kge \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell differentiation
|
J:109547
|
decreased double-positive T cell number
|
J:109547
|
increased double-negative T cell number
|
J:109547
|
\Chek2tm1Mak/\Chek2+ \Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
decreased double-negative T cell number
|
J:103922
|
\Chordc1tm1Mbra/\Chordc1+
(involves: 129 * C57BL/6)
|
abnormal myelopoiesis
|
J:222040
|
\Chrnb2tm1Jpc/\Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6J)
|
myeloid hyperplasia
|
J:140280
|
\Chuktm2Mka/\Chuktm2Mka \Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
|
increased transitional stage B cell number
|
J:113556
|
\Cigs2tm1.1Anse/\Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal class switch recombination
|
J:181313
|
\Ciitam1Btlr/\Ciitam1Btlr
(C57BL/6J-Ciitam1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221483
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221483
|
\Ciitatm1Ccum/\Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal T cell differentiation
|
J:64283
|
\Ciitatm1Ccum/\Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal T cell differentiation
|
J:106081
|
\Ciitatm1Jpyt/\Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-positive T cell number
|
J:57100
|
\Cishtm1.1Cdon/\Cishtm1.1Cdon \Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:204829
|
\Cishtm1.2Cdon/\Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
abnormal T-helper 2 cell differentiation
|
J:204829
|
\Clec4ntm1Yiw/\Clec4ntm1Yiw
(B6.129P2-Clec4ntm1Yiw)
|
abnormal CD4-positive T cell differentiation
|
J:160680
|
\Clptm1ltm1d(EUCOMM)Wtsi/\Clptm1l+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
abnormal class switch recombination
|
J:265892
|
\Cltatm1.2Fmb/\Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:235591
|
\Cog6tm1a(EUCOMM)Wtsi/\Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased transitional stage T2 B cell number
|
J:211773
|
\Col1a1tm1(tetO-Irf4)Sing/\Col1a1tm1(tetO-Irf4)Sing \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+ \Irf4tm1Mak/\Irf4+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
abnormal plasma cell differentiation
|
J:203903
|
\Col1a1tm1(tetO-Irf4)Sing/\Col1a1tm1(tetO-Irf4)Sing \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+ \Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
abnormal plasma cell differentiation
|
J:203903
|
\Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/\Col1a1+ \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:229031
|
myeloid metaplasia
|
J:229031
|
\Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/\Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:229031
|
\Col1a1tm6(tetO-MSI2)Jae/\Col1a1+ \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelopoiesis
|
J:163322
|
\Col10a1tm1Bhr/\Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:62230
|
increased double-negative T cell number
|
J:62230
|
\Col10a1tm1Ksec/\Col10a1tm1Ksec
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:193886
|
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+ \Zbtb11tm1.1Lieg/\Zbtb11tm1.1Lieg
(involves: C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:343208
|
abnormal myelopoiesis
|
J:343208
|
\Copatm1.1Shum/\Copa+
(B6(CBA)-Copatm1.1Shum)
|
decreased double-positive T cell number
|
J:288425
|
\Cops5tm1Rpar/\Cops5tm1Rpar \Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:132114
|
\Cpa3tm3(icre)Hrr/\Cpa3+ \Gt(ROSA)26Sortm1Hjf/? \Notch1tm1Agt/\Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:143731
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
\Cpa3tm3(icre)Hrr/\Cpa3+ \Notch1tm1Agt/\Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:143731
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
decreased double-negative T cell number
|
J:143731
|
decreased double-positive T cell number
|
J:143731
|
\Cr2tm1Hmo/\Cr2tm1Hmo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
abnormal memory B cell differentiation
|
J:151991
|
\Cr2tm2.1(HLA-A)Crr/\Cr2tm2.1(HLA-A)Crr
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
abnormal memory B cell differentiation
|
J:151991
|
\Crebbptm1Jvd/\Crebbptm1Jvd \Ep300tm2Pkb/\Ep300tm2Pkb \Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:105505
|
increased double-negative T cell number
|
J:105505
|
\Crebbptm1Jvd/\Crebbptm1Jvd \Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:105505
|
\Crebbptm1Jvd/\Crebbptm1Jvd \Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB)
|
decreased double-positive T cell number
|
J:88323
|
\Crkltm1Imo/\Crkltm1Imo
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal thymus development
|
J:67826
|
\Crlf2tm1Wjl/\Crlf2tm1Wjl
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:108209
|
\Csf1rtm1Ers/\Csf1rtm1Ers
(FVB.129X1-Csf1rtm1Ers)
|
abnormal macrophage differentiation
|
J:112594
|
\Csf3tm1Ard/\Csf3tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired myelopoiesis
|
J:20400
|
\Csf3rtm1Eur/\Csf3rtm1Eur
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal neutrophil differentiation
|
J:48503
|
\Csktm1Sor/\Csk+ \Ptprcltng/\Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
\Csktm1Tara/\Csktm1Tara \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:49654
|
\Csktm1Tara/\Csktm2Tara \Elanetm1(cre)Roes/\Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6)
|
abnormal myelopoiesis
|
J:89716
|
\Csnk1a1tm1c(KOMP)Wtsi/\Csnk1a1tm1c(KOMP)Wtsi \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
bone marrow failure
|
J:216977
|
\Ctcftm2Gal/\Ctcftm2Gal \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)
|
decreased double-positive T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
decreased double-positive T cell number
|
J:143271
|
increased double-negative T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal \Tg(Lck-cre)1Cwi/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)
|
abnormal T cell differentiation
|
J:143271
|
decreased double-positive T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal \Tg(Lck-cre)1Cwi/0 \Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
decreased double-positive T cell number
|
J:143271
|
increased double-negative T cell number
|
J:143271
|
\Ctla4tm1All/\Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:42481
|
increased double-negative T cell number
|
J:42481
|
\Ctla4tm1All/\Ctla4tm1All \Tg(TcrAND)53Hed/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:119845
|
\Ctla4tm1Shr/\Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal T cell differentiation
|
J:30393
|
decreased double-positive T cell number
|
J:30393
|
increased double-negative T cell number
|
J:30393
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi \Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio)
|
decreased double-positive T cell number
|
J:348981
|
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre \Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
decreased double-positive T cell number
|
J:227618
|
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre \Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased double-positive T cell number
|
J:227618
|
\Ctsdtm1Cptr/\Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
decreased double-positive T cell number
|
J:28201
|
\Ctsetm1Kjy/\Ctsetm1Kjy
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:108745
|
\Ctsgtm2.1(PML/RARA)Ley/\Ctsg+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:84230,
J:86458
|
\Ctsgtm2.1(PML/RARA)Ley/\Ctsg+ \Elanetm1Sds/\Elanetm1Sds
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:86458
|
\Ctslm1Btlr/\Ctslm1Btlr
(C57BL/6J-Ctslm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272869
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272869
|
abnormal T cell differentiation
|
J:272869
|
\Cttnbp2tm1b(KOMP)Wtsi/\Cttnbp2tm1b(KOMP)Wtsi
(C57BL/6N-Cttnbp2tm1b(KOMP)Wtsi/Wtsi)
|
decreased transitional stage T1 B cell number
|
J:211773
|
\Cux1tm1Rhsc/\Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myelopoiesis
|
J:100055
|
abnormal T cell differentiation
|
J:100055
|
decreased double-positive T cell number
|
J:100055
|
\Cxcl12tm1.1Sjm/\Cxcl12tm1.1Sjm \Tg(Prrx1-cre)1Cjt/?
(involves: C57BL/6 * SJL/J)
|
abnormal B cell differentiation
|
J:194748
|
\Cxcl12tm1.1Ystz/\Cxcl12tm1.2Ystz \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased pro-B cell number
|
J:168434
|
\Cxcl12tm1Tng/\Cxcl12tm1.1Link \Tg(Prrx1-cre)1Cjt/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)
|
decreased pre-pro B cell number
|
J:193594
|
\Cxcl12tm1Tng/\Cxcl12tm1.1Link \Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)
|
decreased pre-pro B cell number
|
J:193594
|
\Cxcl12tm1Tng/\Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:34750
|
impaired myelopoiesis
|
J:49070
|
\Cxcl12tm3.1(HBEGF/EGFP)Tng/\Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
|
decreased pro-B cell number
|
J:164657
|
\Cxcr2tm1a(EUCOMM)Wtsi/\Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased immature B cell number
|
J:211773
|
decreased pre-pro B cell number
|
J:211773
|
\Cxcr2tm1Mwm/\Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal granulocyte differentiation
|
J:19570
|
abnormal myelopoiesis
|
J:19570
|
myeloid hyperplasia
|
J:19570
|
\Cxcr2tm1Mwm/\Cxcr2tm1Mwm
(involves: 129S2/SvPas * BALB/c)
|
abnormal myelopoiesis
|
J:113489
|
\Cxcr4tm1.1Bala/\Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
decreased immature B cell number
|
J:186735
|
\Cxcr4tm1Qma/\Cxcr4tm1Qma
(involves: 129X1/SvJ)
|
decreased pro-B cell number
|
J:49070
|
impaired myelopoiesis
|
J:49070
|
\Cxcr4tm1Tng/\Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:69256
|
failure of myelopoiesis
|
J:69256
|
\Cxcr4tm1Tng/\Cxcr4tm1Tng
(B6.Cg-Cxcr4tm1Tng)
|
abnormal T cell differentiation
|
J:82996
|
decreased double-positive T cell number
|
J:82996
|
\Cxcr4tm1Yzo/\Cxcr4tm1Yzo
(Not Specified)
|
abnormal B cell differentiation
|
J:167314
|
abnormal leukopoiesis
|
J:69255
|
abnormal lymphopoiesis
|
J:69255
|
impaired myelopoiesis
|
J:69255
|
\Cxcr4tm2Yzo/\Cxcr4tm2Yzo \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:94911
|
\Cxcr4tm2Yzo/\Cxcr4tm3.1Yzo \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:167314
|
\Cxcr4tm3.1Yzo/\Cxcr4tm3.1Yzo
(Not Specified)
|
decreased pro-B cell number
|
J:167314
|
impaired myelopoiesis
|
J:167314
|
\Cyldtm1.1Awai/\Cyldtm1.1Awai
(Not Specified)
|
abnormal B cell differentiation
|
J:126113
|
abnormal class switch recombination
|
J:126113
|
decreased immature B cell number
|
J:126113
|
increased pro-B cell number
|
J:126113
|
\Cyldtm1Awai/\Cyldtm1Awai \Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
decreased immature B cell number
|
J:126113
|
\Cyldtm1Scs/\Cyldtm1Scs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112392
|
increased double-positive T cell number
|
J:112392
|
\Cyrenem1Vokh/\Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
abnormal class switch recombination
|
J:306598
|
\Cyrentm1.1(KOMP)Vlcg/\Cyrentm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal class switch recombination
|
J:265834
|
\Dbr1Gt(YTA280)Byg/\Dbr1+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:223318
|
\DccTg(H2-Kb-Jak2*V617F)1Shmd/\Dcc+
(involves: C57BL/6 * DBA/2)
|
myeloid hyperplasia
|
J:130189
|
\Dckmemi/\Dckmemi
(C57BL/6J-Dckmemi)
|
abnormal T cell differentiation
|
J:184080
|
\Dcktm1.1Radu/\Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal double-negative T cell morphology
|
J:158373
|
abnormal T cell differentiation
|
J:158373
|
decreased double-positive T cell number
|
J:158373
|
increased double-negative T cell number
|
J:158373
|
increased pro-B cell number
|
J:158373
|
\Dclre1cm1Brck/\Dclre1cm1Brck
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:207533
|
decreased DN4 thymocyte number
|
J:207533
|
decreased double-positive T cell number
|
J:207533
|
\Dclre1ctm1.1Fwa/\Dclre1ctm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:80995
|
arrested T cell differentiation
|
J:80995
|
\Dclre1ctm1.1Jpdv/\Dclre1ctm1.1Jpdv
(involves: 129P1/ReJ)
|
abnormal B cell differentiation
|
J:137743
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
arrested T cell differentiation
|
J:137712
|
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
absent immature B cells
|
J:80995
|
arrested B cell differentiation
|
J:80995
|
arrested T cell differentiation
|
J:80995
|
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
arrested B cell differentiation
|
J:147864
|
decreased double-positive T cell number
|
J:147864
|
\Dclre1ctm1Jsek/\Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:147864
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
decreased double-positive T cell number
|
J:147864
|
increased pro-B cell number
|
J:147864
|
\Dclre1ctm2.1Jpdv/\Dclre1ctm2.2Jpdv \Tg(Cr2-cre)3Cgn/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:153841
|
\Dclre1ctm2.2Jpdv/\Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv)
|
absent immature B cells
|
J:153841
|
arrested B cell differentiation
|
J:153841
|
arrested T cell differentiation
|
J:153841
|
decreased double-positive T cell number
|
J:153841
|
\Dclre1ctm2Mcow/\Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:96535
|
arrested T cell differentiation
|
J:96535
|
\Def6Gt(OST307148)Lex/\Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased immature B cell number
|
J:106469
|
\Del(9Cd3g-Cd3d)1Cpt/\Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
arrested T cell differentiation
|
J:76991
|
\Del(11Jmjd6-Mettl23)1Ysfk/\Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6)
|
abnormal thymus development
|
J:90288
|
\Del(11Stat5a-Stat5b)1Mam/\Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:122463
|
\Del(14Trim13-Rnaseh2b)6Rdf/\+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
\Dffbtm1Osa/\Dffbtm1Osa \Dnase2atm1Osa/\Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:81474
|
decreased double-positive T cell number
|
J:81474
|
increased double-negative T cell number
|
J:81474
|
\Dgkatm1Xpz/\Dgkatm1Xpz \Dgkztm1Gak/\Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:113564
|
\Dh/\Dh+
(B6.CBA-Dh)
|
abnormal T cell differentiation
|
J:5834
|
\Dhx9Tn(pb-Act-RFP)1.071225026-HRAZhu/\Dhx9+ \Igs12tm1Zhu/\Igs12tm1Zhu \Ptprca/\Ptprcb \Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)
|
abnormal T cell differentiation
|
J:207361
|
\Dhx15tm1c(EUCOMM)Wtsi/\Dhx15tm1c(EUCOMM)Wtsi \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
abnormal B cell differentiation
|
J:284624
|
\Dhx36tm1.2Pmt/\Dhx36tm1.2Pmt \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:185179
|
\Dicer1tm1Bdh/\Dicer1+ \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129 * C57BL/6 * CBA/J)
|
abnormal thymus development
|
J:166758
|
\Dicer1tm1Mmk/\Dicer1tm1.1Mmk \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
abnormal immunoglobulin V(D)J recombination
|
J:135783
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
arrested B cell differentiation
|
J:135783
|
decreased immature B cell number
|
J:135783
|
increased pro-B cell number
|
J:135783
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk \Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
abnormal granulocyte differentiation
|
J:158901
|
\Dicer1tm1Tara/\Dicer1tm1Tara \Foxn1tm3(cre)Nrm/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal positive T cell selection
|
J:180783
|
\Dis3tm1.1Uba/\Dis3tm1.1Uba \Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:302856
|
\Dlk1tm1Srba/\Dlk1tm1Srba
(involves: 129X1/SvJ * C57BL/6)
|
decreased immature B cell number
|
J:145076
|
increased immature B cell number
|
J:145076
|
increased transitional stage B cell number
|
J:145076
|
\Dll4tm1Frad/\Dll4tm1Frad \Foxn1tm3(cre)Nrm/\Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm)
|
abnormal T cell differentiation
|
J:143472
|
decreased double-positive T cell number
|
J:143472
|
increased immature B cell number
|
J:143472
|
\Dll4tm1Kaho/\Dll4tm1Kaho \Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphopoiesis
|
J:143473
|
decreased double-positive T cell number
|
J:143473
|
\Dmp1tm1Mis/\Dmp1tm1Mis
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal bone marrow development
|
J:184352
|
\Dnajc11spc/\Dnajc11spc
(B6.Cg-Dnajc11spc)
|
decreased double-positive T cell number
|
J:221543
|
increased DN1 thymic pro-T cell number
|
J:221543
|
increased double-negative T cell number
|
J:221543
|
\Dnmt1tm2Jae/\Dnmt1tm2Jae \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113645
|
decreased pro-B cell number
|
J:113645
|
\Dnmt3btm1Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:106540
|
increased double-negative T cell number
|
J:106540
|
\Dntttm1Gfn/\Dntttm1Gfn \Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
\Dock2m1Btlr/\Dock2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:173592
|
abnormal class switch recombination
|
J:185495
|
\Dock2m1Hsd/\Dock2m1Hsd \Irf5tm1Ttg/\Irf5tm1Ttg
(B6NHsd.Cg-Irf5tm1Ttg Dock2m1Hsd)
|
abnormal B cell differentiation
|
J:182658
|
increased immature B cell number
|
J:182658
|
\Dock2m2Btlr/\Dock2m2Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
abnormal class switch recombination
|
J:185495
|
\Dock2m3Btlr/\Dock2m3Btlr
(C57BL/6J-Dock2m3Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:191187
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:191187
|
\Dock2m4Btlr/\Dock2m4Btlr
(C57BL/6J-Dock2m4Btlr)
|
abnormal B cell differentiation
|
J:221486
|
abnormal CD4-positive T cell differentiation
|
J:221486
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221486
|
\Dock2m5Btlr/\Dock2+
(C57BL/6J-Dock2m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:225938
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
\Dock2m5Btlr/\Dock2m5Btlr
(C57BL/6J-Dock2m5Btlr)
|
abnormal B cell differentiation
|
J:225938
|
abnormal CD4-positive T cell differentiation
|
J:225938
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
\Dock2m11Btlr/\Dock2m11Btlr
(C57BL/6J-Dock2m11Btlr)
|
abnormal B cell differentiation
|
J:272405
|
abnormal CD4-positive T cell differentiation
|
J:272405
|
\Dock2tm1Tsas/\Dock2tm1Tsas \Tg(Tcra2B4)1Mmd/? \Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:84581
|
\Dock8m4Btlr/\Dock8m4Btlr
(C57BL/6J-Dock8m4Btlr)
|
abnormal B cell differentiation
|
J:274856
|
abnormal CD4-positive T cell differentiation
|
J:274856
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274856
|
abnormal T cell differentiation
|
J:274856
|
\Dock10tm1a(EUCOMM)Hmgu/\Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
arrested B cell differentiation
|
J:236911
|
\Dok1tm1Yyam/\Dok1tm1Yyam \Dok2tm1Yyam/\Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam)
|
abnormal myelopoiesis
|
J:95335
|
\Dot1ltm1.1Saam/\Dot1ltm1.1Saam \Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal leukopoiesis
|
J:193161
|
\Droshatm1Litt/\Droshatm1.1Litt \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased double-positive T cell number
|
J:138683
|
\Dsg3sqk/\Dsg3sqk
(C57BL/6-Dsg3sqk)
|
decreased double-positive T cell number
|
J:219200
|
decreased immature B cell number
|
J:219200
|
decreased transitional stage B cell number
|
J:219200
|
\Duoxa2tm1b(KOMP)Wtsi/\Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased immature B cell number
|
J:211773
|
decreased transitional stage T1 B cell number
|
J:211773
|
\Dyrk1atm1Jdc/\Dyrk1atm1Jdc \Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
decreased double-positive T cell number
|
J:223138
|
decreased immature B cell number
|
J:223138
|
\E2f1tm1Meg/\E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
abnormal double-positive T cell morphology
|
J:33100
|
\E2f1tm1Meg/\E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal double-positive T cell morphology
|
J:93708
|
decreased double-positive T cell number
|
J:93708
|
\E2f2tm1Zubi/\E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:76318
|
\E2f4tm1Jrn/\E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:64192
|
increased double-negative T cell number
|
J:64192
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug \Polr2atm1(cre/ERT2)Bbd/\Polr2a+
(involves: C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
decreased immature B cell number
|
J:182210
|
decreased transitional stage B cell number
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug \Polr2atm1(cre/ERT2)Bbd/\Polr2a+ \Tg(BCL2)#Wehi/0
(involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)
|
decreased immature B cell number
|
J:182210
|
\Ebf1tm1Rug/\Ebf1tm1Rug
(involves: 129S2/SvPas)
|
arrested B cell differentiation
|
J:52607
|
decreased pro-B cell number
|
J:52607
|
\Ebi3Gt716Lex/\Ebi3Gt716Lex \Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:134148
|
\Ece1tm1Reh/\Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
persistent cervical thymus
|
J:46640
|
\Eef1a1tm2Arge/\Eef1a1+ \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal double-positive T cell morphology
|
J:197167
|
\Efnb1tm1.1Jwu/\Efnb1tm1.1Jwu \Efnb2tm1.1Jwu/\Efnb2tm1.1Jwu \Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
abnormal T cell differentiation
|
J:178148
|
abnormal T-helper 1 cell differentiation
|
J:178148
|
abnormal T-helper 17 cell differentiation
|
J:178148
|
decreased DN4 thymocyte number
|
J:178148
|
decreased double-positive T cell number
|
J:178148
|
increased DN3 thymocyte number
|
J:178148
|
increased double-negative T cell number
|
J:178148
|
\Egln1tm1Fong/\Egln1tm1Fong
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
|
abnormal lymph organ development
|
J:114669
|
\Eif2ak2em1Btlr/\Eif2ak2em1Btlr \Zfp574em1Btlr/\Zfp574em1Btlr
(C57BL/6J-Zfp574em1Btlr Eif2ak2em1Btlr)
|
abnormal class switch recombination
|
J:354285
|
\Elavl1tm1Dkon/\Elavl1tm1Dkon \Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal spleen development
|
J:149149
|
\Elavl1tm1Dkon/\Elavl1tm1Dkon \Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal positive T cell selection
|
J:148866
|
increased double-negative T cell number
|
J:148866
|
increased double-positive T cell number
|
J:148866
|
\Elavl1tm1Dkon/\Elavl1tm1Dkon \Tg(Lck-cre)I57Jxm/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)
|
abnormal negative T cell selection
|
J:148866
|
\Elavl1tm1Thla/\Elavl1tm1Thla \Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129)
|
decreased double-positive T cell number
|
J:155109
|
\Elf1tm1Jml/\Elf1tm1Jml
(Not Specified)
|
abnormal B cell differentiation
|
J:100734
|
\Elf4em1Hdu/\Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
abnormal CD4-positive T cell differentiation
|
J:328935
|
\Elf4tm1Nim/\Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
abnormal T cell differentiation
|
J:79568
|
\Elk4tm1Rtr/\Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal positive T cell selection
|
J:88515
|
abnormal T cell selection
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129/Sv * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr \Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
abnormal positive T cell selection
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr \Tg(TcrLCMV)327Sdz/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:88515
|
\Eomestm1.1Twa/? \Il15tm1Imx/\Il15tm1Imx
(involves: C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/? \Tbx21tm1Glm/\Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/? \Tg(CD2-Tbx21)#Staka/?
(involves: C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/? \Tg(Itgax-TGFBR2)1Flv/?
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1Srnr/\Eomestm1Srnr \Tbx21tm1Srnr/\Tbx21tm1Srnr \Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:137655
|
\Ep300tm2Pkb/\Ep300tm2Pkb \Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:105505
|
\Eps15tm1Noff/\Eps15tm1Noff
(involves: 129 * C57BL/6)
|
increased transitional stage T1 B cell number
|
J:195689
|
\Epsti1em1Mjnh/\Epsti1em1Mjnh
(Not Specified)
|
abnormal macrophage differentiation
|
J:272013
|
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:92471
|
\Ercc6l2em1Mengf/\Ercc6l2em1Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
\Ercc6l2em1Mengf/\Ercc6l2em1Mengf \Nhej1em1Mengf/\Nhej1em1Mengf
(Not Specified)
|
abnormal T cell receptor V(D)J recombination
|
J:311900
|
\Ercc6l2em2Mengf/\Ercc6l2em2Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
\Ergmld2/\Erg+
(involves: 129S1/Sv * C57BL/6)
|
decreased transitional stage B cell number
|
J:137835
|
\Ern1tm1Rjk/\Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pro-B cell morphology
|
J:106975
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
increased double-positive T cell number
|
J:110416
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:110923
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal B cell differentiation
|
J:63462
|
decreased immature B cell number
|
J:63462
|
\Esr1tm1Ksk/\Esr1tm1Ksk \Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
increased double-positive T cell number
|
J:110416
|
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal leukopoiesis
|
J:83617
|
abnormal lymphopoiesis
|
J:83617
|
increased pro-B cell number
|
J:83617
|
\Ets1tm1.1Dds/\Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal lymphopoiesis
|
J:121460
|
increased double-positive T cell number
|
J:121460
|
\Ets1tm1Fwa/\Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
abnormal B cell differentiation
|
J:93845
|
decreased pro-B cell number
|
J:93845
|
increased pro-B cell number
|
J:93845
|
\Ets1tm1Jml/\Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125056
|
increased double-negative T cell number
|
J:125056
|
\Ets1tm1Jml/\Ets1tm1Jml \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased double-negative T cell number
|
J:125056
|
\Etv2tm1Dlim/\Etv2tm2.1Dlim \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
impaired myelopoiesis
|
J:172687
|
\Etv6tm1(RUNX1)Haho/\Etv6+ \Tg(Gata1-cre)1Sho/0
(involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)
|
abnormal B cell differentiation
|
J:151639
|
\Etv6tm1(RUNX1)Haho/\Etv6+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:151639
|
myeloid hyperplasia
|
J:151639
|
\Etv6tm1(RUNX1)Haho/\Etv6+ \Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:151639
|
decreased pro-B cell number
|
J:151639
|
\Ewsr1tm1Sblee/\Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased double-positive T cell number
|
J:122058
|
decreased immature B cell number
|
J:122058
|
\Exo1tm2Wed/\Exo1tm2Wed
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:198719
|
abnormal somatic hypermutation frequency
|
J:198719
|
\Ezh1tm1Sgon/\Ezh1tm1Sgon \Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased immature B cell number
|
J:193722
|
decreased pro-B cell number
|
J:193722
|
\Ezh2tm1Tara/\Ezh2tm1Tara \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:83216
|
abnormal immunoglobulin V(D)J recombination
|
J:83216
|
abnormal pro-B cell morphology
|
J:83216
|
decreased immature B cell number
|
J:83216
|
\Ezh2tm2Sho/\Ezh2tm2.1Sho \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
increased double-negative T cell number
|
J:182211
|
\Ezh2tm2Sho/\Ezh2tm2Sho \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
increased double-negative T cell number
|
J:182211
|
\Faddtm1Wnt/\Faddtm1Wnt \Tg(Fadd)33Wnt/0 \Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR)
|
abnormal T cell differentiation
|
J:69617
|
decreased double-positive T cell number
|
J:69617
|
increased double-negative T cell number
|
J:69617
|
\Faddtm1Wnt/\Faddtm1Wnt \Tg(Fadd)33Wnt/0 \Tg(Lck-cre)I57Jxm/0 \Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)
|
increased double-negative T cell number
|
J:69617
|
\Fam72atm1.1(KOMP)Vlcg/\Fam72atm1.1(KOMP)Vlcg
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg)
|
abnormal class switch recombination
|
J:326431
|
abnormal somatic hypermutation frequency
|
J:326431
|
\Fam72atm1.1(KOMP)Vlcg/\Fam72atm1.1(KOMP)Vlcg \Msh2tm1Mak/\Msh2tm1Mak
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
abnormal somatic hypermutation frequency
|
J:326431
|
\Faslpr-cg/\Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
|
abnormal T cell differentiation
|
J:24805
|
\Faslpr/\Faslpr
(MRL/Mp-Faslpr)
|
abnormal B cell receptor editing
|
J:131138
|
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr/J)
|
decreased immature B cell number
|
J:122315
|
decreased transitional stage B cell number
|
J:122315
|
\Faslpr/\Faslpr
(B6.MRL-Faslpr/J)
|
increased immature B cell number
|
J:132217
|
increased transitional stage B cell number
|
J:132217
|
\Faslpr/\Faslpr
(B6.MRL-Faslpr)
|
increased double-negative T cell number
|
J:135036
|
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr)
|
increased double-negative T cell number
|
J:137066
|
\Faslpr/\Faslpr
(involves: 129P2/OlaHsd * MRL)
|
increased double-negative T cell number
|
J:26250
|
\Faslpr/\Faslpr \Fcer1gtm1Tks/\Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
increased double-negative T cell number
|
J:106188
|
\Faslpr/\Faslpr \Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
increased double-negative T cell number
|
J:186484
|
\Faslpr/\Faslpr \Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased double-negative T cell number
|
J:39600
|
\Faslpr/\Faslpr \Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg)
|
abnormal B cell receptor editing
|
J:131138
|
\Faslpr/\Faslpr \Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
|
arrested B cell differentiation
|
J:119584
|
\Faslpr/\Faslpr \Itfg2Gt(OST215121)Lex/\Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
increased double-negative T cell number
|
J:205951
|
\Faslpr/\Faslpr \Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
increased double-negative T cell number
|
J:122222
|
\Faslpr/\Faslpr \Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
|
decreased double-negative T cell number
|
J:113557
|
\Faslpr/\Faslpr \Tlr9tm1Aki/\Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:135036
|
\Faslpr/\Faslpr \Tlr9tm1Aki/\Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:113557
|
\Faslpr/\Faslpr \Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased double-negative T cell number
|
J:127197,
J:126929
|
\Faslpr/\Fastm1Cgn \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
\Fastm1Ach/\Fastm1Ach \Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N)
|
increased double-positive T cell number
|
J:123556
|
\Fastm1Ach/\Fastm1Ach \Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:123556
|
\Fastm1Cgn/\Fastm1Cgn \Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
increased double-negative T cell number
|
J:114948
|
\Fastm1Osa/\Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell clonal deletion
|
J:32125
|
\Faslgld/\Faslgld
(C3H/HeJ-Faslgld/J)
|
abnormal T cell differentiation
|
J:12002,
J:8267
|
\Fasltm1.1Lest/\Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:87990
|
\Fbxo4tm1.1Jadi/\Fbxo4+
(Not Specified)
|
myeloid hyperplasia
|
J:178645
|
\Fbxo4tm1.1Jadi/\Fbxo4tm1.1Jadi
(Not Specified)
|
myeloid hyperplasia
|
J:178645
|
\Fbxo7tm1a(EUCOMM)Hmgu/\Fbxo7tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased pro-B cell number
|
J:183053
|
\Fbxo7tm1a(EUCOMM)Wtsi/\Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal T cell differentiation
|
J:272313
|
increased double-negative T cell number
|
J:272313
|
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai \Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137138
|
decreased double-negative T cell number
|
J:137138
|
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai \Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:200006
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei \Rbpjtm1Hon/\Rbpjtm1Hon \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:128523
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:128523
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei \Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:128523
|
increased double-positive T cell number
|
J:128523
|
\Fcamrtm1Shib/\Fcamrtm1Shib
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal memory B cell differentiation
|
J:150824
|
abnormal somatic hypermutation frequency
|
J:150824
|
\Fcgr1tm1Jgjw/\Fcgr1tm1Jgjw
(involves: 129 * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:112436
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk \Il17atm1Yiw/\Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk \Traf3ip2tm1Sbn/\Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk \Traf3ip2tm1Sbn/\Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
\Festm2Pag/\Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myelopoiesis
|
J:98590
|
increased pro-B cell number
|
J:98590
|
\Fgfr2tm3Dsn/\Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus development
|
J:67731
|
\Flcntm1Baba/\Flcntm1.1Lss \Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:189078
|
\Fli1tm1.1Dkw/\Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
abnormal B cell differentiation
|
J:137876
|
abnormal class switch recombination
|
J:137876
|
increased transitional stage B cell number
|
J:137876
|
\Fli1tm1Morl/\Fli1tm1Morl \Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal thrombopoiesis
|
J:167426
|
\Flt3tm1.1Dosm/\Flt3+
(B6.129(C)-Flt3tm1.1Dosm)
|
arrested B cell differentiation
|
J:205200
|
\Flt3tm1Dgg/\Flt3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
\Flt3tm1Dgg/\Flt3tm1Dgg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
\Flt3tm1Dosm/\Flt3+ \Tg(Mx1-cre)1Cgn/0
(B6.Cg-Flt3tm1Dosm Tg(Mx1-cre)1Cgn)
|
arrested B cell differentiation
|
J:133528
|
increased pro-B cell number
|
J:133528
|
\Flt3tm1Irl/\Flt3tm1Irl
(either: 129S/SvEv-Flt3tm1Irl or (involves: 129S/SvEv * C57BL/6J))
|
abnormal B cell differentiation
|
J:27238,
J:99149
|
decreased pro-B cell number
|
J:27238
|
\Flt3tm1Irl/\Flt3tm1Irl \KitW/\KitW-v
(involves: 129S/SvEv * C57BL/6)
|
abnormal myelopoiesis
|
J:27238
|
decreased double-negative T cell number
|
J:27238
|
decreased double-positive T cell number
|
J:27238
|
decreased pro-B cell number
|
J:27238
|
\Flt3tm2.1Dosm/\Flt3+
(B6.129(C)-Flt3tm2.1Dosm)
|
abnormal myelopoiesis
|
J:205200
|
increased pre-pro B cell number
|
J:205200
|
increased pro-B cell number
|
J:205200
|
myeloid hyperplasia
|
J:205200
|
\Flt3ltm1Imx/\Flt3ltm1Imx
(C57BL/6-Flt3ltm1Imx)
|
abnormal immature B cell morphology
|
J:62536
|
decreased double-negative T cell number
|
J:79569
|
decreased pro-B cell number
|
J:79569,
J:62536
|
impaired myelopoiesis
|
J:62536
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
arrested B cell differentiation
|
J:189078
|
decreased transitional stage B cell number
|
J:189078
|
increased pro-B cell number
|
J:189078
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg \Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
increased immature B cell number
|
J:189078
|
\Fnip1LPAB.1/\Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
arrested B cell differentiation
|
J:187318
|
\Fnip1M3Btlr/\Fnip1M3Btlr
(C57BL/6J-Fnip1M3Btlr)
|
abnormal B cell differentiation
|
J:272802
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
arrested B cell differentiation
|
J:189078
|
decreased transitional stage B cell number
|
J:189078
|
increased pro-B cell number
|
J:189078
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba \Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
increased immature B cell number
|
J:189078
|
\Fostm1Pa/\Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:3233
|
\Fostm1Wag/\Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-positive T cell number
|
J:3493
|
\Foxn1nu-StL/\Foxn1tm1Tbo
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymus development
|
J:63313
|
\Foxn1nu-Y/\Foxn1nu-Y
(101/HY-Foxn1nu-Y)
|
abnormal thymus development
|
J:4060
|
\Foxn1nu/\Foxn1nu
(involves: NMRI)
|
abnormal thymus development
|
J:6363
|
\Foxn1nu/\Foxn1nu
(involves: C57BL/10Sn * C57BR/cd)
|
abnormal thymus development
|
J:7898
|
\Foxn1tm1.1Cbln/\Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6)
|
increased DN1 thymic pro-T cell number
|
J:177992
|
increased double-positive T cell number
|
J:177992
|
\Foxn1tm1.1Dmsu/\Foxn1tm1.1Dmsu \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:159773
|
\Foxn1tm1Nrm/\Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:86255
|
abnormal thymus development
|
J:86255
|
decreased double-negative T cell number
|
J:86255
|
decreased double-positive T cell number
|
J:86255
|
\Foxn1tm1Tbo/\Foxn1tm1Tbo
(involves: 129S1/Sv)
|
abnormal thymus development
|
J:33796
|
\Foxn1tm3(cre)Nrm/\Foxn1+ \Gt(ROSA)26Sortm1(Tbx1)Rche/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NHsd)
|
abnormal thymus development
|
J:214094
|
\Foxo1tm1.1Stlp/\Foxo1tm1.1Stlp \Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
decreased double-positive T cell number
|
J:154205
|
\Foxp1tm1Rao/\Foxp1tm1Rao
(B6.129-Foxp1tm1Rao)
|
abnormal B cell differentiation
|
J:112644
|
arrested B cell differentiation
|
J:112644
|
\Foxp3tm1.1Ayr/\Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:125405
|
decreased double-positive T cell number
|
J:125405
|
\Foxp3tm1Ayr/\Foxp3tm1Ayr \Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125405
|
decreased double-positive T cell number
|
J:125405
|
\Foxp3tm1Kuch/? \Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:123352
|
\Foxp3tm2Ayr/? \Zap70rps/\Zap70rps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:211510
|
abnormal T cell differentiation
|
J:211510
|
\Foxp3tm5.2Ayr/\Foxp3tm5.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:156942
|
\Fts/\Fts+
(B6.Cg-Fts)
|
abnormal CD4-positive T cell differentiation
|
J:108193
|
\Fyntm1Rmp/\Fyntm1Rmp \Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas)
|
arrested T cell differentiation
|
J:37062,
J:37940
|
decreased double-positive T cell number
|
J:37940
|
\Fyntm1Sor/\Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal T cell clonal deletion
|
J:2242
|
\Fyntm1Sor/\Fyntm1Sor \Yes1tm1Sor/\Yes1tm1Sor
(involves: 129S7/SvEvBrd)
|
myeloid hyperplasia
|
J:20346
|
\Fyntm1Yik/\Fyntm1Yik \Ptk2tm1Lfr/\Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:110771
|
decreased double-positive T cell number
|
J:110771
|
\Fzd9tm1Uta/\Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased pro-B cell number
|
J:98133
|
\Gab2tm1Thir/\Gab2tm1Thir
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal mast cell differentiation
|
J:75092
|
\Gabrb3tm2.1Geh/\Gabrb3tm2.1Geh \Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:333883
|
abnormal T-helper 17 cell differentiation
|
J:333883
|
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
\Gadd45btm1Flv/\Gadd45btm1Flv
(involves: 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Gadd45btm1Flv/\Gadd45btm1Flv \Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Gata1Plt13/\Gata1+
(BALB/c-Gata1Plt13)
|
abnormal myelopoiesis
|
J:113720
|
abnormal thrombopoiesis
|
J:113720
|
\Gata1tm1Mym/Y \Tg(Gata1*V205G)1Mym/0
(involves: C57BL/6 * DBA/2)
|
abnormal thrombopoiesis
|
J:89054
|
\Gata3tm1Iho/\Gata3tm1Iho \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:86996
|
\Gata3tm1Iho/\Gata3tm1Iho \Tg(DO11.10)10Dlo/0 \Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:86996
|
decreased double-positive T cell number
|
J:86996
|
\Gata3tm1Iho/\Gata3tm1Iho \Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
arrested T cell differentiation
|
J:86996
|
decreased double-positive T cell number
|
J:86996
|
\Gata3tm1Jfz/\Gata3tm1Jfz \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Cd4-cre)1Cwi/0 \Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
\Gata3tm1Jfz/\Gata3tm1Jfz \Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
\Gata3tm2Jeng/\Gata3tm2Jeng
(Not Specified)
|
abnormal double-positive T cell morphology
|
J:155686
|
abnormal T cell differentiation
|
J:155686
|
decreased double-negative T cell number
|
J:155686
|
\Gba1tm1.1Pmis/\Gba1tm1.1Pmis \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
decreased double-positive T cell number
|
J:167081
|
\Gba1tm1.1Pmis/\Gba1tm1.2Pmis \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
decreased double-positive T cell number
|
J:167081
|
\Gbx2tm1.1Mrt/\Gbx2tm1.1Mrt \Fgf8tm1.4Mrt/\Fgf8+
(B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt)
|
abnormal thymus development
|
J:100584
|
\Gcnt1tm1Jxm/\Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:86387
|
\Gfi1Gen/\Gfi1+
(C57BL/6J-Gfi1Gen)
|
abnormal myelopoiesis
|
J:182679
|
abnormal NK cell differentiation
|
J:182679
|
\Gfi1tm1.1Wep/\Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep)
|
arrested T cell differentiation
|
J:117105
|
\Gfi1tm1Tmo/\Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal granulocyte differentiation
|
J:75143
|
abnormal monocyte differentiation
|
J:75143
|
abnormal myelopoiesis
|
J:75143
|
abnormal T cell differentiation
|
J:75143
|
\Gfi1tm2Tmo/\Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:93337
|
\Gfi1tm4Tmo/\Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:116870
|
abnormal T cell differentiation
|
J:116870
|
decreased double-negative T cell number
|
J:116870
|
\Gfi1tm5.1(GFI1*)Tmo/\Gfi1+ \Krastm4Tyj/\Kras+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
\Gfi1tm5.1(GFI1*)Tmo/\Gfi1tm5.1(GFI1*)Tmo \Krastm4Tyj/\Kras+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
\Gfi1tm6.1(GFI1)Tmo/\Gfi1tm6.1(GFI1)Tmo \Krastm4Tyj/\Kras+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
\Ggta1tm1Jbl/\Ggta1+ \Ightm1Jiac/\Ightm1Jiac \Igktm1Jiac/\Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal B cell selection
|
J:133032
|
\Gimap1tm1.1Gwb/\Gimap1tm1.1Gwb \Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased transitional stage T2 B cell number
|
J:160782
|
\Gimap5tm1Wlr/\Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:143620
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:160613
|
\Git2tm1Hsb/\Git2tm1Hsb
(involves: C57BL/6 * CBA)
|
abnormal neutrophil differentiation
|
J:112663
|
\Glb1tm1Jmat/\Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
|
abnormal lymphopoiesis
|
J:43534
|
\Gm36723em1Flv/\Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
abnormal lymphopoiesis
|
J:258967
|
\Gmdstm1a(KOMP)Wtsi/\Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi)
|
decreased transitional stage T2 B cell number
|
J:211773
|
\Gmnntm1.1Kio/\Gmnntm1.2Kio \Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased DN1 thymic pro-T cell number
|
J:159657
|
decreased DN4 thymocyte number
|
J:159657
|
decreased double-positive T cell number
|
J:159657
|
\Gnrh1hpg/\Gnrh1hpg
(HPG/BmJ)
|
increased immature B cell number
|
J:19436
|
\Gon4ljusty/\Gon4ljusty
(C3HeB/FeJ-Gon4ljusty)
|
arrested B cell differentiation
|
J:163412
|
decreased immature B cell number
|
J:163412
|
decreased pro-B cell number
|
J:163412
|
\Gpr15tm1.1Litt/\Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
decreased double-negative T cell number
|
J:199126
|
\Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
abnormal T-helper 1 cell differentiation
|
J:222307
|
\Grap2tm1Amch/\Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:76696
|
increased double-negative T cell number
|
J:76696
|
\Grap2tm1Amch/\Grap2tm1Amch \Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:150304
|
decreased double-positive T cell number
|
J:150304
|
\Grap2tm1Eac/\Grap2tm1Eac
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:92023
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua \Tg(DO11.10)10Dlo/0 \Tg(Lck-cre)1Jtak/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua \Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
decreased double-positive T cell number
|
J:161294
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua \Tg(Lck-cre)1Jtak/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:161294
|
increased double-positive T cell number
|
J:161294
|
\Grb2tm1Lnit/\Grb2tm1Lnit \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * BALB/cJ)
|
abnormal B cell differentiation
|
J:171222
|
decreased transitional stage T1 B cell number
|
J:171222
|
decreased transitional stage T2 B cell number
|
J:171222
|
\Gsta4tm1Pzim/\Gsta4tm1Pzim
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal bone marrow development
|
J:87983
|
\Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:208980
|
abnormal class switch recombination
|
J:208980
|
abnormal transitional stage T3 B cell morphology
|
J:208980
|
decreased immature B cell number
|
J:208980
|
decreased transitional stage T1 B cell number
|
J:208980
|
\Gt(ROSA)26Sortm1(CAG-NPM1*)Geno/\Gt(ROSA)26Sor+ \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:196690
|
\Gt(ROSA)26Sortm1(CAG-SETBP1*G870S,-EGFP)Ase/\Gt(ROSA)26Sor+ \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
myeloid hyperplasia
|
J:363041
|
\Gt(ROSA)26Sortm1(CAG-SETBP1*G870S,-EGFP)Ase/\Gt(ROSA)26Sortm1(CAG-SETBP1*G870S,-EGFP)Ase \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal myelopoiesis
|
J:363041
|
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sortm1(Tcfe2a/Tal1)Xhsu
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:144569
|
abnormal myelopoiesis
|
J:144569
|
\Gt(ROSA)26Sortm1(CTNNB1)Nerl/\Gt(ROSA)26Sortm1(CTNNB1)Nerl \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:112660
|
decreased double-negative T cell number
|
J:112660
|
impaired myelopoiesis
|
J:112660
|
\Gt(ROSA)26Sortm1(DTA)Lky/\Gt(ROSA)26Sortm1(DTA)Lky \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:133382
|
abnormal T cell receptor V(D)J recombination
|
J:133382
|
decreased double-positive T cell number
|
J:133382
|
\Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/\Gt(ROSA)26Sor+ \Cd79atm3(cre/ERT2)Reth/\Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal plasma cell differentiation
|
J:208904
|
\Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/\Gt(ROSA)26Sor+ \Cd79atm3(cre/ERT2)Reth/\Cd79a+ \Tg(BCL2)22Wehi/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)
|
abnormal plasma cell differentiation
|
J:208904
|
\Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/\Gt(ROSA)26Sor+ \Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:129039
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+ \Ighg1tm1(cre)Cgn/\Ighg1+ \Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal plasma cell differentiation
|
J:167612
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+ \Plcg1tm1Gcrp/\Plcg1tm1Rwen \Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:157757
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:157757
|
increased double-positive T cell number
|
J:157757
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+ \Rev3ltm1.1Diaz/\Rev3ltm1.1Diaz
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:188723
|
abnormal somatic hypermutation frequency
|
J:188723
|
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+ \Ighg1tm1(cre)Cgn/\Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+ \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:160931
|
decreased double-positive T cell number
|
J:160931
|
\Gt(ROSA)26Sortm1(rtTA)Awu/\Gt(ROSA)26Sortm1(rtTA)Awu \Xisttm1Awu/Y
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:112954
|
abnormal myelopoiesis
|
J:112954
|
abnormal T cell differentiation
|
J:112954
|
decreased double-positive T cell number
|
J:112954
|
decreased immature B cell number
|
J:112954
|
decreased pro-B cell number
|
J:112954
|
\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:205858
|
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+ \Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
arrested B cell differentiation
|
J:202090
|
decreased double-positive T cell number
|
J:202090
|
decreased pro-B cell number
|
J:202090
|
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+ \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
arrested B cell differentiation
|
J:202090
|
decreased double-positive T cell number
|
J:202090
|
decreased pro-B cell number
|
J:202090
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
decreased transitional stage T2 B cell number
|
J:179036
|
increased transitional stage T1 B cell number
|
J:179036
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
decreased transitional stage T2 B cell number
|
J:179036
|
increased transitional stage T1 B cell number
|
J:179036
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+ \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6J)
|
arrested B cell differentiation
|
J:179036
|
\Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6)
|
abnormal granulocyte differentiation
|
J:192055
|
abnormal monocyte differentiation
|
J:192055
|
\Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:137122
|
\Gt(ROSA)26Sortm2.1(Mirn150)Rsky/\Gt(ROSA)26Sortm2.1(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
arrested B cell differentiation
|
J:127234
|
arrested T cell differentiation
|
J:127234
|
\Gt(ROSA)26Sortm3(CAG-EYFP)Hze/\Gt(ROSA)26Sor+ \Stat5atm2Mam \Stat5btm1Mam/\Del(11Stat5a-Stat5b)1Mam \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky \Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal T cell differentiation
|
J:133215
|
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+ \Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo \Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:188749
|
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+ \Ighg1tm1(cre)Cgn/\Ighg1+ \Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:167612
|
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky \Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:191824
|
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal B cell differentiation
|
J:181546
|
increased pro-B cell number
|
J:181546
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:181546
|
increased pro-B cell number
|
J:181546
|
\H2-Ab1b-tm1.1Jssh/\H2-Ab1b-tm1.1Jssh
(C57BL/6-H2-Ab1b-tm1.1Jssh)
|
abnormal T cell differentiation
|
J:201198
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru \Tg(Ab1TL)1Gru/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:91341
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru \Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
\H2-Ab1bm12/\H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
|
increased double-negative T cell number
|
J:4554
|
\H2-DMatm1Lkrl/\H2-DMatm1Lkrl
(involves: 129P2/OlaHsd)
|
abnormal positive T cell selection
|
J:31786
|
\H2-DMatm1Luc/\H2-DMatm1Luc
(involves: 129S4/SvJae)
|
abnormal positive T cell selection
|
J:125548
|
\H2-Kbm1/\H2-Kbm1 \Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867
|
\H2-Kbm5/\H2-Kbm5 \Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:133645
|
\H2b/\H2b \Itktm1Ljb/\Itktm1Ljb \Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
\H2b/\H2b \Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:131357
|
\H2b/\H2b \Ptcratm1Vbo/\Ptcratm1Vbo \Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
\H2b/\H2b \Ptcratm1Vbo/\Ptcratm1Vbo \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
\H2b/\H2b \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
\H2b/\H2b \Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
abnormal T cell differentiation
|
J:81564
|
\H2b/\H2b \Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
abnormal T cell differentiation
|
J:81564
|
\H2b/\H2b \Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
abnormal double-positive T cell morphology
|
J:81564
|
abnormal negative T cell selection
|
J:81564
|
abnormal T cell differentiation
|
J:81564
|
decreased double-positive T cell number
|
J:131357
|
\H2b/\H2d
((C57BL/6 x DBA/2)F1)
|
abnormal T cell differentiation
|
J:106141
|
\H2b/\H2d \Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:133645
|
\H2b/\H2d \Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
\H2b/\H2k \Itktm1Ljb/\Itktm1Ljb \Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
\H2b/\H2k \Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
|
abnormal negative T cell selection
|
J:133645
|
\H2b/\H2s \Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)
|
abnormal negative T cell selection
|
J:133645
|
\H2d/\H2d
(DBA/2)
|
abnormal T cell differentiation
|
J:106141
|
\H2d/\H2d \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
\H2d/\H2d \Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky \Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
\H2d/\H2d \Tg(TcraP1.5,TcrbP1.5)29Amsv/0 \Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2)
|
abnormal T cell clonal deletion
|
J:180807
|
\H2dlAb1-Ea/\H2dlAb1-Ea \Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
\H2u/\H2u \Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J)
|
decreased double-positive T cell number
|
J:92992
|
increased double-negative T cell number
|
J:92992
|
\H2u/\H2u \Tg(TCRA)B1Jg/? \Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
decreased double-positive T cell number
|
J:92991
|
\H2u/\H2u \Tg(TCRA)B1Jg/0 \Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)
|
abnormal double-negative T cell morphology
|
J:92992
|
abnormal double-positive T cell morphology
|
J:92992
|
decreased double-positive T cell number
|
J:92992
|
increased double-negative T cell number
|
J:92992
|
\H2u/\H2u \Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J)
|
abnormal double-negative T cell morphology
|
J:92992
|
abnormal double-positive T cell morphology
|
J:92992
|
\H2axtm1Fwa/\H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:84879
|
\H2axtm1Nus/\H2axtm1Nus
(Not Specified)
|
abnormal class switch recombination
|
J:194603,
J:120658
|
\Hand2tm1Cse/\Hand2+ \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal thymus development
|
J:155265
|
\Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
|
abnormal T cell differentiation
|
J:186484
|
increased double-negative T cell number
|
J:186484
|
\Hax1tm1.1Gach/\Hax1tm1.1Gach
(involves: BALB/c)
|
decreased double-positive T cell number
|
J:174159
|
decreased immature B cell number
|
J:174159
|
decreased pro-B cell number
|
J:174159
|
decreased transitional stage T1 B cell number
|
J:174159
|
decreased transitional stage T2 B cell number
|
J:174159
|
\Hax1tm1Jni/\Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:132627
|
decreased immature B cell number
|
J:132627
|
\Hcls1tm1Wtn/\Hcls1tm1Wtn \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:28146
|
decreased double-positive T cell number
|
J:28146
|
\Hdac1tm1.1Pmt/\Hdac1tm1.1Pmt \Hdac2tm1.1Pmt/\Hdac2tm1.1Pmt \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)
|
arrested B cell differentiation
|
J:157903
|
decreased pro-B cell number
|
J:157903
|
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc \Hdac2tm1.1Shmc/\Hdac2+ \Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
decreased double-positive T cell number
|
J:194769
|
increased double-negative T cell number
|
J:194769
|
increased double-positive T cell number
|
J:194769
|
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc \Hdac2tm1.1Shmc/\Hdac2tm1.1Shmc \Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
decreased double-positive T cell number
|
J:194769
|
increased double-positive T cell number
|
J:194769
|
\Hellstm1Kmu/\Hellstm1Kmu
(involves: 129S1/Sv)
|
increased double-negative T cell number
|
J:61948
|
\Hes1tm1.1Frad/\Hes1tm1.1Frad \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167000
|
decreased DN1 thymic pro-T cell number
|
J:167000
|
decreased DN2 thymocyte number
|
J:167000
|
decreased DN3 thymocyte number
|
J:167000
|
decreased DN4 thymocyte number
|
J:167000
|
decreased double-positive T cell number
|
J:167000
|
increased DN1 thymic pro-T cell number
|
J:167000
|
increased immature B cell number
|
J:167000
|
\Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
\Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
\Hhextm1Ngu/\Hhextm1Ngu
(involves: 129/Sv * C57BL/6)
|
abnormal monocyte differentiation
|
J:65105
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo \Tg(Tal1-cre/ERT)42-056Jrg/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:192126
|
abnormal T cell differentiation
|
J:192126
|
\Hip1tm4Tsr/\Hip1+ \Runx1tm3Dow/\Runx1+ \Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:151974
|
\Hip1tm4Tsr/\Hip1+ \Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:151974
|
\Hivep2tm1Sis/\Hivep2tm1Sis \Tg(DO11.10)10Dlo/?
(involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal positive T cell selection
|
J:96024
|
\Hivep3tm1Lcw/\Hivep3tm1Lcw
(chimera involves: 129S/SvEv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:79652
|
\Hmga1tm1Afus/\Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6)
|
myeloid hyperplasia
|
J:106702
|
\Hmgb3tm1Dmb/Y
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal leukopoiesis
|
J:96514
|
\Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo \Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
abnormal T cell differentiation
|
J:188749
|
decreased double-positive T cell number
|
J:188749
|
increased double-negative T cell number
|
J:188749
|
\Hnrnpllthdr/\Hnrnpllthdr
(C57BL/6JSfdAnu-Hnrnpllthdr/Anu)
|
abnormal T cell differentiation
|
J:142641
|
\Hoxc4tm2.1Mrc/\Hoxc4tm2.1Mrc
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:148278
|
abnormal somatic hypermutation frequency
|
J:148278
|
\Hprt1b-m3/Y \Impdh1tm1Bmi/\Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
\Hprt1tm1(CUX1)Anep/\Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))
|
myeloid hyperplasia
|
J:113393
|
\Hsd17b11Gt(OST237628)Lex/\Hsd17b11Gt(OST237628)Lex
(B6;129S5-Hsd17b11Gt(OST237628)Lex/Mmucd)
|
increased immature B cell number
|
J:171883
|
\Hspa13tm1.1Smoc/\Hspa13tm1.1Smoc \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6)
|
abnormal class switch recombination
|
J:303927
|
abnormal somatic hypermutation frequency
|
J:303927
|
\Htra2mnd2/\Htra2mnd2
(involves: C57BL/6J)
|
decreased double-positive T cell number
|
J:132627
|
decreased pro-B cell number
|
J:132627
|
\Icostm1.1Wks/\Icostm1.1Wks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell selection
|
J:155586
|
abnormal class switch recombination
|
J:155586
|
\Icostm1Mak/\Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:66702
|
\Icostm1Shr/\Icostm1Shr
(Not Specified)
|
abnormal T cell differentiation
|
J:87124
|
\Icosltm1Cdon/\Icosltm1Cdon
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:86697
|
\Icosltm1Mak/\Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:84668
|
abnormal T-helper 2 cell differentiation
|
J:84668
|
\Id1tm1Zhu/\Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6)
|
abnormal myelopoiesis
|
J:155384
|
myeloid hyperplasia
|
J:155384
|
\Id1tm1Zhu/\Id1tm1Zhu \Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
arrested B cell differentiation
|
J:44278
|
\Id2tm1Yyk/\Id2tm1Yyk \Rorctm2Litt/\Rorc+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal lymph organ development
|
J:87395
|
\Id3tm1Cmu/\Id3tm1Cmu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal double-positive T cell morphology
|
J:59969
|
abnormal T cell differentiation
|
J:59969
|
\Id3tm1Zhu/\Id3tm1Zhu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell differentiation
|
J:144696
|
\Id3tm2.1Zhu/\Id3tm2.1Zhu \Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:172701
|
\Idd6.2NOD/\Idd6.2NOD
(B6.NOD-(D6Mit259-D6Mit304))
|
abnormal T cell differentiation
|
J:120148
|
\Idd7NOD/ShiLt/\Idd7NOD/ShiLt
(involves: C57BL/6 * NOD/ShiLt)
|
abnormal T cell clonal deletion
|
J:131557
|
\Ifnar1tm1Agt/\Ifnar1tm1Agt \Slamf1tm1Oono/\Slamf1tm1Oono
(B6.129-Slamf1tm1Oono Ifnar1tm1Agt)
|
abnormal lymphopoiesis
|
J:117810
|
\Ifnb1tm1Acgp/\Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:86527
|
\Ifngtm1.1Hayg/\Ifngtm1.1Hayg
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:220784
|
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
abnormal lymphopoiesis
|
J:138728
|
\Ifngr2tm1Pbro/\Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
abnormal class switch recombination
|
J:48016
|
abnormal T-helper 1 cell differentiation
|
J:48016
|
\Igbp1tm1Imku/Y \Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR)
|
decreased double-negative T cell number
|
J:84395
|
\Igh-8tm1.1Aak/\Igh-8tm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
\Igh-8tm1Aak/\Igh-8tm1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:107063
|
\Igh-8tm2(Ighg1)Aak/\Igh-8tm2(Ighg1)Aak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:130574
|
\Igh-Jtm1(3H9-VDJ)Mwg/\Igh-Jtm1(3H9-VDJ)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\Igh-Jtm1(CB20)Riho/\Igh-J+
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
increased immature B cell number
|
J:179456
|
\Igh-Jtm1(CB20)Riho/\Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
increased immature B cell number
|
J:179456
|
\Igh-Jtm1.1Lave/\Igh-J+
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
decreased immature B cell number
|
J:155798
|
decreased transitional stage B cell number
|
J:155798
|
decreased transitional stage T1 B cell number
|
J:155798
|
decreased transitional stage T2 B cell number
|
J:155798
|
increased pro-B cell number
|
J:155798
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
arrested B cell differentiation
|
J:179317
|
decreased immature B cell number
|
J:155798
|
decreased transitional stage B cell number
|
J:155798
|
decreased transitional stage T1 B cell number
|
J:155798
|
decreased transitional stage T2 B cell number
|
J:155798
|
increased pro-B cell number
|
J:155798
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave \Igk-Jtm1.1Lave/\Igk-Jtm1.1Lave
(Not Specified)
|
abnormal B cell clonal deletion
|
J:179317
|
abnormal B cell differentiation
|
J:205708
|
arrested B cell differentiation
|
J:205708,
J:179317
|
decreased immature B cell number
|
J:205708
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave \Igk-Jtm1.1Lave/\Igk-Jtm1.1Lave \Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:179317
|
\Igh-Jtm1Cgn/\Ightm11.1Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113434
|
\Igh-Jtm1Cgn/\Igh-J+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:64285
|
\Igh-Jtm1Cgn/\Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
\Igh-Jtm1Cgn/\Igh-Jtm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:64285
|
\Igh-Jtm1Dhu/\Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Igh-Jtm1Dhu/\Ightm1Tim
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:88410
|
\Igh-Jtm1Dhu/\Igh-Jtm1(VDJ-17.2.25)Wabl \Igktm1Dhu/\Igktm1Dhu
(Not Specified)
|
abnormal B cell differentiation
|
J:33628
|
abnormal immature B cell morphology
|
J:89757
|
\Igh-Jtm1Dim/\Igh-J+ \Igk-Jtm1Dim/\Igk-J+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:107241
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:137738,
J:23827
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGH@yH1)2BJkbv/0 \Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
decreased immature B cell number
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv \Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
decreased immature B cell number
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv \Tg(IGK@yK2)J23.1Jkbv/\Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
decreased immature B cell number
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGH@yH2)J9.2Jkbv/0 \Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:70620
|
abnormal immunoglobulin light chain V-J recombination
|
J:70620
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGH@yH2)J9.2Jkbv/0 \Tg(IGK@yK2)J23.1Jkbv/\Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Tg(IGH@yH1)2BJkbv/0 \Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
increased late pro-B cell number
|
J:23827
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv \Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
decreased immature B cell number
|
J:137738
|
increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Mcdl/\Igh-Jtm1Mcdl \Igk-Jtm1Mcdl/\Igk-Jtm1Mcdl \Rag1tm1Mom/\Rag1tm1Mom \Tg(DO11.10)10Dlo/?
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:100072
|
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell receptor editing
|
J:131138
|
\Igh-Jtm2.1(4E10)Lave/\Igh-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:205708
|
\Igh-Jtm2.1(4E10)Lave/\Igh-Jtm2.1(4E10)Lave \Igk-Jtm2.1(4E10)Lave/\Igk-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:205708
|
arrested B cell differentiation
|
J:205708
|
decreased immature B cell number
|
J:205708
|
\Igh-Jtm3(3H9-VDJ*)Mwg/\Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\IghdeltaD/\Igh+
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
\IghdeltaD/\IghdeltaD
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
arrested B cell differentiation
|
J:95981
|
\IghdeltaD/\Ightm11.1Cgn
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:113434
|
\Ightm1(PAX5)Mbu/\Igh+
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
decreased double-negative T cell number
|
J:118111
|
decreased double-positive T cell number
|
J:118111
|
increased pro-B cell number
|
J:118111
|
\Ightm1(PAX5)Mbu/\Igh+ \Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:118111
|
\Ightm1(PAX5)Mbu/\Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
decreased double-negative T cell number
|
J:118111
|
decreased double-positive T cell number
|
J:118111
|
increased pro-B cell number
|
J:118111
|
\Ightm1(VH558)Mss/\Igh+
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
\Ightm1(VH558)Mss/\Ightm1(VH558)Mss
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
\Ightm1.1(b12)Nemz/\Ightm1.1(b12)Nemz
(involves: C57BL/6N * FVB/N)
|
decreased immature B cell number
|
J:205766
|
\Ightm1.1(b12)Nemz/\Ightm1.1(b12)Nemz \Igktm1.1(b12)Nemz/\Igktm1.1(b12)Nemz
(involves: C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased immature B cell number
|
J:205766
|
\Ightm1.1(Rr361-HBB)Aak/\Ightm1.1(Rr361-HBB)Aak
(129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak)
|
abnormal class switch recombination
|
J:333279
|
\Ightm1.1Hmj/\Ightm1.1Hmj
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:140486
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:140486
|
\Ightm1.1Hws/\Ightm1.1Hws
(BALB/cJ-Ightm1.1Hws)
|
decreased immature B cell number
|
J:119391
|
increased late pro-B cell number
|
J:119391
|
\Ightm1.1Hws/\Ightm1.1Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
decreased late pro-B cell number
|
J:142069
|
increased early pro-B cell number
|
J:142069
|
\Ightm1.1Lnit/\Igh+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:119484
|
\Ightm1.1Rsky/\Ightm1.1Rsky
(BALB/c-Ightm1.1Rsky)
|
abnormal class switch recombination
|
J:125719
|
\Ightm1.1Twin/\Igh+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased pro-B cell number
|
J:174233
|
\Ightm1.1Twin/\Ightm1.1Twin
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:174233
|
decreased immature B cell number
|
J:174233
|
decreased transitional stage T2 B cell number
|
J:174233
|
\Ightm1.1Vmd/\Igh+
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
\Ightm1.1Vmd/\Ightm1.1Vmd
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
\Ightm1.2Rsky/\Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
decreased transitional stage B cell number
|
J:125719
|
increased pro-B cell number
|
J:125719
|
\Ightm1.2Rsky/\Ightm1.2Rsky \Tg(CD19-cre/ERT2)1Cgn/?
(involves: BALB/c)
|
abnormal class switch recombination
|
J:125719
|
\Ightm1Aak/\Ightm1Aak
(Not Specified)
|
abnormal B cell differentiation
|
J:158402
|
increased pro-B cell number
|
J:158402
|
\Ightm1Cgn/\Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm1Cgn/\Ightm2Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm1Cog/\Ightm1Cog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:80654
|
arrested B cell differentiation
|
J:80654
|
\Ightm1Kplm/\Igh+
(Not Specified)
|
abnormal B cell differentiation
|
J:115292
|
\Ightm1Kplm/\Ightm3Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:115292
|
\Ightm1Kplm/\Ightm4Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
\Ightm1Leck/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immature B cell morphology
|
J:144033
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
\Ightm1Mnz/\Ightm1Mnz \Dis3tm1.1Uba/\Dis3tm1.1Uba \Aicdatm1(cre)Uba/\Aicda+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:302856
|
\Ightm1Rbr/\Igh+ \Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6)
|
increased immature B cell number
|
J:132538
|
\Ightm1Rbr/\Igh+ \Tg(IgkHyHEL10)1Rbr/0 \Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6 * C57BL/6JSfd)
|
increased immature B cell number
|
J:132538
|
\Ightm2.1Fwa/\Ightm2.1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:161437
|
abnormal somatic hypermutation frequency
|
J:161437
|
\Ightm2.1Hws/\Ightm2.1Hws
(involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)
|
decreased transitional stage B cell number
|
J:124421
|
increased early pro-B cell number
|
J:124421
|
\Ightm2.1Hws/\Ightm2.1Hws
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:142069
|
decreased immature B cell number
|
J:142069
|
decreased late pro-B cell number
|
J:142069
|
decreased transitional stage B cell number
|
J:142069
|
increased early pro-B cell number
|
J:142069
|
\Ightm2Cgn/\Igh+
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm2Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
\Ightm2Cgn/\Igh+ \Igktm1Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
\Ightm2Cgn/\Igh+ \Igktm2Rsky/\Igk+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:150435
|
\Ightm2Cgn/\Igh+ \Igktm2Rsky/\Igk+ \Prkdcscid/\Prkdcscid
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal class switch recombination
|
J:150435
|
\Ightm2Cgn/\Igh+ \Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:44361
|
\Ightm2Cgn/\Ightm2Cgn \Igktm1Rsky/\Igktm1Rsky \Lig4tm1Fwa/\Lig4tm1Fwa \Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Ightm2Cgn/\Ightm2Cgn \Igktm1Rsky/\Igktm1Rsky \Trp53tm1Tyj/\Trp53tm1Tyj \Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Ightm2Cgn/\Ightm3Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm2Cgn/\Ightm4.1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm2Emo/\Ightm2Emo
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:108098
|
\Ightm2Rsky/\Igh+ \Igktm1Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
\Ightm2Rsky/\Igh+ \Igktm2Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
\Ightm3.1Tim/\Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Ightm3Cgn/\Igh+
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:79556,
J:115292
|
\Ightm3Cgn/\Ightm3Cgn
(involves: C57BL/6)
|
decreased immature B cell number
|
J:76117
|
\Ightm3Hws/\Ightm3Hws
(BALB/c-Ightm3Hws)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:142068
|
\Ightm3Hws/\Ightm3Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
decreased late pro-B cell number
|
J:142069
|
decreased transitional stage B cell number
|
J:142069
|
\Ightm3Tim/\Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Ightm4.1Cog/\Ightm4.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:184094
|
\Ightm4.1Fwa/\Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm4.1Fwa/\Ightm4.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm4Cgn/\Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
\Ightm5.1Cgn/\Ightm5.1Cgn
(BALB/c-Ightm5.1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
decreased immature B cell number
|
J:88472
|
increased pro-B cell number
|
J:88472
|
\Ightm5.1Fwa/\Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
\Ightm5.1Fwa/\Ightm5.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
\Ightm5Cgn/\Ightm5Cgn
(involves: BALB/c)
|
arrested B cell differentiation
|
J:88472
|
\Ightm5Cgn/\Ightm5Cgn \Tg(CD19-cre/ERT2)1Cgn/0
(C.Cg-Ightm5Cgn Tg(CD19-cre/ERT2)1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
increased pro-B cell number
|
J:88472
|
\Ightm7(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm8(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm9(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm11.1Cgn/\Ightm11.1Cgn
(Not Specified)
|
abnormal B cell differentiation
|
J:113434
|
decreased immature B cell number
|
J:113434
|
increased pro-B cell number
|
J:113434
|
\Ightm12Cgn/\Ightm12Cgn
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:66031
|
\Ighatm2Grh/\Ighatm2Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:72521
|
\Ighdtm1Lam/\Ighdtm1Lam
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukopoiesis
|
J:111020
|
\Ighg1em1Wliu/\Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
|
abnormal plasma cell differentiation
|
J:266937
|
\Ighg1tm1(cre)Cgn/\Ighg1+ \Irf4tm1Rdf/\Irf4tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal class switch recombination
|
J:112643
|
\Ighg1tm1(cre)Cgn/\Ighg1+ \Myd88em1.1Rsky/\Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
abnormal somatic hypermutation frequency
|
J:308792
|
\Ighg1tm1(cre)Cgn/\Ighg1+ \Tbl1xr1tm1.1Meln/\Tbl1xr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
\Ighg1tm1(cre)Cgn/\Ighg1+ \Tbl1xr1tm1c(EUCOMM)Hmgu/\Tbl1xr1tm1c(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
\Ighg1tm2Cgn/\Ighg1+
((C57BL/6 x 129P2/OlaHsd)F1)
|
abnormal class switch recombination
|
J:146428
|
\Ighg1tm3Cgn/\Ighg1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:166887
|
\Ighg2cem1Wliu/\Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu)
|
abnormal plasma cell differentiation
|
J:322180
|
\Ighg2cem2Wliu/\Ighg2cem2Wliu
(C57BL/6J-Ighg2cem2Wliu)
|
abnormal plasma cell differentiation
|
J:322180
|
\Ighmtm1.1(IGH-2)Cog/\Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:157575
|
abnormal plasma cell differentiation
|
J:157575
|
decreased transitional stage B cell number
|
J:157575
|
increased pro-B cell number
|
J:157575
|
\Ighmtm1.1Aak/\Ighmtm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
increased pro-B cell number
|
J:171251
|
\Ighmtm1Cgn/\Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Ighmtm1Cgn/\Ighm+
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:70398
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:64298,
J:70398
|
absent immature B cells
|
J:64298
|
arrested B cell differentiation
|
J:64298
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
arrested B cell differentiation
|
J:119584
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas)
|
arrested B cell differentiation
|
J:118453
|
\Ighmtm1Msn/\Ighmtm1Msn
(involves: 129S/SvEv)
|
abnormal immature B cell morphology
|
J:49405
|
\Ighmtm1Sls/\Ighmtm1Sls
(Not Specified)
|
abnormal class switch recombination
|
J:99465
|
\Ighmtm2.1Bgmn/\Ighmtm2.1Bgmn
(involves: 129/Sv * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118453
|
\Ighmtm3Bgmn/\Ighmtm3Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
\Ighmtm3Bgmn/\Ighmtm3Bgmn \Igkctm1Bgmn/\Igkctm1Bgmn \Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd * 129/Sv)
|
abnormal B cell differentiation
|
J:130864
|
\Ighmtm4Bgmn/\Ighmtm4Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
\Igktm1Dhu/\Igktm1Dhu \Iglc1tm1Ust/\Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:68144
|
\Igktm1Dhu/\Igktm1Dhu \Iglc1tm2Ust/\Iglc1tm2Ust
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal B cell differentiation
|
J:74717
|
decreased immature B cell number
|
J:74717
|
decreased transitional stage T1 B cell number
|
J:74717
|
decreased transitional stage T2 B cell number
|
J:74717
|
\Igktm1Rsky/\Igk+ \Igll1tm1Cgn/\Igll1tm1Cgn
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:35357
|
decreased immature B cell number
|
J:35357
|
\Igktm2Ybgn/\Igktm2Ybgn
(Not Specified)
|
increased immature B cell number
|
J:123344
|
\Igkctm1(IGKC)Mnz/\Igkc+ \Igk-Jtm1(CD4*)Mss/\Igk-J+
(involves: 129S4/SvJae)
|
abnormal immunoglobulin light chain V-J recombination
|
J:143876
|
\Igkctm1Bgmn/\Igkctm1Bgmn \Igltm1.1Bgmn/\Igltm1.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn \Igltm1Bgmn/\Igltm1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn \Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn \Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:130864
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:130864
|
\Igkctm1Bgmn/\Igkctm1Bgmn \Igltm2Bgmn/\Igltm2Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118712
|
\Igkctm1Cgn/\Igkctm1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:64287
|
increased immature B cell number
|
J:64287
|
\Igkctm1Jkbv/\Igkctm1Jkbv
(Not Specified)
|
abnormal B cell differentiation
|
J:137738
|
abnormal immunoglobulin light chain V-J recombination
|
J:137738
|
decreased immature B cell number
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv \Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
decreased immature B cell number
|
J:137738
|
\Igkctm2(IGKC)Cgn/\Igkctm2(IGKC)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113008
|
\Igkrstm1Nemz/\Igkrstm1Nemz
(B6.129-Igkrstm1Nemz)
|
abnormal immunoglobulin light chain V-J recombination
|
J:132125
|
decreased immature B cell number
|
J:132125
|
\Igkrstm1Nemz/\Igkrstm1Nemz \Tg(UBC-scFv)2Nemz/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal B cell clonal deletion
|
J:132125
|
decreased immature B cell number
|
J:132125
|
\Iglc1tm2Ust/\Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal immunoglobulin light chain V-J recombination
|
J:74717
|
\Igll1tm1Cgn/\Igll1tm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal lymphopoiesis
|
J:64284
|
increased pro-B cell number
|
J:64284
|
\Igll1tm1Cgn/\Igll1tm1Cgn \Tg(Igk-V4CH27)1-2Shc/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:35357
|
\Igll1tm1Shim/\Igll1tm1Shim \Vpreb1atm1Shim/\Vpreb1atm1Shim \Vpreb1btm1Shim/\Vpreb1btm1Shim
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76947
|
decreased immature B cell number
|
J:76947
|
increased late pro-B cell number
|
J:76947
|
\IkbkbM1Btlr/\Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
\IkbkbM1Btlr/\IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
\Ikbkgtm1.1Mpa/\Ikbkgtm1.1Mpa \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113365
|
\Ikzf1plstc/\Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal B cell differentiation
|
J:84569
|
abnormal lymphopoiesis
|
J:84569
|
abnormal T cell differentiation
|
J:84569
|
decreased double-negative T cell number
|
J:84569
|
decreased double-positive T cell number
|
J:84569
|
increased pro-B cell number
|
J:84569
|
myeloid hyperplasia
|
J:84569
|
\Ikzf1plstc/\Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal granulocyte differentiation
|
J:84569
|
abnormal lymphopoiesis
|
J:84569
|
abnormal macrophage differentiation
|
J:84569
|
abnormal myelopoiesis
|
J:84569
|
absent pro-B cells
|
J:84569
|
arrested B cell differentiation
|
J:84569
|
\Ikzf1tm1(Pax5)Mbu/\Ikzf1tm1(Pax5)Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:80815
|
\Ikzf1tm1(Pax5)Mbu/\Ikzf1tm1(Pax5)Mbu \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:80815
|
arrested T cell differentiation
|
J:80815
|
increased early pro-B cell number
|
J:80815
|
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:80815
|
decreased double-positive T cell number
|
J:118111
|
increased pro-B cell number
|
J:80815
|
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+ \Tcf3tm1Mbu/\Tcf3tm1Mbu \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:137719
|
\Ikzf1tm1.1Smale/\Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale)
|
decreased DN1 thymic pro-T cell number
|
J:208211
|
decreased immature B cell number
|
J:208211
|
\Ikzf1tm1Kast/\Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:82813
|
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:29355
|
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell differentiation
|
J:29355
|
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
arrested T cell differentiation
|
J:20671
|
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
arrested T cell differentiation
|
J:20671
|
\Ikzf1tm2.1Smale/\Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale)
|
abnormal lymphopoiesis
|
J:208211
|
abnormal T cell differentiation
|
J:208211
|
decreased DN2 thymocyte number
|
J:208211
|
decreased DN3 thymocyte number
|
J:208211
|
decreased double-negative T cell number
|
J:208211
|
decreased double-positive T cell number
|
J:208211
|
decreased immature B cell number
|
J:208211
|
decreased pre-pro B cell number
|
J:208211
|
\Ikzf1tm2Kge/\Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:208211,
J:37317
|
abnormal thymus development
|
J:37317
|
absent pro-B cells
|
J:37317
|
decreased double-positive T cell number
|
J:37317
|
\Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu \Cd79atm1(cre)Reth/\Cd79a+ \Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
decreased pro-B cell number
|
J:209928
|
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:50626
|
\Il1r1tm1Roml/\Il1r1tm1Roml \Nlrp1aNeut1/\Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
abnormal leukopoiesis
|
J:191055
|
\Il1rntm1Sush/\Il1rntm1Sush
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:97684
|
\Il2tm1Hor/\Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:15573
|
abnormal T-helper 1 cell differentiation
|
J:37220
|
decreased double-negative T cell number
|
J:15223
|
decreased double-positive T cell number
|
J:37220
|
increased double-negative T cell number
|
J:37220
|
increased pro-B cell number
|
J:16662
|
\Il2tm1Hor/\Il2tm1Hor \Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pro-B cell number
|
J:16662
|
\Il2rbM3Btlr/\Il2rbM3Btlr
(C57BL/6J-Il2rbM3Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272833
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
decreased double-positive T cell number
|
J:25940
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(D2.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
\Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
abnormal gamma-delta T cell differentiation
|
J:111821
|
\Il2rgtm1Cgn/\Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
\Il2rgtm1Cgn/\Il2rgtm1Cgn \Kittm1.1Bsm/\Kittm1.1Bsm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:90485
|
\Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myelopoiesis
|
J:31167
|
arrested B cell differentiation
|
J:31167
|
\Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-negative T cell number
|
J:24117
|
decreased double-positive T cell number
|
J:24117
|
decreased immature B cell number
|
J:24117
|
\Il2rgtm1Wjl/Y \Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immature B cell number
|
J:109833
|
\Il2rgtm1Wjl/\Il2rgtm1Wjl \Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immature B cell number
|
J:109833
|
\Il3tm1Glli/\Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal mast cell differentiation
|
J:80500
|
\Il3ram1/\Il3ram1
(A/J)
|
abnormal leukopoiesis
|
J:23971
|
\Il4tm1.1Wep/\Il4+ \Stat6tm1Gru/\Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm1.1Wep/\Il4tm1.1Wep
(C.129P2-Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm1.1Wep/\Il4tm1.1Wep \Stat6tm1Gru/\Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm2Nnt/\Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J)
|
abnormal dendritic cell differentiation
|
J:141937
|
\Il5ratm1Ktk/\Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:33140
|
abnormal lymphopoiesis
|
J:33140
|
abnormal T cell differentiation
|
J:33140
|
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:17360
|
\Il6tm1Kopf/\Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased pro-B cell number
|
J:117320
|
\Il6tm1Kopf/\Il6tm1Kopf \Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:117320
|
abnormal myelopoiesis
|
J:117320
|
decreased pro-B cell number
|
J:117320
|
\Il6sttm1Ard/\Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:110742
|
\Il6sttm1Kish/\Il6sttm1Kish
(involves: 129P2/OlaHsd * CD-1)
|
abnormal bone marrow development
|
J:88710
|
\Il6sttm1Thir/\Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal T cell clonal deletion
|
J:133059
|
decreased double-positive T cell number
|
J:133059
|
increased double-negative T cell number
|
J:133059
|
\Il6sttm1Thir/\Il6sttm1Thir \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal negative T cell selection
|
J:133059
|
\Il6sttm1Wme/\Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:67677
|
abnormal thrombopoiesis
|
J:67677
|
\Il7tm1.1Mysl/\Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
arrested B cell differentiation
|
J:200544
|
\Il7tm1Dnax/\Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:24165
|
\Il7tm2.1Iku/\Il7tm2.1Iku \Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal B cell differentiation
|
J:190615
|
decreased double-negative T cell number
|
J:190615
|
\Il7rtm1Abra/\Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal T cell differentiation
|
J:125360
|
increased double-positive T cell number
|
J:125360
|
\Il7rtm1Iku/\Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:34658
|
abnormal gamma-delta T cell differentiation
|
J:34658
|
decreased double-positive T cell number
|
J:34658
|
decreased immature B cell number
|
J:34658
|
increased double-negative T cell number
|
J:34658
|
\Il7rtm1Imx/\Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd)
|
arrested B cell differentiation
|
J:21135
|
arrested T cell differentiation
|
J:21135
|
\Il7rtm1Imx/\Il7rtm1Imx
(B6.129S7-Il7rtm1Imx)
|
abnormal T cell differentiation
|
J:125360
|
decreased double-positive T cell number
|
J:125360
|
\Il7rtm2Iku/\Il7rtm2Iku \Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:193283
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:193283
|
\Il10tm1Cgn/\Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelopoiesis
|
J:15222
|
\Il10tm1Cgn/\Il10tm1Cgn \Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:111712
|
\Il10tm1Cgn/\Il10tm1Cgn \Il12btm1Jm/\Il12btm1Jm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:111712
|
\Il10rbtm1Agt/\Il10rbtm1Agt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal granulocyte differentiation
|
J:45917
|
\Il11ra1tm1Gos/\Il11ra1tm1Gos
(involves: 129S2/SvPas * C57BL/6J * CD-1)
|
abnormal NK cell differentiation
|
J:93811
|
\Il13tm1.1Anjm/\Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
\Il13tm1.1Anjm/\Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm)
|
abnormal dendritic cell differentiation
|
J:141937
|
\Il13tm2Anjm/\Il13tm2Anjm
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
\Il13ra1tm1Zagh/\Il13ra1tm1Zagh
(involves: BALB/c * C57BL/6)
|
abnormal thymus development
|
J:183111
|
impaired myelopoiesis
|
J:183111
|
\Il15tm1Imx/\Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
\Il15ratm1Ama/\Il15ratm2.1Ama \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal NK cell differentiation
|
J:155298
|
\Il15ratm1Ama/\Il15ratm2.1Ama \Tg(Itgax-cre)1-1Reiz/0
(involves: 129X1/SvJ * C57BL/6J * CBA)
|
abnormal NK cell differentiation
|
J:155298
|
\Il17ratm1Koll/\Il17ratm1Koll
(involves: 129 * C57BL/6)
|
abnormal granulocyte differentiation
|
J:71097
|
\Il17ratm1Koll/\Il17ratm1Koll
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:158594
|
\Il18bptm1(KOMP)Vlcg/\Il18bptm1(KOMP)Vlcg
(C57BL/6-Il18bptm1(KOMP)Vlcg)
|
abnormal NK cell differentiation
|
J:255309
|
\Il21tm1Lex/\Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal T cell differentiation
|
J:123351
|
\Il21tm1Llit/\Il21tm1Llit
(involves: 129 * C57BL/6J)
|
abnormal class switch recombination
|
J:114783
|
\Il21rtm1Day/\Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955,
J:123352
|
\Il21rtm1Wjl/\Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
abnormal CD4-positive T cell differentiation
|
J:139075
|
\Il23rtm1Kuch/\Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
|
abnormal CD4-positive T cell differentiation
|
J:148248
|
\Il27tm1Cua/\Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
abnormal CD4-positive T cell differentiation
|
J:147706
|
\Immp2lTg(HLA-A/H2-D)2Enge/?
((C57BL/6 x CBA)F1)
|
abnormal negative T cell selection
|
J:31937
|
abnormal positive T cell selection
|
J:31937
|
\Impdh1tm1Bmi/\Impdh1tm1Bmi \Impdh2tm1Bmi/\Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
\Inpp5dm1Btlr/\Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
abnormal B cell differentiation
|
J:140987
|
\Inpp5dm5Btlr/\Inpp5dm5Btlr
(C57BL/6J-Inpp5dm5Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272856
|
abnormal T cell differentiation
|
J:272856
|
\Inpp5dtm1.1Wgk/\Inpp5dtm1.1Wgk
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal mononuclear cell differentiation
|
J:94861
|
\Inpp5dtm1Rav/\Inpp5dtm1Rav \Cd79atm1(cre)Reth/\Cd79a+ \Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
abnormal B cell negative selection
|
J:178833
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal granulocyte differentiation
|
J:48193
|
abnormal lymphopoiesis
|
J:48193
|
abnormal monocyte differentiation
|
J:48193
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:117320
|
decreased pro-B cell number
|
J:117320
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh \Rag1tm1(GFP)Imku/\Rag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:117320
|
\Irak3tm1Flv/\Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
abnormal T cell differentiation
|
J:229884
|
\Irf1tm1Mak/\Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
increased double-positive T cell number
|
J:64286
|
\Irf4m1Btlr/\Irf4m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Irf4tm1.1Rdf/\Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:112643
|
\Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:42683
|
arrested B cell differentiation
|
J:42683
|
\Irf4tm1Mak/\Irf4tm1Mak
(B6.129P2-Irf4tm1Mak)
|
abnormal T-helper 1 cell differentiation
|
J:78909
|
\Irf8myls/\Irf8+
(involves: BXH2/TyJ * C57BL/6)
|
increased transitional stage B cell number
|
J:168923
|
\Irf8myls/\Irf8myls
(involves: BALB/cJ * BXH2/TyJ-Irf8myls)
|
abnormal myelopoiesis
|
J:97931
|
\Irf8myls/\Irf8myls \Slc11a1r/\Slc11a1r
(BXH2/TyJ)
|
abnormal myelopoiesis
|
J:97931
|
\Irf8tm1Hor/\Irf8tm1Hor \Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84577
|
arrested B cell differentiation
|
J:84577
|
\Is(14)1Rdf \Is(14)5Rdf/\Del(14Trim13-Rnaseh2b)6Rdf \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
\Is(14)1Rdf/\Is(14)1Rdf \Is(14)5Rdf/\Is(14)5Rdf \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
\Itchtm1.1Alta/\Itchtm1.1Alta \Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:204685
|
abnormal T-helper 2 cell differentiation
|
J:204685
|
\Itga4tm1Tpa/\Itga4tm1Tpa \Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:86861
|
\Itgavtm2Hyn/\Itgavtm2.1Hyn \Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
abnormal dendritic cell differentiation
|
J:125508
|
\Itgb2M1Btlr/\Itgb2M1Btlr
(C57BL/6J-Itgb2M1Btlr)
|
abnormal NK cell differentiation
|
J:139559
|
\Itgb2M4Btlr/\Itgb2M4Btlr
(C57BL/6J-Itgb2M4Btlr)
|
abnormal T cell differentiation
|
J:272843
|
\Itgb2tm1Bay/\Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
myeloid hyperplasia
|
J:32126
|
\Itgb2tm1Bay/\Itgb2tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myeloid hyperplasia
|
J:13599
|
\Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myeloid hyperplasia
|
J:48542
|
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
\Itktm1Litt/\Itktm1Litt
(B6.129S4-Itktm1Litt)
|
abnormal positive T cell selection
|
J:141390
|
increased double-negative T cell number
|
J:141390
|
\Itktm1Litt/\Itktm1Litt \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:31230
|
increased double-positive T cell number
|
J:31230
|
\Itktm1Litt/\Itktm1Litt \Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased double-negative T cell number
|
J:31230
|
\Itktm1Litt/\Itktm1Litt \Vav1tm2Bbd/\Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141390
|
abnormal positive T cell selection
|
J:141390
|
decreased double-positive T cell number
|
J:141390
|
\Itktm1Ljb/\Itktm1Ljb
(B10.129-Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:113408
|
\Itktm1Ljb/\Itktm1Ljb \Rag1tm1Mom/\Rag1tm1Mom \Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
abnormal CD4-positive T cell differentiation
|
J:93606
|
\ItpkbT-less/\ItpkbT-less
(C57BL/6-ItpkbT-less)
|
arrested T cell differentiation
|
J:89286
|
\Itpkbtm1Ssch/\Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
arrested T cell differentiation
|
J:86257
|
increased double-positive T cell number
|
J:86257
|
\Itpkbtm1Ssch/\Itpkbtm1Ssch \Itpkctm1Ssch/\Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
arrested T cell differentiation
|
J:86257
|
\Jag2tm1Grid/\Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal gamma-delta T cell differentiation
|
J:46930
|
\Jak1tm1Rds/\Jak1tm1Rds
(involves: 129)
|
abnormal B cell differentiation
|
J:47300
|
abnormal lymphopoiesis
|
J:47300
|
abnormal T cell differentiation
|
J:47300
|
arrested B cell differentiation
|
J:47300
|
increased double-negative T cell number
|
J:47300
|
\Jak2tm1Mohi/\Jak2+ \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:183821
|
\Jak2tm1Mohi/\Jak2tm1Mohi \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:183821
|
\Jak2tm2.1Jlvl/\Jak2+ \Tg(Vav1-cre)#Cgp/0
(involves: 129S2/SvPas * C57BL/6NTac)
|
abnormal myelopoiesis
|
J:202234
|
myeloid hyperplasia
|
J:202234
|
\Jak3bfy/\Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb)
|
abnormal lymphopoiesis
|
J:104190
|
\Jak3m3Btlr/\Jak3m3Btlr
(C57BL/6J-Jak3m3Btlr)
|
decreased immature B cell number
|
J:225935
|
\Jak3M7Btlr/\Jak3M7Btlr
(C57BL/6J-Jak3M7Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272401
|
\Jak3tm1Flv/\Jak3tm1Flv
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:95794
|
\Jak3tm1Jni/\Jak3tm1Jni \Crlf2tm1Jni/\Crlf2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:89031
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:29722
|
decreased immature B cell number
|
J:29722
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal myelopoiesis
|
J:56629
|
abnormal T cell differentiation
|
J:64861
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(B6;129S4-Jak3tm1Ljb/J)
|
abnormal dendritic cell differentiation
|
J:123902
|
\Jak3tm1Tks/\Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:31231
|
abnormal lymphopoiesis
|
J:31231
|
\Jak3wil/\Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu)
|
arrested B cell differentiation
|
J:104190
|
\Kat6atm1.1Glac/\Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:148955
|
decreased immature B cell number
|
J:148955
|
decreased pro-B cell number
|
J:148955
|
\Kat6atm1Avo/\Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
abnormal thymus development
|
J:108453
|
decreased double-negative T cell number
|
J:108453
|
\Kat6atm1Iki/\Kat6atm1Iki
(Not Specified)
|
abnormal myelopoiesis
|
J:108699
|
\Kctd9em1Beij/\Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
abnormal NK cell differentiation
|
J:281803
|
\Kdelr1m1Btlr/\Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
abnormal T cell differentiation
|
J:224970
|
decreased transitional stage T1 B cell number
|
J:224970
|
decreased transitional stage T2 B cell number
|
J:224970
|
\Khdrbs1tm1Rchd/\Khdrbs1tm1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal bone marrow development
|
J:115775
|
\Kittm3.1Bsm/\Kittm3.1Bsm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:90485
|
abnormal T cell differentiation
|
J:90485
|
\Kittm3Ber/\Kittm3Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested B cell differentiation
|
J:89602
|
\KitW-vkd/\KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)
|
abnormal B cell differentiation
|
J:79128
|
abnormal T cell differentiation
|
J:79128
|
\KitW/\KitW \Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6)
|
abnormal B cell differentiation
|
J:79128
|
abnormal T cell differentiation
|
J:79128
|
\Kitltm3.1Pbes/\Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased double-negative T cell number
|
J:157170
|
decreased double-positive T cell number
|
J:157170
|
\Klf2tm2Ling/\Klf2tm2Ling \Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:151604
|
\Klf13tm1Kren/\Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
increased double-positive T cell number
|
J:145839
|
\Klhl6m1Anu/\Klhl6m1Anu
(C57BL/6JAnu-Klhl6m1Anu)
|
increased immature B cell number
|
J:104190
|
\Klhl6M7Btlr/\Klhl6M7Btlr
(C57BL/6J-Klhl6M7Btlr)
|
abnormal B cell differentiation
|
J:272397
|
\Klhl6tm1Sato/\Klhl6tm1Sato
(either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))
|
abnormal B cell differentiation
|
J:101363
|
\Klrk1tm1.1Bpol/\Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
abnormal NK cell differentiation
|
J:151878
|
\Klrk1tm2.1Bpol/\Klrk1tm2.1Bpol
(Not Specified)
|
abnormal NK cell differentiation
|
J:215590
|
\Kmt2atm1(AFF1)Ksy/\Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB)
|
increased pro-B cell number
|
J:110241
|
myeloid hyperplasia
|
J:110241
|
\Kmt2atm1(MLL1/ERT)Divo/?
(involves: 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:189329
|
\Kmt2atm1.1(Sh3gl1)Lcc/\Kmt2a+ \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:205605
|
\Kmt2atm1Clgr/\Kmt2a+
(B6.129-Kmt2atm1Clgr)
|
abnormal myelopoiesis
|
J:115001
|
\Kmt2atm2(MLLT3)Thr/\Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased pro-B cell number
|
J:110241
|
\Kmt2atm2Sjk/\Kmt2a+ \Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:95914
|
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:228913
|
\Kmt2etm1.1Hjf/\Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf)
|
abnormal lymphopoiesis
|
J:145579
|
decreased double-negative T cell number
|
J:145579
|
decreased double-positive T cell number
|
J:145579
|
decreased pro-B cell number
|
J:145579
|
\Kmt2etm1Apa/\Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa)
|
abnormal granulocyte differentiation
|
J:145445
|
abnormal neutrophil differentiation
|
J:145445
|
\Kmt5btm1Jnw/\Kmt5btm1Jnw \Kmt5ctm1.1Jnw/\Kmt5ctm1.1Jnw \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal class switch recombination
|
J:139510
|
abnormal lymphopoiesis
|
J:139510
|
decreased double-positive T cell number
|
J:139510
|
\Krastm4Tyj/\Kras+ \Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+ \Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased double-negative T cell number
|
J:247853
|
decreased double-positive T cell number
|
J:247853
|
\Krastm4Tyj/\Kras+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:88163
|
myeloid hyperplasia
|
J:88163
|
\Krastm4Tyj/\Kras+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:87429
|
myeloid hyperplasia
|
J:87429
|
\Ksr1tm1Shaw/\Ksr1tm1Shaw \Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75739
|
\Lama2tm1Stk/\Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
decreased double-positive T cell number
|
J:61802
|
\Lama5tm1Lsor/\Lama5tm1Lsor \Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased transitional stage T2 B cell number
|
J:198783
|
increased transitional stage T1 B cell number
|
J:198783
|
\Lattm1.1Lov/\Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:77099
|
abnormal T cell differentiation
|
J:77099
|
decreased double-positive T cell number
|
J:77099
|
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:77098
|
abnormal T cell selection
|
J:77098
|
decreased double-positive T cell number
|
J:77098
|
\Lattm1Bpay/\Lattm1Bpay
(involves: 129S2/SvPas)
|
abnormal T cell differentiation
|
J:103904
|
arrested T cell differentiation
|
J:103904
|
decreased double-negative T cell number
|
J:103904
|
\Lattm1Les/\Lattm1.1Wz \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:147946
|
increased double-positive T cell number
|
J:147946
|
\Lattm1Les/\Lattm1.2Wz
(involves: C57BL/6 * FVB/N)
|
arrested T cell differentiation
|
J:147946
|
\Lattm1Les/\Lattm1Les
(Not Specified)
|
arrested T cell differentiation
|
J:116964,
J:54059
|
decreased double-negative T cell number
|
J:54059
|
\Lattm1Les/\Lattm1Les \Lcp2tm5(Lat/Lcp2)Gak/\Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
decreased double-positive T cell number
|
J:147721
|
\Lattm1Les/\Lattm1Les \Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal T cell differentiation
|
J:116964
|
decreased double-positive T cell number
|
J:116964
|
\Lattm2.1Lov/\Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:77695
|
\Lattm2.1Mal/\Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:94074
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
abnormal lymphopoiesis
|
J:94074
|
arrested T cell differentiation
|
J:94074
|
decreased double-positive T cell number
|
J:94074
|
\Lattm3.1Mal/\Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
arrested T cell differentiation
|
J:94074
|
decreased double-positive T cell number
|
J:94074
|
\Lattm4.1Mal/\Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
arrested T cell differentiation
|
J:94074
|
decreased double-positive T cell number
|
J:94074
|
\Lattm4.1Mal/\Lattm4.1Mal \Trdctm1Mal/\Trdctm1Mal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
\Lattm5.1Mal/\Lattm5.1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:152363
|
\Lattm8.1(CD2,-ECFP)Mal/\Lattm8.1(CD2,-ECFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:152149
|
abnormal T cell receptor gamma chain V-J recombination
|
J:152149
|
arrested T cell differentiation
|
J:152149
|
increased double-negative T cell number
|
J:152149
|
\Lattm9Mal/\Lattm9Mal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:205441
|
\LbrGt(XE569)Byg/\LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal granulocyte differentiation
|
J:138854
|
\Lbric-J/\Lbric-J
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil differentiation
|
J:143838
|
\Lckm1Btlr/\Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:144695
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:144695
|
\Lcktm1Dbs/\Lcktm1Dbs
(involves: C3H * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:114660
|
abnormal T cell differentiation
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C3H * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:114660
|
abnormal T cell differentiation
|
J:114660
|
arrested T cell differentiation
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs \Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
arrested T cell differentiation
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs \Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:110847
|
decreased double-positive T cell number
|
J:1119,
J:110847
|
\Lcktm1Mak/\Lcktm1Mak
(B6.129S2-Lcktm1Mak)
|
abnormal T cell differentiation
|
J:111646
|
\Lcktm1Mak/\Lcktm1Mak \Rag1tm1Mom/\Rag1+ \Tg(Lck-Fyn*Y528F)5525Cjg/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:37062
|
\Lcn2tm1Mrgr/\Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
abnormal myelopoiesis
|
J:173490
|
myeloid hyperplasia
|
J:173490
|
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
abnormal T cell differentiation
|
J:150304
|
decreased double-negative T cell number
|
J:150304
|
increased double-negative T cell number
|
J:150304
|
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:150304
|
\Lcp2tm3Gak/\Lcp2tm3Gak
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:132995
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)
|
abnormal negative T cell selection
|
J:132995
|
increased double-positive T cell number
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak \Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal double-negative T cell morphology
|
J:132995
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
abnormal negative T cell selection
|
J:132995
|
increased double-positive T cell number
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak \Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
\Lcp2tm5(Lat/Lcp2)Gak/\Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
decreased double-positive T cell number
|
J:147721
|
\Lcp2twm/\Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
abnormal double-positive T cell morphology
|
J:104190
|
abnormal negative T cell selection
|
J:104190
|
abnormal positive T cell selection
|
J:104190
|
arrested T cell differentiation
|
J:104190
|
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:50865
|
abnormal lymphopoiesis
|
J:50865
|
abnormal T cell differentiation
|
J:63078
|
arrested B cell differentiation
|
J:63078
|
arrested T cell differentiation
|
J:50865
|
\Lig4tm1Fwa/\Lig4tm1Fwa \Tg(Cr2-cre)3Cgn/0 \Xrcc4tm2Fwa/\Xrcc4tm2Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:157574
|
abnormal T cell differentiation
|
J:157574
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:157574
|
abnormal T cell receptor V(D)J recombination
|
J:157574
|
decreased double-negative T cell number
|
J:157574
|
decreased double-positive T cell number
|
J:157574
|
\Lig4tm3.1Fwa/\Lig4tm3.1Fwa \Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
abnormal class switch recombination
|
J:157537
|
\Lime1tm1.1Mal/\Lime1tm1.1Mal \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcraH-Y,TcrbH-Y)1Pas/?
(B6.Cg-Rag2tm1Fwa Lime1tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)
|
abnormal CD4-positive T cell differentiation
|
J:126321
|
\Lmb1C57BL/6Scr/\Lmb1C57BL/6Scr
(MRL.Cg-Lmb1C57BL/6Scr Faslpr)
|
increased double-negative T cell number
|
J:125557
|
\Lmb2MRL/MpScr/\Lmb2MRL/MpScr
(B6.MRL-Lmb2MRL/MpScr Faslpr)
|
decreased double-negative T cell number
|
J:125557
|
\Lmbr1lem1Btlr/\Lmbr1lem1Btlr
(C57BL/6J-Lmbr1lem1Btlr)
|
abnormal B cell differentiation
|
J:274568
|
\Lmbr1lm1Btlr/\Lmbr1lm1Btlr
(C57BL/6J-Lmbr1lm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274568
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274568
|
abnormal T cell differentiation
|
J:274568
|
\Lmo4tm1Slp/\Lmo4tm1Slp \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
\Lmo4tm1Slp/\Lmo4tm1Slp \Yeats4em1Zfa/\Yeats4em1Zfa \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
\Lpxntm1b(EUCOMM)Hmgu/\Lpxntm1b(EUCOMM)Hmgu
(C57BL/6N-Lpxntm1b(EUCOMM)Hmgu/Wtsi)
|
abnormal plasma cell differentiation
|
J:305662
|
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased double-negative T cell number
|
J:126456
|
\Lrrc8atm1.1Geha/\Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal B cell differentiation
|
J:211308
|
abnormal T cell differentiation
|
J:211308
|
abnormal T cell selection
|
J:211308
|
decreased DN2 thymocyte number
|
J:211308
|
decreased DN3 thymocyte number
|
J:211308
|
decreased DN4 thymocyte number
|
J:211308
|
decreased double-negative T cell number
|
J:211308
|
decreased double-positive T cell number
|
J:211308
|
decreased immature B cell number
|
J:211308
|
decreased transitional stage B cell number
|
J:211308
|
increased pro-B cell number
|
J:211308
|
\Lsp1tm1Jejb/\Lsp1tm1Jejb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:64219
|
\Ltahlb382/\Ltahlb382
(C57BL/6J-Ltahlb382/J)
|
decreased transitional stage B cell number
|
J:134498
|
\Ltatm1.1Sned/\Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal class switch recombination
|
J:109621
|
abnormal lymphopoiesis
|
J:109621
|
\Ltatm1Dch/\Ltatm1Dch
(B6.129S2-Ltatm1Dch)
|
abnormal class switch recombination
|
J:80616
|
\Ltatm1Dch/\Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:109621
|
\Ltatm1Dch/\Ltatm1Dch
(B6.129S2-Ltatm1Dch/J)
|
abnormal lymph organ development
|
J:73100
|
\Ltatm1Dch/\Ltatm1Dch \Tg(Igk-Lta/Ltb)4Cys/0
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
abnormal lymph organ development
|
J:73100
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltbtm1Kpf/\Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
abnormal class switch recombination
|
J:80616
|
\Ly6atm2(RUNX1)Grau/\Ly6a+
(involves: 129X1/SvJ * C57BL/6J)
|
myeloid hyperplasia
|
J:93408
|
\Lyl1tm1Fsky/\Lyl1tm1Fsky
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:116300
|
arrested B cell differentiation
|
J:116300
|
decreased pro-B cell number
|
J:116300
|
\Lynm2Anu/\Lynm2Anu
(C57B/6JAnu-Lynm2Anu/AnuApb)
|
increased immature B cell number
|
J:104190
|
\Lynmld4/\Lynmld4
(involves: C57BL/6)
|
abnormal myelopoiesis
|
J:144799
|
decreased transitional stage B cell number
|
J:144799
|
\Lyntm1.1Calo/\Lyntm1.1Calo \Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:200745
|
\Lyntm1Ard/\Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
abnormal myelopoiesis
|
J:144799
|
decreased transitional stage B cell number
|
J:144799
|
\Lyntm1Ard/\Lyntm1Ard \Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
decreased transitional stage B cell number
|
J:146161
|
myeloid hyperplasia
|
J:146161
|
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:29751
|
\Lynweeb/\Lynweeb
(C57BL/6-Lynweeb)
|
decreased transitional stage B cell number
|
J:146161
|
X/\m1Nish
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:204833
|
abnormal NK cell differentiation
|
J:204833
|
decreased immature B cell number
|
J:204833
|
\M7321Wlst/\M7321Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
\M7324Wlst/\M7324Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
\M7325Wlst/\M7325Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
\Malt1tm1Vmd/\Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:86770
|
abnormal double-negative T cell morphology
|
J:86770
|
abnormal T cell differentiation
|
J:86770
|
\Maml1tm1Mkit/\Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:122286
|
\Map3k3tm1Kuro/\Map3k3tm1Kuro \Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:147103
|
increased double-negative T cell number
|
J:147103
|
\Map3k14aly/\Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
abnormal lymphopoiesis
|
J:16865
|
\Map3k14m1Btlr/\Map3k14m1Btlr
(C57BL/6J-Map3k14m1Btlr)
|
arrested B cell differentiation
|
J:152065
|
\Map3k14m1Btlr/\Map3k14m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
arrested B cell differentiation
|
J:185495
|
\Map3k14tm1.2Gne/\Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
decreased transitional stage T1 B cell number
|
J:240453
|
decreased transitional stage T2 B cell number
|
J:240453
|
\Map3k14tm1Rds/\Map3k14tm1Rds
(involves: 129)
|
abnormal class switch recombination
|
J:188560
|
\Map4k3Gt(RRO270)Byg/\Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
abnormal T-helper 1 cell differentiation
|
J:177642
|
abnormal T-helper 2 cell differentiation
|
J:177642
|
abnormal T-helper 17 cell differentiation
|
J:177642
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Mapk3tm1Gpg/\Mapk3tm1Gpg \Tg(Cd4-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Mapk3tm1Gpg/\Mapk3tm1Gpg \Tg(Cd4-cre)1Cwi/0 \Tg(TcrAND)53Hed/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Mapk3tm1Gpg/\Mapk3tm1Gpg \Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
increased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Tg(Lck-cre)1Cwi/0 \Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed \Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal double-positive T cell morphology
|
J:113280
|
abnormal positive T cell selection
|
J:113280
|
\Mapk1tm2Moga/\Mapk1tm2Moga \Mapk3tm1Gpg/\Mapk3tm1Gpg \Tg(Mx1-cre)1Cgn/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pro-B cell differentiation
|
J:134528
|
abnormal pro-B cell morphology
|
J:134528
|
\Mapk8tm1Flv/\Mapk8tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:51510
|
\Mapk8tm1Rjd/\Mapk8tm1Rjd \Mapk9tm2.1Rjd/\Mapk9tm2.1Rjd \Lyz2tm1(cre)Ifo/\Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
abnormal macrophage differentiation
|
J:192551
|
\Mapk9tm1Flv/\Mapk9tm1Flv
(involves: 129S2/SvPas)
|
abnormal T-helper 1 cell differentiation
|
J:50628
|
\Mapk11tm1Jda/\Mapk11tm1Jda \Mapk14tm1Jda/\Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:165966
|
abnormal T-helper 2 cell differentiation
|
J:165966
|
abnormal T-helper 17 cell differentiation
|
J:165966
|
\Mapk14tm1Jda/\Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
increased double-negative T cell number
|
J:146088
|
\Mar1tm1Wtg/\Mar1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
\Mar1tm1Wtg/\Mar1tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
\Marchf1tm1.1Sish/\Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:201198
|
\Matn1tm1Ref/\Matn1tm1Ref \Matn2tm1Asz/\Matn2tm1Asz \Matn3tm1Asz/\Matn3tm1Asz \Matn4tm1.1Asz/\Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:237230
|
\Mcattm1.1Ssmi/\Mcattm1.1Ssmi \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal myelopoiesis
|
J:192213
|
\Mcemp1em1Jngj/\Mcemp1em1Jngj
(C57BL/6-Mcemp1em1Jngj)
|
abnormal mast cell differentiation
|
J:335318
|
\Mcl1tm1Dmta/\Mcl1tm1Dmta \Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
abnormal B cell differentiation
|
J:166069
|
\Mcl1tm1Yen/\Mcl1tm1Yen
(B6.129-Mcl1tm1Yen)
|
abnormal double-positive T cell morphology
|
J:146246
|
decreased double-negative T cell number
|
J:146246
|
\Mcl1tm1Yen/\Mcl1tm1Yen \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal double-positive T cell morphology
|
J:146246
|
\Mcl1tm1Yen/\Mcl1tm1Yen \Tg(TcraTcrb)425Cbn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:146246
|
\Mcl1tm1Ywh/\Mcl1tm1Ywh \Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:137400
|
\Mcl1tm1Ywh/\Mcl1tm1Ywh \Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137400
|
decreased double-negative T cell number
|
J:137400
|
decreased double-positive T cell number
|
J:137400
|
\Mcl1tm2Sjk/\Mcl1tm3Sjk \Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:86906
|
decreased double-negative T cell number
|
J:86906
|
decreased double-positive T cell number
|
J:86906
|
\Mcm4Sdla/\Mcm4+
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:194117
|
\Mdc1Gt(OST441263)Lex/\Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:137341
|
\Mdm2tm1Bay/\Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:81065
|
decreased double-negative T cell number
|
J:81065
|
decreased double-positive T cell number
|
J:81065
|
decreased immature B cell number
|
J:81065
|
\MecomJbo/\Mecom+
(C3N.C-MecomJbo)
|
abnormal neutrophil differentiation
|
J:113445
|
\Mef2ctm1Jjs/\Mef2ctm1Jjs \Mir223tm1Fcam/\Mir223tm1Fcam \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * C57BL/6)
|
abnormal neutrophil differentiation
|
J:140009
|
\Mertktm1Gkm/\Mertktm1Gkm \Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
decreased double-positive T cell number
|
J:147153
|
\Mgat2tm1.1Jxm/\Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal B cell differentiation
|
J:80661
|
\Mir142hgGt(IST11580H2)Tigm/\Mir142hgGt(IST11580H2)Tigm
(involves: C57BL/6N)
|
abnormal dendritic cell differentiation
|
J:207516
|
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:167922
|
myeloid hyperplasia
|
J:167922,
J:173230
|
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
myeloid hyperplasia
|
J:173671
|
\Mir146tm2.1Bal/\Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
myeloid hyperplasia
|
J:173671
|
\Mir155tm1.1Rsky/\Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
|
abnormal T-helper 17 cell differentiation
|
J:226678
|
\Mir155tm1Brd/\Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:121095
|
\Mir155tm1Rsky/\Mir155tm1Rsky
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:136224
|
\Mir223tm1Fcam/\Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil differentiation
|
J:140009
|
\Mirc1tm1.1Aven/\Mirc1tm1.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased pro-B cell number
|
J:223213
|
\Mirc1tm1.2Tyj/\Mirc1tm1.2Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
abnormal B cell differentiation
|
J:134861
|
\Mirc1tm1.3Tyj/\Mirc1tm1.3Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:134861
|
\Mirc1tm1Tyj/\Mirc1tm1Tyj \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:134861
|
\Mirc1tm3.1Aven/\Mirc1tm3.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased pro-B cell number
|
J:223213
|
\Mirc11tm1Rdhl/\Mirc11tm1Rdhl
(B6.129-Mirc11tm1Rdhl)
|
abnormal B cell differentiation
|
J:243248
|
impaired myelopoiesis
|
J:243248
|
increased immature B cell number
|
J:243248
|
increased pre-pro B cell number
|
J:243248
|
increased pro-B cell number
|
J:243248
|
increased transitional stage T1 B cell number
|
J:243248
|
\Mirc14tm1.1Ankr/\Mirc14tm1.1Ankr
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:196134
|
decreased double-positive T cell number
|
J:196134
|
\Mirc14tm1.1Czc/\Mirc14tm1.1Czc \Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))
|
decreased double-positive T cell number
|
J:188125
|
\Mirc14tm1.2Czc/\Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
decreased DN3 thymocyte number
|
J:188125
|
decreased double-positive T cell number
|
J:188125
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal T cell differentiation
|
J:203157
|
abnormal T cell receptor V(D)J recombination
|
J:203157
|
decreased DN1 thymic pro-T cell number
|
J:203157
|
decreased double-positive T cell number
|
J:203157
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv \Mirc15tm1.2Flv/\Mirc15tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased immature B cell number
|
J:203157
|
increased pro-B cell number
|
J:203157
|
\Mirc30em1Hhzg/\Mirc30em1Hhzg \Tg(Vav1-cre)#Cgp/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)
|
increased pro-B cell number
|
J:320883
|
\Mmdtm1Beij/\Mmdtm1Beij
(Not Specified)
|
abnormal macrophage differentiation
|
J:304637
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac * CD-1)
|
impaired myelopoiesis
|
J:149957
|
\Mmp19tm1Rase/\Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
abnormal T cell differentiation
|
J:137128
|
increased double-positive T cell number
|
J:137128
|
\Morrbidem1Flv/\Morrbidem1Flv
(C57BL/6N-Morrbidem1Flv)
|
abnormal myelopoiesis
|
J:236609
|
\Mpltm1Wsa/\Mpltm1Wsa \MybPlt3/\Myb+
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:89601
|
\Mpltm1Wsa/\Mpltm1Wsa \MybPlt3/\MybPlt3
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:89601
|
abnormal thrombopoiesis
|
J:89601
|
\Mpltm1Wsa/\Mpltm1Wsa \MybPlt4/\Myb+
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:89601
|
\Mpltm1Wsa/\Mpltm1Wsa \MybPlt4/\MybPlt4
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:89601
|
\Mpltm1Wsa/\Mpltm1Wsa \Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:136262
|
\Mpltm1Wsa/\Mpltm1Wsa \Suz12Plt8/\Suz12+
(B6.Cg-Mpltm1Wsa Suz12Plt8)
|
abnormal thrombopoiesis
|
J:136262
|
\Mre11atm1.1Rchd/\Mre11atm1.1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:184053
|
\Ms4a1tm1Tft/\Ms4a1tm1Tft
(involves: 129 * C57BL/6)
|
increased transitional stage B cell number
|
J:88933
|
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:80893
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Msh2tm1Htr/\Msh2tm1Htr \Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Msh2tm1Mak/\Msh2tm1Mak
(C57BL/6NTac-Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
abnormal somatic hypermutation frequency
|
J:326431
|
\Msh2tm1Rak/\Msh2tm1Rak
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:56764
|
\Msh2tm1Wed/\Msh2tm1Wed
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:86278
|
\Msi2Gt(E035H03)Wrst/\Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst)
|
decreased DN2 thymocyte number
|
J:174870
|
decreased DN3 thymocyte number
|
J:174870
|
decreased double-negative T cell number
|
J:174870
|
decreased double-positive T cell number
|
J:174870
|
decreased immature B cell number
|
J:174870
|
\Msmpem1Jzx/\Msmpem1Jzx
(C57BL/6-Msmpem1Jzx)
|
abnormal macrophage differentiation
|
J:311042
|
\Mtortm1.2Koz/\Mtortm1.2Koz \Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:150108
|
\Mtortm1Lgm/\Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:168600
|
decreased transitional stage T1 B cell number
|
J:168600
|
\Mtss1Gt(CSC156)Byg/\Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
abnormal B cell differentiation
|
J:186118
|
decreased immature B cell number
|
J:186118
|
\Mybboo/\Mybboo
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:167270
|
\MybM303V/\MybM303V
(involves: 129S1/SvlmJ * C57BL/6)
|
arrested B cell differentiation
|
J:96507
|
arrested T cell differentiation
|
J:96507
|
\Mybtm1.1Cgn/\Myb+
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:127234
|
\Mybtm1Cgn/\Mybtm1.1Cgn \Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:91122
|
\Mybtm1Cgn/\Mybtm1Cgn \Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:91122
|
decreased double-negative T cell number
|
J:91122
|
decreased double-positive T cell number
|
J:91122
|
\Mybtm1Cgn/\Mybtm1Cgn \Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:91122
|
\Mybtm1Epr/\Mybtm1Epr \Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:93481
|
decreased double-positive T cell number
|
J:93481
|
\Mybtm1Epr/\Mybtm1Epr \Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal double-negative T cell morphology
|
J:93481
|
abnormal T cell differentiation
|
J:93481
|
decreased double-positive T cell number
|
J:93481
|
\Mybtm1Jof/\Mybtm1Jof
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:85344
|
abnormal double-negative T cell morphology
|
J:85344
|
abnormal T cell differentiation
|
J:85344
|
\Mybtm1Jof/\Mybtm1Ssp
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:85344
|
\Mybl2tm1.1Epr/\Mybl2tm1.1Epr \Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
abnormal myelopoiesis
|
J:206816
|
\Mybl2tm1.1Jof/\Mybl2+ \Tg(Zp3-cre)3Mrt/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
abnormal myelopoiesis
|
J:196804
|
myeloid hyperplasia
|
J:196804
|
\Myctm3(Tcrb)Fwa/\Myc+
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
\Myd88tm1Aki/\Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
abnormal dendritic cell differentiation
|
J:139001
|
\Myd88tm1Defr/\Myd88tm1Defr \Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
abnormal dendritic cell differentiation
|
J:139001
|
abnormal T-helper 1 cell differentiation
|
J:139001
|
\Myh9tm1.1Dash/\Myh9+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal thrombopoiesis
|
J:204923
|
\Mysm1tm1b(KOMP)Wtsi/\Mysm1tm1b(KOMP)Wtsi \Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal T cell differentiation
|
J:179287
|
arrested B cell differentiation
|
J:179287
|
decreased immature B cell number
|
J:179287
|
decreased pro-B cell number
|
J:179287
|
\Mzb1tm1.2Rug/\Mzb1tm1.2Rug
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
increased pro-B cell number
|
J:211639
|
\Mzf1tm1Ppp/\Mzf1tm1Ppp
(involves: 129)
|
abnormal bone marrow development
|
J:70407
|
abnormal myelopoiesis
|
J:70407
|
\Nampttm1Oleo/\Nampttm1Oleo \Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)
|
decreased double-negative T cell number
|
J:141448
|
\Nbnem7Jpt/\Nbntm2Zqw \Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:277750
|
\Nbntm2Zqw/\Nbntm2Zqw \Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
abnormal bone marrow development
|
J:251434
|
\Nbr1tm1.1Jmos/\Nbr1tm1.1Jmos \Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:165438
|
abnormal T-helper 2 cell differentiation
|
J:165438
|
\Ncaph2nes/\Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu)
|
abnormal double-negative T cell morphology
|
J:123300
|
decreased double-negative T cell number
|
J:123300
|
decreased double-positive T cell number
|
J:123300
|
\Ncaph2nes/\Ncaph2nes \Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd)
|
abnormal double-negative T cell morphology
|
J:123300
|
decreased double-positive T cell number
|
J:123300
|
\Nckap1lm1Iri/\Nckap1lm1Iri
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:141377
|
abnormal lymphopoiesis
|
J:141377
|
decreased double-positive T cell number
|
J:141377
|
increased double-negative T cell number
|
J:141377
|
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal lymphopoiesis
|
J:109522
|
\Ncor1tm1Rsd/\Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested T cell differentiation
|
J:65417
|
\Ncstntm1.1Akli/\Ncstntm1.1Akli \Tet2tm1.1Iaai/\Tet2tm1.1Iaai \Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:196407
|
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+ \Rragatm2Dmsa/\Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:213516
|
\Ndst2tm1Rls/\Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls)
|
abnormal mast cell differentiation
|
J:142880
|
\Nf1tm1Par/\Nf1tm1Par \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:90973
|
\Nfatc1tm1Glm/\Nfatc1tm2Glm
(chimera involves: 129S2/SvPas)
|
decreased double-positive T cell number
|
J:78376
|
increased double-negative T cell number
|
J:78376
|
\Nfatc1tm1Rao/\Nfatc1tm1Rao \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
abnormal class switch recombination
|
J:177319
|
\Nfatc1tm1Rao/\Nfatc1tm1Rao \Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:177319
|
\Nfatc2tm1Rao/\Nfatc2tm1Rao \Nfatc3tm1Grc/\Nfatc3tm1Grc \Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal double-negative T cell morphology
|
J:141917
|
abnormal T cell differentiation
|
J:141917
|
\Nfatc3tm1Glm/\Nfatc3tm1Glm \Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:50124
|
increased double-negative T cell number
|
J:50124
|
\Nfatc3tm1Grc/\Nfatc3tm1Grc \Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal T cell differentiation
|
J:141917
|
increased double-negative T cell number
|
J:141917
|
\Nfil3tm1.1Brad/\Nfil3tm1.1Brad
(B6.Cg-Nfil3tm1.1Brad)
|
abnormal NK cell differentiation
|
J:152774
|
\Nfil3tm1Look/\Nfil3tm1Look
(B6.129X1-Nfil3tm1Look)
|
abnormal NK cell differentiation
|
J:155677
|
\Nfil3tm1Pbro/\Nfil3tm1Pbro
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:156521
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:30268
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal \Nfkb2tm1Sbn/\Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
arrested B cell differentiation
|
J:45119
|
decreased double-positive T cell number
|
J:45119
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal \Relatm1Bal/\Relatm1Bal
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal dendritic cell differentiation
|
J:113514
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal \Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb1tm1Bal Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
increased transitional stage B cell number
|
J:113556
|
\Nfkb1tm1Brv/\Nfkb1tm1Brv
(involves: 129S1/Sv)
|
myeloid hyperplasia
|
J:46912
|
\Nfkb2Lym1/\Nfkb2+
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:188560
|
\Nfkb2Lym1/\Nfkb2Lym1
(involves: BALB/c)
|
abnormal class switch recombination
|
J:154812
|
abnormal plasma cell differentiation
|
J:154812
|
abnormal T cell differentiation
|
J:154812
|
decreased transitional stage B cell number
|
J:154812
|
increased double-negative T cell number
|
J:154812
|
increased double-positive T cell number
|
J:154812
|
increased transitional stage B cell number
|
J:154812
|
\Nfkb2m3Btlr/\Nfkb2m3Btlr
(C57BL/6J-Nfkb2m3Btlr)
|
abnormal B cell differentiation
|
J:274960
|
abnormal CD4-positive T cell differentiation
|
J:274960
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274960
|
abnormal T cell differentiation
|
J:274960
|
\Nfkb2tm1Brv/\Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:43469
|
\Nfkb2tm1Sbn/\Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:45437
|
\Nfkb2xdr/\Nfkb2xdr
(C57BL/6JSfdAnu-Nfkb2xdr/Anu)
|
decreased transitional stage T2 B cell number
|
J:79725
|
\Nfkbiatm1.1Pjc/\Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:163686
|
\Nfkbiatm1.1Smiy/\Nfkbia+
(B6.129-Nfkbiatm1.1Smiy)
|
decreased transitional stage T2 B cell number
|
J:168977
|
increased pro-B cell number
|
J:168977
|
\Nfkbiatm1.1Smiy/\Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
abnormal B cell differentiation
|
J:168977
|
decreased transitional stage T2 B cell number
|
J:168977
|
increased immature B cell number
|
J:168977
|
increased pro-B cell number
|
J:168977
|
\Nfkbiatm1Bal/\Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal granulocyte differentiation
|
J:30058
|
decreased double-positive T cell number
|
J:30058
|
\Nfkbiatm1Bal/\Nfkbiatm1Bal \Nfkbietm1Syme/\Nfkbietm1Syme
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:88142
|
abnormal T cell differentiation
|
J:88142
|
decreased immature B cell number
|
J:88142
|
\Nfkbiatm1Fey/\Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:110817
|
decreased double-negative T cell number
|
J:110817
|
\Nfkbiatm1Stw/\Nfkbiatm1Stw
(involves: 129S1/Sv)
|
abnormal myelopoiesis
|
J:32527
|
\Nfkbidm1Btlr/\Nfkbidm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Nfkbidtm1a(EUCOMM)Wtsi/\Nfkbidtm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:185495
|
\Nfkbietm1Syme/\Nfkbietm1Syme
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal double-negative T cell morphology
|
J:88538
|
\Nhej1tm1.1Ics/\Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
\Nhej1tm1.1Ics/\Nhej1tm1.1Ics \Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
\Nhej1tm1Fwa/\Nhej1tm1Fwa
(involves: 129)
|
abnormal class switch recombination
|
J:138774
|
\Niban3tm1Jyw/\Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
abnormal B cell differentiation
|
J:282961
|
abnormal class switch recombination
|
J:282961
|
abnormal transitional stage B cell morphology
|
J:282961
|
increased transitional stage T2 B cell number
|
J:282961
|
\Nkaptm1.1Viss/Y \Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:165961
|
decreased DN4 thymocyte number
|
J:165961
|
decreased double-positive T cell number
|
J:165961
|
increased DN3 thymocyte number
|
J:165961
|
\Nkapd1tm1.1Tak/\Nkapd1tm1.1Tak \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal B cell differentiation
|
J:350073
|
\Nktcn1C57BL/6J/\Nktcn1C57BL/6J
(NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))
|
abnormal T cell differentiation
|
J:137521
|
\Nlktm1Tbo/\Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo)
|
abnormal bone marrow development
|
J:73353
|
decreased double-positive T cell number
|
J:73353
|
decreased pro-B cell number
|
J:73353
|
impaired myelopoiesis
|
J:73353
|
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru \Nmt2tm1.1Poru/\Nmt2tm1.1Poru \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased DN4 thymocyte number
|
J:226234
|
decreased double-positive T cell number
|
J:226234
|
increased double-negative T cell number
|
J:226234
|
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
\Nmt2tm1.1Poru/\Nmt2tm1.1Poru \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
\Noc2ltm1.1Arte/\Noc2ltm1.1Arte \Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
arrested T cell differentiation
|
J:216490
|
decreased DN3 thymocyte number
|
J:216490
|
decreased DN4 thymocyte number
|
J:216490
|
decreased double-positive T cell number
|
J:216490
|
decreased immature B cell number
|
J:216490
|
decreased pro-B cell number
|
J:216490
|
\Nod2tm1Jhgt/\Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
increased double-negative T cell number
|
J:124575
|
\Notch1tm1Agt/\Notch1tm1Agt \Notch2tm1Frad/\Notch2tm1Frad \Tg(Mx1-cre)1Cgn/0
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:125373
|
arrested T cell differentiation
|
J:125373
|
\Notch1tm1Agt/\Notch1tm1Agt \Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
abnormal T cell differentiation
|
J:125373,
J:55400
|
decreased double-negative T cell number
|
J:55400
|
decreased double-positive T cell number
|
J:55400
|
increased immature B cell number
|
J:143472
|
\Notch1tm2Pst/\Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
abnormal T cell differentiation
|
J:131563
|
decreased double-negative T cell number
|
J:131563
|
\Notch2tm1Frad/\Notch2tm1Frad \Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
\Npm1tm1Hft/\Npm1+
(involves: 129)
|
abnormal granulocyte differentiation
|
J:194999
|
myeloid hyperplasia
|
J:194999
|
\Npm1tm1Ppp/\Npm1+
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:101494
|
\Nprl3tm1.1Drhi/\Nprl3tm1.1Drhi
(involves: 129P2/OlaHsd)
|
abnormal lymph organ development
|
J:183988
|
\Npy1rtm1.1Wpg/\Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
decreased transitional stage B cell number
|
J:118850
|
\Nqo2tm1Akj/\Nqo2tm1Akj
(Not Specified)
|
abnormal lymphopoiesis
|
J:80549
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda \Rag2tm1.1Cgn/\Rag2tm1.1Cgn \Tg(Lck-cre)548Jxm/0 \Tg(TcrAND)53Hed/0
(B6.Cg-Rag2tm1.1Cgn Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)
|
decreased double-positive T cell number
|
J:189951
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda \Tcratm1Mom/\Tcratm1Mom \Tg(Lck-cre)548Jxm/0
(B6.Cg-Tcratm1Mom Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda \Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
\Nr4a1tm1Jmi/\Nr4a1tm1Jmi \Nr4a3tm1Omc/\Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal leukopoiesis
|
J:121903
|
abnormal myelopoiesis
|
J:121903
|
\Nr4a2tm1.1Pcn/\Nr4a2tm1.1Pcn \Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 1 cell differentiation
|
J:205658
|
abnormal T-helper 17 cell differentiation
|
J:205658
|
\Nr4a2tm1.1Pcn/\Nr4a2tm1.1Pcn \Tg(Lck-cre)1Jtak/0
(Not Specified)
|
abnormal T-helper 1 cell differentiation
|
J:205658
|
abnormal T-helper 17 cell differentiation
|
J:205658
|
\Nrastm1.1Emfu/\Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N)
|
abnormal granulocyte differentiation
|
J:189834
|
\Nrastm1Tyj/\Nrastm1Tyj \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:174880
|
myeloid hyperplasia
|
J:204263
|
\Nudcd3em1(IMPC)Wtsi/\Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
abnormal immunoglobulin light chain V-J recombination
|
J:351330
|
abnormal T cell differentiation
|
J:351330
|
abnormal T cell receptor V(D)J recombination
|
J:351330
|
increased DN3 thymocyte number
|
J:351330
|
increased double-negative T cell number
|
J:351330
|
increased double-positive T cell number
|
J:351330
|
\Nuggctm1Diaz/\Nuggctm1Diaz \Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal somatic hypermutation frequency
|
J:190402
|
\Ogttm1Gwh/Y \Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:93112
|
\Otub1tm1c(EUCOMM)Hmgu/\Otub1tm1c(EUCOMM)Hmgu \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
decreased immature B cell number
|
J:280549
|
\Otud5tm1Vmd/\Otud5tm1Vmd \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
\Otud5tm1Vmd/\Otud5tm1Vmd \Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased double-positive T cell number
|
J:116017
|
\Patz1tm1.2Welm/\Patz1tm1.2Welm \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Patz1tm1.2Welm Commd10Tg(Vav1-icre)A2Kio)
|
abnormal mast cell differentiation
|
J:209168
|
\Pax1un-i/\Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased double-negative T cell number
|
J:100951
|
decreased double-positive T cell number
|
J:100951
|
increased double-negative T cell number
|
J:100951
|
\Pax1un/\Pax1+ \Tcf3tm1Cmu/\Tcf3tm1Cmu
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:103567
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:38813
|
abnormal lymphopoiesis
|
J:38813
|
arrested B cell differentiation
|
J:113076
|
decreased immature B cell number
|
J:113076
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129S2/SvPas)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:139510
|
arrested B cell differentiation
|
J:75504
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(either: 129 or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal late pro-B cell
|
J:21935
|
abnormal lymphopoiesis
|
J:21935
|
absent late pro-B cells
|
J:21935
|
arrested B cell differentiation
|
J:21935
|
\Pax5tm3.1Mbu/\Pax5tm3.1Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:75504
|
\Pax5tm3Mbu/\Pax5+ \Tcf3tm1(PBX1)Mlc/\Tcf3+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:226241
|
arrested B cell differentiation
|
J:226241
|
decreased immature B cell number
|
J:226241
|
\Paxxem1Spj/\Paxxem1Spj
(C57BL/6NTac-Paxxem1Spj)
|
decreased transitional stage B cell number
|
J:236776
|
\Pbrm1tm1Zhwa/\Pbrm1tm1Zhwa \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:236906
|
\Pbx1tm1Koss/\Pbx1tm1Koss \Nkx2-5tm2(cre)Rph/\Nkx2-5+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal spleen mesenchyme morphology
|
J:184521
|
\Pbx1tm1Mlc/\Pbx1tm3.1Mlc \Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased double-negative T cell number
|
J:149799
|
decreased pro-B cell number
|
J:149799
|
\Pclaftm1a(EUCOMM)Wtsi/\Pclaftm1a(EUCOMM)Wtsi
(C57BL/6N-Pclaftm1a(EUCOMM)Wtsi/Wtsi)
|
increased pro-B cell number
|
J:211773
|
\Pcnatm1.1Mdsc/\Pcnatm1.1Mdsc \Tg(Pcna*K164R)1Mdsc/0
(involves: FVB/N)
|
abnormal class switch recombination
|
J:141098
|
abnormal somatic hypermutation frequency
|
J:141098
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:125916
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454,
J:177630
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs \Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Pcsk1tm1Dfs/\Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:184882
|
\Pdap1em1Rkuhn/\Pdap1em1Rkuhn \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal class switch recombination
|
J:298705
|
abnormal somatic hypermutation frequency
|
J:298705
|
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukopoiesis
|
J:50688
|
abnormal myelopoiesis
|
J:50688
|
\Pdgfratm8Sor/\Pdgfratm8Sor \Pdgfrbtm1Mdt/\Pdgfrbtm1Mdt \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C57BL/6 * CBA)
|
abnormal thymus development
|
J:122584
|
\Pdia6em1Btlr/\Pdia6m1Btlr
(involves: C57BL/6J)
|
decreased double-negative T cell number
|
J:288824
|
decreased double-positive T cell number
|
J:288824
|
decreased transitional stage B cell number
|
J:288824
|
\Pdpk1tm1Mlw/\Pdpk1tm1Mlw \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:165626
|
\Pepdtm1a(KOMP)Wtsi/\Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd)
|
decreased immature B cell number
|
J:211773
|
decreased transitional stage T1 B cell number
|
J:211773
|
\PfasSofa-2J/\Pfas+
(B6(Cg)-PfasSofa-2J/GrsrJ)
|
abnormal transitional stage B cell morphology
|
J:223062
|
\Pfdn1Gt(GTR1.3)1Rul/\Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal B cell differentiation
|
J:137415
|
\Pgam1tm1.1Hiko/\Pgam1tm1.1Hiko \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:293746
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:293746
|
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
abnormal T-helper 2 cell differentiation
|
J:203443
|
\Pgdtm1.1Pse/\Pgdtm1.1Pse \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:306553
|
\Pgm3Gt(W037B08)Wrst/\Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:125094
|
increased pro-B cell number
|
J:125094
|
\Pgm3mld1/\Pgm3mld1
(C57BL/6-Pgm3mld1)
|
abnormal thrombopoiesis
|
J:125094
|
increased pro-B cell number
|
J:125094
|
\Phc1tm1Os/\Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:75707
|
\Phf6em1Wencc/Y \Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
decreased double-negative T cell number
|
J:278804
|
increased pro-B cell number
|
J:278804
|
\Phf6em1Wencc/\Phf6em1Wencc \Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
decreased double-negative T cell number
|
J:278804
|
increased pro-B cell number
|
J:278804
|
\Phf6tm1.1Avo/Y \Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:276228
|
decreased DN2 thymocyte number
|
J:276228
|
\Phf20Gt(XN131)Byg/\Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:228714
|
decreased double-positive T cell number
|
J:228714
|
increased double-negative T cell number
|
J:228714
|
\Pias4tm1Rug/\Pias4tm1Rug
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myelopoiesis
|
J:94291
|
\Picalmtm1Towa/\Picalmtm1Towa
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B cell differentiation
|
J:185312
|
\Pik3ap1m1Btlr/\Pik3ap1m1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
\Pik3ap1tm1Kuro/\Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:75075
|
\Pik3c2atm1Bvan/\Pik3c2a+
(involves: C57BL/6)
|
abnormal thrombopoiesis
|
J:226344
|
\Pik3cdem1.1Pls/\Pik3cd+
(Not Specified)
|
abnormal B cell differentiation
|
J:282486
|
abnormal class switch recombination
|
J:282486
|
increased transitional stage B cell number
|
J:282486
|
increased transitional stage T1 B cell number
|
J:282486
|
\Pik3cdtm1.1Bvan/\Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell differentiation
|
J:78412
|
\Pik3cdtm1Jni/\Pik3cdtm1Jni \Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr \Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:125791
|
decreased double-positive T cell number
|
J:125791
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr \Ptentm2.1Ppp/\Ptentm2.1Ppp \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:130950
|
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
abnormal T cell differentiation
|
J:60347
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:52229
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
decreased immature B cell number
|
J:104166
|
increased pro-B cell number
|
J:104166
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr \Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
arrested B cell differentiation
|
J:104166
|
decreased immature B cell number
|
J:104166
|
\Pik3r1tm1Tka/\Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased pro-B cell number
|
J:52228
|
\Pik3r1tm2Dfr/\Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
abnormal B cell differentiation
|
J:94077
|
\Pim1tm1Pwl/\Pim1tm1Pwl \Pim2tm1Brn/\Pim2tm1Brn \Pim3tm1Brn/\Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased pro-B cell number
|
J:91592
|
increased early pro-B cell number
|
J:91592
|
\Pirbtm1Ttk/\Pirbtm1Ttk
(involves: 129X1/SvJ)
|
abnormal dendritic cell differentiation
|
J:76770
|
\Pkn1tm1Kik/\Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
abnormal somatic hypermutation frequency
|
J:193187
|
\Pknox1Gt(OST71835)Lex/\Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased double-negative T cell number
|
J:103769
|
\Pknox1tm2.1Fbla/\Pknox1tm2.1Fbla \Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:192251
|
\Pla2g3tm1Murm/\Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6)
|
abnormal mast cell differentiation
|
J:197334
|
\Pla2g4atm1Jvb/\Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
abnormal mast cell differentiation
|
J:54619
|
\Pla2g6m1Sein/\Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
decreased double-positive T cell number
|
J:155328
|
\Plcd1tm1Tta/\Plcd1tm1Tta
(involves: 129P2/OlaHsd)
|
abnormal granulocyte differentiation
|
J:205633
|
\Plcg1tm1Gcrp/\Plcg1tm1Rwen \Tg(Cd4-cre)1Cwi/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased double-negative T cell number
|
J:157757
|
increased double-positive T cell number
|
J:157757
|
\Plcg2Ali5/\Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
decreased transitional stage B cell number
|
J:97930
|
\Plcg2m1Btlr/\Plcg2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
\Plcg2tm1.1Kuro/\Plcg2tm1.1Kuro
(Not Specified)
|
abnormal B cell differentiation
|
J:131161
|
increased pro-B cell number
|
J:131161
|
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:86373
|
increased pro-B cell number
|
J:104166
|
increased transitional stage T2 B cell number
|
J:86373
|
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:117023
|
\Plcg2tm1Kuro/\Plcg2tm1Kuro \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:63744
|
increased pro-B cell number
|
J:63744
|
\Plek2tm1Pji/\Plek2tm1Pji
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal granulocyte differentiation
|
J:257910
|
\Plek2tm1Pji/\Plek2tm1Pji \Jak2tm1.1Ble/\Jak2+ \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal granulocyte differentiation
|
J:257910
|
\Plscr1tm1Lex/\Plscr1tm1Lex
(129S/SvEvBrd-Plscr1tm1Lex)
|
abnormal granulocyte differentiation
|
J:76790
|
abnormal myelopoiesis
|
J:76790
|
abnormal neutrophil differentiation
|
J:76790
|
\Plscr1tm1Lex/\Plscr1tm1Lex \Plscr3tm1Sims/\Plscr3tm1Sims
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal myelopoiesis
|
J:92404
|
\Pmltm1Ppp/\Pmltm1Ppp
(involves: 129S7/SvEvBrd)
|
abnormal myelopoiesis
|
J:46381
|
\Pms2tm1.1Wed/\Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal class switch recombination
|
J:162378
|
\Pms2tm1Lisk/\Pms2tm1Lisk
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:162378
|
\Pnpf/\Pnpf
(involves: C3H/HeHa * C57BL/6J)
|
increased double-negative T cell number
|
J:522
|
\Pnpf/\Pnpf
(C57BL/6J-Pnpf)
|
decreased double-positive T cell number
|
J:39328
|
\Pnpg/\Pnpg
(involves: C57BL/6 * DBA/2J)
|
decreased double-positive T cell number
|
J:39328
|
increased double-negative T cell number
|
J:39328
|
\Pnptm1Cmr/\Pnptm1Cmr
(involves: 129)
|
abnormal myelopoiesis
|
J:62870
|
decreased double-positive T cell number
|
J:62870
|
increased double-negative T cell number
|
J:62870
|
\Polbtm1.1Jbsw/\Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:206872
|
abnormal somatic hypermutation frequency
|
J:206872
|
\Pole3em3Tbo/\Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
decreased double-positive T cell number
|
J:298827
|
decreased immature B cell number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
\Pole3em4Tbo/\Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
decreased immature B cell number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
\Pole3tm1(KOMP)Vlcg/\Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB)
|
decreased DN4 thymocyte number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
abnormal B cell differentiation
|
J:261973
|
abnormal T cell differentiation
|
J:261973
|
arrested B cell differentiation
|
J:261973
|
increased double-negative T cell number
|
J:261973
|
\Polgtm1Prol/\Polgtm1Prol
(B6J.129S7-Polgtm1Prol)
|
abnormal lymphopoiesis
|
J:154187
|
decreased double-positive T cell number
|
J:154187
|
decreased immature B cell number
|
J:154187
|
decreased pro-B cell number
|
J:154187
|
\Polltm1Crey/\Polltm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
\Polltm1Crey/\Polltm1Crey \Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113406
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
\Polqtm1Jcs/\Polqtm1Jcs
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal somatic hypermutation frequency
|
J:103365
|
\Polqtm1Jow/\Polqtm1Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal somatic hypermutation frequency
|
J:101409
|
\Polqtm2Jow/\Polqtm2Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:115989
|
\Pou2af1tm1Pjln/\Pou2af1tm1Pjln
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:67362
|
decreased immature B cell number
|
J:67362
|
\Pou2af1tm1Pmt/\Pou2af1tm1Pmt \Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:81805
|
\Pou2af1tm1Rgr/\Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
abnormal B cell differentiation
|
J:114816,
J:35785
|
arrested B cell differentiation
|
J:114816
|
\Pou2f2tm1Bal/\Pou2f2tm1Bal
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
\Pou2f2tm1Lmc/\Pou2f2tm1Lmc
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
\Ppargtm1Tka/\Pparg+
(involves: C57BL/6 * CBA)
|
abnormal bone marrow development
|
J:89250
|
\Ppargtm2Rev/\Ppargtm2Rev \Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:153358
|
\Ppicem1Igc/\Ppicem1Igc
(C57BL/6-Ppicem1Igc)
|
increased transitional stage T1 B cell number
|
J:321155
|
increased transitional stage T2 B cell number
|
J:321155
|
\Ppm1dtm1Lad/\Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
myeloid hyperplasia
|
J:74284
|
\Ppp2r3ctm1Imku/\Ppp2r3ctm1Imku \Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
decreased immature B cell number
|
J:100706
|
decreased transitional stage B cell number
|
J:100706
|
increased pro-B cell number
|
J:100706
|
increased transitional stage B cell number
|
J:100706
|
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell differentiation
|
J:77729
|
\Ppp3r1tm2Grc/\Ppp3r1tm2.1Grc \Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:89771
|
\Ppp4ctm1Tht/\Ppp4ctm1Tht \Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
abnormal T cell differentiation
|
J:117684
|
decreased double-positive T cell number
|
J:117684
|
increased double-negative T cell number
|
J:117684
|
\Ppp4ctm1Tht/\Ppp4ctm1Tht \Tg(Lck-cre)548Jxm/0 \Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
decreased double-positive T cell number
|
J:117684
|
\Prdm1tm1Clme/\Prdm1tm1Clme \Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T follicular helper cell differentiation
|
J:178876
|
\Primpolem1Nki/\Primpolem1Nki
(C57BL/6-Primpolem1Nki)
|
abnormal somatic hypermutation frequency
|
J:242620
|
\Prkar1atm2Gsm/\Prkar1atm2Gsm \Tg(Cr2-cre)3Cgn/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147785
|
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:143854
|
increased transitional stage B cell number
|
J:143854
|
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
decreased DN4 thymocyte number
|
J:186080
|
decreased double-positive T cell number
|
J:186080
|
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc \Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal positive T cell selection
|
J:186080
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
decreased DN4 thymocyte number
|
J:186080
|
decreased double-negative T cell number
|
J:186080
|
decreased double-positive T cell number
|
J:186080
|
\Prkcqtm1Litt/\Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal T-helper 1 cell differentiation
|
J:94285
|
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal positive T cell selection
|
J:186080
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy \Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy \Tg(Lck-cre)1Jtak/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:236298
|
\Prkdchanky/\Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))
|
myeloid hyperplasia
|
J:104190
|
\Prkdcm1Btlr/\Prkdcm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Prkdcm14Btlr/\Prkdcm14Btlr
(C57BL/6J-Prkdcm14Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272442
|
\PrkdcM16Btlr/\PrkdcM16Btlr
(C57BL/6J-PrkdcM16Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272520
|
\Prkdcm18Btlr/\Prkdcm18Btlr
(C57BL/6J-Prkdcm18Btlr)
|
abnormal B cell differentiation
|
J:274730
|
abnormal CD4-positive T cell differentiation
|
J:274730
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274730
|
abnormal T cell differentiation
|
J:274730
|
\Prkdcm19Btlr/\Prkdcm19Btlr
(C57BL/6J-Prkdcm19Btlr)
|
abnormal B cell differentiation
|
J:274763
|
abnormal CD4-positive T cell differentiation
|
J:274763
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274763
|
abnormal T cell differentiation
|
J:274763
|
\Prkdcscid/\Prkdcscid \Tg(Tcrb)93Vbo/0
(involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)
|
abnormal double-positive T cell morphology
|
J:111476
|
abnormal T cell differentiation
|
J:111476
|
\Prkdctm1.1Bpcc/\Prkdctm1.1Bpcc
(involves: 129 * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:171351
|
arrested B cell differentiation
|
J:171351
|
decreased double-negative T cell number
|
J:171351
|
decreased double-positive T cell number
|
J:171351
|
\Prkdctm1Fwa/\Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:50221
|
abnormal T cell receptor V(D)J recombination
|
J:50221
|
arrested B cell differentiation
|
J:50221
|
arrested T cell differentiation
|
J:50221
|
decreased double-positive T cell number
|
J:50221
|
\Prkdctm1Gcl/\Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:53765
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:53765
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:53765
|
arrested B cell differentiation
|
J:53765
|
\Prkdctm1Get/\Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
abnormal B cell differentiation
|
J:50222
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:50222
|
abnormal immunoglobulin light chain V-J recombination
|
J:50222
|
abnormal T cell differentiation
|
J:50222
|
abnormal T cell receptor alpha chain V-J recombination
|
J:50222
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:50222
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:50222
|
arrested B cell differentiation
|
J:50222
|
arrested T cell differentiation
|
J:50222
|
increased double-negative T cell number
|
J:50222
|
increased double-positive T cell number
|
J:50222
|
\Prnptm1Cwe/\Prnptm1Cwe \Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:129512
|
decreased DN2 thymocyte number
|
J:129512
|
decreased DN4 thymocyte number
|
J:129512
|
decreased double-positive T cell number
|
J:129512
|
increased DN3 thymocyte number
|
J:129512
|
increased double-negative T cell number
|
J:129512
|
\Procrtm1.1Pcl/\Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6)
|
bone marrow failure
|
J:225914
|
\Prox1tm1Gco/\Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
abnormal lymph organ development
|
J:57646
|
\Prss16tm1.1Mal/\Prss16+ \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
\Prss16tm1.1Mal/\Prss16tm1.1Mal \Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
decreased double-positive T cell number
|
J:148034
|
\Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
abnormal T cell receptor V(D)J recombination
|
J:196156
|
\Psmb11tm1.1(Psmb8)Khog/\Psmb11tm1.1(Psmb8)Khog \Psmb8tm1Hjf/\Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
abnormal T cell receptor V(D)J recombination
|
J:196156
|
\Psme3tm1Jjm/\Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
decreased double-positive T cell number
|
J:88626
|
\Ptch1tm1Hahn/\Ptch1tm1Hahn \Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:127207
|
decreased double-positive T cell number
|
J:127207
|
decreased immature B cell number
|
J:127207
|
decreased transitional stage B cell number
|
J:127207
|
increased double-negative T cell number
|
J:127207
|
\Ptcratm1(icre)Hjf/\Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf)
|
decreased DN4 thymocyte number
|
J:197923
|
decreased double-positive T cell number
|
J:197923
|
\Ptcratm1.1Shoy/\Ptcratm1.1Shoy
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:166147
|
increased DN3 thymocyte number
|
J:166147
|
\Ptcratm1Bjf/\Ptcra+
(involves: 129X1/SvJ)
|
abnormal T cell differentiation
|
J:94338
|
decreased double-negative T cell number
|
J:94338
|
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
increased double-negative T cell number
|
J:91542
|
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
abnormal double-positive T cell morphology
|
J:123569
|
decreased DN4 thymocyte number
|
J:123569
|
increased DN3 thymocyte number
|
J:123569
|
\Ptger1tm1Sna/\Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:128435
|
abnormal T-helper 1 cell differentiation
|
J:128435
|
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal class switch recombination
|
J:140698
|
abnormal memory B cell differentiation
|
J:140698
|
\Pthlhtm1Hmk/\Pthlhtm1Hmk \Pth1rtm1Hmk/\Pth1rtm2Hmk \Tg(Col2a1-PTHLH)1Ecw/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * SJL)
|
abnormal bone marrow development
|
J:99641
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
decreased double-positive T cell number
|
J:42595
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr)
|
abnormal negative T cell selection
|
J:186843
|
abnormal positive T cell selection
|
J:186843
|
abnormal T cell differentiation
|
J:186843
|
decreased double-positive T cell number
|
J:186843
|
decreased immature B cell number
|
J:186843
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr)
|
decreased double-positive T cell number
|
J:186843
|
decreased immature B cell number
|
J:186843
|
\Ptpn2tm2.1Ttig/\Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig)
|
abnormal negative T cell selection
|
J:186843
|
abnormal positive T cell selection
|
J:186843
|
abnormal T cell differentiation
|
J:186843
|
decreased double-positive T cell number
|
J:186843
|
decreased immature B cell number
|
J:186843
|
\Ptpn6m3Btlr/\Ptpn6+
(C57BL/6J-Ptpn6m3Btlr)
|
decreased immature B cell number
|
J:234259
|
\Ptpn6m3Btlr/\Ptpn6m3Btlr
(C57BL/6J-Ptpn6m3Btlr)
|
decreased immature B cell number
|
J:234259
|
\Ptpn6m6Btlr/\Ptpn6m6Btlr
(C57BL/6J-Ptpn6m6Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272439
|
abnormal T cell differentiation
|
J:272439
|
\Ptpn6m7Btlr/\Ptpn6m7Btlr
(C57BL/6J-Ptpn6m7Btlr)
|
abnormal T cell differentiation
|
J:272440
|
\Ptpn6me-v/\Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
abnormal thymus development
|
J:16613
|
\Ptpn9tm1Dny/\Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
abnormal T cell differentiation
|
J:118880
|
\Ptpn11tm1Bgn/\Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
myeloid hyperplasia
|
J:91609
|
\Ptpn11tm1Ckq/\Ptpn11+ \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
myeloid hyperplasia
|
J:177285
|
\Ptpn11tm1Ckq/\Ptpn11+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
arrested B cell differentiation
|
J:177285
|
myeloid hyperplasia
|
J:177285
|
\Ptpn11tm6Bgn/\Ptpn11+ \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:148430
|
\Ptpn11tm6Bgn/\Ptpn11+ \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:148430
|
\Ptpn22tm1.1Draw/\Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
increased double-positive T cell number
|
J:201448
|
increased transitional stage T1 B cell number
|
J:201448
|
\Ptpn22tm1.1Draw/\Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
abnormal T cell differentiation
|
J:201448
|
increased double-positive T cell number
|
J:201448
|
increased transitional stage T1 B cell number
|
J:201448
|
\Ptpn22tm2Achn/\Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
\Ptpn22tm2Achn/\Ptpn22tm2Achn \Ptprctm1Weis/\Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
increased transitional stage B cell number
|
J:147129
|
\Ptprcloc/\Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal double-positive T cell morphology
|
J:104190
|
abnormal T cell selection
|
J:104190
|
arrested T cell differentiation
|
J:104190
|
decreased double-positive T cell number
|
J:104190
|
\Ptprcltng/\Ptprcltng
(C57BL/6-Ptprcltng)
|
abnormal T cell differentiation
|
J:158876
|
decreased double-positive T cell number
|
J:158876
|
\Ptprcltng/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
decreased double-positive T cell number
|
J:158876
|
\Ptprcm1Smv/\Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
abnormal CD4-positive T cell differentiation
|
J:214487
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214487
|
decreased DN4 thymocyte number
|
J:214487
|
increased DN3 thymocyte number
|
J:214487
|
increased double-negative T cell number
|
J:214487
|
\PtprcM9Btlr/\PtprcM9Btlr
(C57BL/6J-PtprcM9Btlr)
|
abnormal B cell differentiation
|
J:272745
|
\PtprcM11Btlr/\PtprcM11Btlr
(C57BL/6J-PtprcM11Btlr)
|
abnormal B cell differentiation
|
J:274863
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274863
|
\Ptprctm1Holm/\Ptprctm1Holm
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:33466
|
abnormal T cell differentiation
|
J:33466
|
decreased double-positive T cell number
|
J:33466
|
increased double-negative T cell number
|
J:33466
|
\Ptprctm1Mak/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:158876
|
increased double-negative T cell number
|
J:13163
|
\Ptprctm1Mak/\Ptprctm1Mak
(B6.Cg-Ptprctm1Mak)
|
abnormal T cell differentiation
|
J:111646
|
\Ptprctm1Mak/\Ptprctm1Mak \Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal myelopoiesis
|
J:131736
|
\Ptprctm1Mak/\Ptprctm1Mak \Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis)
|
abnormal B cell differentiation
|
J:131736
|
abnormal myelopoiesis
|
J:131736
|
abnormal transitional stage B cell morphology
|
J:131736
|
decreased immature B cell number
|
J:131736
|
\Ptprctm1Tyb/\Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
abnormal positive T cell selection
|
J:57681
|
abnormal T cell differentiation
|
J:57681
|
decreased double-positive T cell number
|
J:57681
|
increased double-negative T cell number
|
J:57681
|
\Ptprctm1Weis/\Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
abnormal granulocyte differentiation
|
J:66501
|
\Ptprctm1Weis/\Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal double-positive T cell morphology
|
J:147129
|
increased transitional stage B cell number
|
J:147129
|
\Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal B cell differentiation
|
J:131736
|
\Rac2tm1Mddw/\Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6)
|
abnormal granulocyte differentiation
|
J:53362
|
\Racgap1tm1Mahi/\Racgap1tm1Mahi \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:137760
|
abnormal myelopoiesis
|
J:137760
|
decreased pro-B cell number
|
J:137760
|
decreased transitional stage B cell number
|
J:137760
|
\Rad21tm1.1Mmk/\Rad21tm1.1Mmk \Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:175827
|
decreased double-positive T cell number
|
J:175827
|
\Rad50tm2Jpt/\Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased immature B cell number
|
J:78820
|
increased late pro-B cell number
|
J:78820
|
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-negative T cell number
|
J:103922
|
decreased pro-B cell number
|
J:103922
|
\Rad50tm2Jpt/\Rad50tm2Jpt \Smc1atm1Mbk/\Smc1atm1Mbk
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
decreased double-negative T cell number
|
J:103922
|
\Rag1/Rag2tm1Mnz/\Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
abnormal double-positive T cell morphology
|
J:90487
|
\Rag1/Rag2tm1Mnz/\Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
abnormal double-positive T cell morphology
|
J:90487
|
\Rag1em2Mvw/\Rag1em2Mvw
(A/J-Rag1em2Mvw/MvwJ)
|
arrested B cell differentiation
|
J:332675
|
arrested T cell differentiation
|
J:332675
|
\Rag1em3Mvw/\Rag1em3Mvw
(129S1/SvImJ-Rag1em3Mvw/MvwJ)
|
arrested B cell differentiation
|
J:332675
|
arrested T cell differentiation
|
J:332675
|
\Rag1m1Btlr/\Rag1m1Btlr
(C57BL/6J-Rag1m1Btlr)
|
absent late pro-B cells
|
J:150635
|
\Rag1m2Btlr/\Rag1m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Rag1m4Btlr/\Rag1m4Btlr
(C57BL/6J-Rag1m4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272094
|
abnormal T cell differentiation
|
J:272094
|
\Rag1tm1(cre)Thr/\Rag1tm1(cre)Thr
(Not Specified)
|
abnormal lymphopoiesis
|
J:86869
|
\Rag1tm1(GFP)Imku/? \Zfp335blt/\Zfp335blt
(involves: C57BL/6 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
\Rag1tm1(GFP)Imku/\Rag1tm1(GFP)Imku
(involves: C57BL/6 * CBA)
|
abnormal immunoglobulin V(D)J recombination
|
J:79416
|
\Rag1tm1.1Sadu/\Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
\Rag1tm1Bal/\Rag1tm1Bal \Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
arrested T cell differentiation
|
J:113270
|
\Rag1tm1Fwa/\Rag1tm1Fwa
(involves: 129)
|
abnormal B cell differentiation
|
J:86464
|
abnormal T cell differentiation
|
J:86464
|
increased double-negative T cell number
|
J:86464
|
\Rag1tm1Jsek/\Rag1+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:146912
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
abnormal T cell differentiation
|
J:146912
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
decreased double-positive T cell number
|
J:146912
|
\Rag1tm1Jsek/\Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
abnormal lymphopoiesis
|
J:146912
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
abnormal T cell receptor V(D)J recombination
|
J:146912
|
absent immature B cells
|
J:146912
|
arrested B cell differentiation
|
J:146912
|
arrested T cell differentiation
|
J:146912
|
decreased double-positive T cell number
|
J:146912
|
increased double-negative T cell number
|
J:146912
|
increased pro-B cell number
|
J:146912
|
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal B cell differentiation
|
J:1934
|
abnormal immunoglobulin V(D)J recombination
|
J:1934
|
abnormal T cell differentiation
|
J:1934
|
abnormal T cell receptor V(D)J recombination
|
J:1934
|
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.129S7(B6)-Rag1tm1Mom)
|
increased immature B cell number
|
J:109843
|
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal double-negative T cell morphology
|
J:112990
|
\Rag1tm1Mom/\Rag1tm1Mom \Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
increased immature B cell number
|
J:109843
|
\Rag1tm1Mom/\Rag1tm1Mom \Slc46a2tm1Moki/\Slc46a2+ \Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:140121
|
decreased double-positive T cell number
|
J:140121
|
\Rag1tm1Mom/\Rag1tm1Mom \Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
\Rag1tm1Mom/\Rag1tm1Mom \Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell receptor V(D)J recombination
|
J:47667
|
\Rag1tm1Mom/\Rag1tm1Mom \Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Rag1tm1Mom Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell differentiation
|
J:131347
|
\Rag1tm1Mom/\Rag1tm1Mom \Tg(TcraBDC12-4.1)10Jos/0 \Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased double-positive T cell number
|
J:111874
|
\Rag1tm1Mom/\Rag1tm1Mom \Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:84536
|
\Rag1tm1Mom/\Rag1tm1Mom \Vtcn1tm1Lpc/\Vtcn1tm1Lpc
(involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
abnormal neutrophil differentiation
|
J:145712
|
\Rag2tm1.1Cgn/\Rag2tm1.1Cgn
(C57BL/6-Rag2tm1.1Cgn)
|
arrested B cell differentiation
|
J:72214
|
arrested T cell differentiation
|
J:72214
|
\Rag2tm1.1Desi/\Rag2tm1.1Desi
(involves: 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
\Rag2tm1.1Mss/\Rag2tm1.1Mss
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:171970
|
increased DN3 thymocyte number
|
J:171970
|
\Rag2tm1Avla/\Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:122108
|
arrested T cell differentiation
|
J:122108
|
decreased double-positive T cell number
|
J:122108
|
\Rag2tm1Cgn/\Rag2tm1.1Cgn \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
absent immature B cells
|
J:72214
|
arrested B cell differentiation
|
J:72214
|
arrested T cell differentiation
|
J:72214
|
\Rag2tm1Cgn/\Rag2tm1Cgn \Xrcc4tm1Fwa/\Xrcc4tm2Fwa \Tg(Cr2-cre)3Cgn/?
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:150339
|
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
abnormal immunoglobulin V(D)J recombination
|
J:1935
|
abnormal T cell receptor V(D)J recombination
|
J:1935
|
arrested B cell differentiation
|
J:1935
|
arrested T cell differentiation
|
J:1935
|
decreased double-positive T cell number
|
J:1935
|
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
decreased double-negative T cell number
|
J:81133,
J:91542
|
increased double-negative T cell number
|
J:91542
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Rr299391tm1.1Fwa/\Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:149413
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Sos1tm1.1Les/\Sos1tm1.1Les \Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:174536
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:166065
|
\Rag2tm1Fwa/\Rag2tm1Fwa \TcraLn3Jae/\Tcra+ \TcrbLn3Jae/\Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
\Rag2tm1Fwa/\Rag2tm1Fwa \TcrbLn3Jae/\Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
increased double-positive T cell number
|
J:143006
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(EmuSR-tTa)83Bop/0 \Tg(tetO-Nfatct1*)1Grc/0
(involves: 129S/SvEv * C57BL/6J * CBA/J * FVB/N)
|
abnormal double-positive T cell morphology
|
J:141917
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Lck-Akt1*)M-1Pnt/0
(involves: 129S/SvEv * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Tcra5CC7,Tcrb5CC7)IWep/? \Themis5AT161/\Themis5AT161
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:151076
|
increased double-positive T cell number
|
J:151076
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125548
|
abnormal positive T cell selection
|
J:125548
|
increased double-positive T cell number
|
J:125548
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:78309
|
\Rag2tm1Fwa/\Rag2tm1Fwa \Tg(TcrHEL3A9)1Mmd/0 \Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
decreased double-positive T cell number
|
J:78309
|
\Rag2tm1Fwa/\Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:81837
|
arrested B cell differentiation
|
J:81837
|
arrested T cell differentiation
|
J:81837
|
decreased double-negative T cell number
|
J:81837
|
decreased immature B cell number
|
J:81837
|
increased immature B cell number
|
J:81837
|
\Rag2tm1Libo/\Rag2tm1Libo
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:84563
|
\Rag2tm1Mao/\Rag2tm1Mao
(involves: 129 * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:81837
|
arrested B cell differentiation
|
J:81837
|
arrested T cell differentiation
|
J:81837
|
decreased double-negative T cell number
|
J:81837
|
decreased immature B cell number
|
J:81837
|
increased immature B cell number
|
J:81837
|
\Rag2tm1Tgi/\Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:113641
|
arrested T cell differentiation
|
J:113641
|
decreased double-positive T cell number
|
J:113641
|
\Ramp2tm1Kmca/\Ramp2tm1Kmca
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lymph organ development
|
J:130930
|
\Raratm1.1Ybe/\Raratm1.1Ybe
(involves: C57BL/6N)
|
abnormal lymphopoiesis
|
J:207485
|
\Raratm1Ipc/\Raratm1Ipc \Rarbtm1Ipc/\Rarbtm1Ipc
(involves: 129S2/SvPas)
|
persistent cervical thymus
|
J:21034
|
\Raratm1Ipc/\Raratm1Ipc \Rarbtm1Mma/\Rarbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
persistent cervical thymus
|
J:43344
|
\Raratm1Ipc/\Raratm1Ipc \Rargtm1Ipc/\Rargtm1Ipc
(involves: 129S2/SvPas)
|
persistent cervical thymus
|
J:21034
|
\Rarres1tm1.2Mhl/\Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
abnormal B cell differentiation
|
J:324270
|
abnormal plasma cell differentiation
|
J:324270
|
\Rasa3tm1.1Llp/\Rasa3tm1.1Llp \Tg(Mx1-cre)1Cgn/?
(involves: 129S1/SvImJ * C57BL/6J * CBA/J)
|
bone marrow failure
|
J:301035
|
\Rasgrp1lag/\Rasgrp1lag
(involves: 129 * C57BL/6)
|
abnormal positive T cell selection
|
J:85189
|
\Rasgrp1m1Anu/\Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu)
|
abnormal T cell differentiation
|
J:104190
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225109
|
abnormal T cell differentiation
|
J:225109
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:225109
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz \Tg(TcraTcrb)425Cbn/?
(involves: C57BL/6 * BALB/c)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
\Rasgrp1tm1Jstn/\Rasgrp1tm1Jstn
(involves: 129P3/J)
|
abnormal double-positive T cell morphology
|
J:207898
|
\Rassf5tm1Kina/\Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal B cell differentiation
|
J:92670
|
\Rb1tm1Mlh/\Rb1tm1Mlh
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal myelopoiesis
|
J:2498
|
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas)
|
abnormal macrophage differentiation
|
J:105548
|
\Rb1tm2Mlh/\Rb1tm2Mlh
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal myelopoiesis
|
J:2498
|
\Rb1cc1tm1.1Guan/\Rb1cc1tm1.1Guan \Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv)
|
abnormal myelopoiesis
|
J:167258
|
\Rbm15tm1Dgg/\Rbm15tm1.1Dgg \Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA * FVB/N)
|
abnormal B cell differentiation
|
J:120321
|
\Rbpjtm1Hon/\Rbpjtm1Hon \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal T-helper 2 cell differentiation
|
J:90018
|
\Rbpjtm1Hon/\Rbpjtm1Hon \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:99747
|
abnormal lymphopoiesis
|
J:99747
|
arrested T cell differentiation
|
J:125869,
J:99747
|
decreased double-positive T cell number
|
J:99747
|
increased double-negative T cell number
|
J:99747
|
\Rc3h1san/\Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
|
abnormal T cell differentiation
|
J:98938
|
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)
|
abnormal B cell differentiation
|
J:177784
|
decreased immature B cell number
|
J:177784
|
\Rc3h1tm1.2Mass/\Rc3h1tm1.2Mass
(involves: C57BL/6 * CBA * NZB * SJL)
|
abnormal thymus development
|
J:177784
|
\RelM2Btlr/\RelM2Btlr
(C57BL/6J-RelM2Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272778
|
abnormal T cell differentiation
|
J:272778
|
\Reltm1Grd/\Reltm1Grd \Relatm1Bal/\Relatm1Bal
(B6.129S-Reltm1Grd Relatm1Bal)
|
abnormal monocyte differentiation
|
J:111325
|
\Reltm1Hcl/\Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:79107
|
\Relatm1Yuo/\Relatm1Yuo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:63099
|
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
myeloid hyperplasia
|
J:22675
|
\Rev1tm1.1Jow/\Rev1tm1.1Jow
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:151700
|
\Rev1tm1Ndew/\Rev1tm1Ndew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:119176
|
\Rev3ltm1.1Kunk/\Rev3ltm1.1Kunk
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:188723
|
\Rev3ltm1Rsky/\Rev3ltm1.1Rsky \Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:146453
|
abnormal somatic hypermutation frequency
|
J:146453
|
\Rftn1tm1Ayos/\Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
|
abnormal CD4-positive T cell differentiation
|
J:150299
|
\Rgs13tm1.1Jhk/\Rgs13tm1.1Jhk
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:199530
|
\Rhohtm1Brak/\Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143161
|
decreased double-positive T cell number
|
J:143161
|
increased double-negative T cell number
|
J:143161
|
\Rhohtm1Brak/\Rhohtm1Brak \Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:143161
|
increased double-negative T cell number
|
J:143161
|
\Rhohtm1Daw/\Rhohtm1Daw
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:113565
|
decreased double-positive T cell number
|
J:113565
|
\Rictortm1.1Klg/\Rictortm1.1Klg \Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
abnormal double-negative T cell morphology
|
J:189736
|
decreased DN1 thymic pro-T cell number
|
J:189736
|
decreased DN2 thymocyte number
|
J:189736
|
decreased DN3 thymocyte number
|
J:189736
|
decreased DN4 thymocyte number
|
J:189736
|
decreased double-positive T cell number
|
J:189736
|
increased double-negative T cell number
|
J:189736
|
\Rif1Gt(XT0278)Wtsi/\Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
abnormal class switch recombination
|
J:195061
|
\Rigitm1Zgwg/\Rigitm1Zgwg
(involves: 129S1/Sv)
|
abnormal B cell differentiation
|
J:139016
|
\Rinltm1.1Boun/\Rinltm1.1Boun \Tg(TcraTcrb)425Cbn/0
(involves: C57BL/6)
|
abnormal T follicular helper cell differentiation
|
J:346452
|
\Ripply3tm1Sjt/\Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymus development
|
J:167713
|
\Rnf2tm1Mvi/\Rnf2tm1Mvi \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)
|
abnormal B cell differentiation
|
J:130397
|
\Rnf8Gt(AS0574)Wtsi/\Rnf8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
\Rnf8Gt(AS0574)Wtsi/\Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
decreased double-negative T cell number
|
J:161240
|
decreased double-positive T cell number
|
J:161240
|
decreased immature B cell number
|
J:161240
|
decreased pro-B cell number
|
J:161240
|
\Rnf8Gt(RRR260)Byg/\Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
decreased double-negative T cell number
|
J:161240
|
decreased double-positive T cell number
|
J:161240
|
decreased immature B cell number
|
J:161240
|
decreased pro-B cell number
|
J:161240
|
\Rnf168Gt(156B6)Cmhd/\Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
increased DN3 thymocyte number
|
J:198260
|
increased double-negative T cell number
|
J:198260
|
\Rnf168Gt(405F11)Cmhd/\Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
increased DN3 thymocyte number
|
J:198260
|
increased double-negative T cell number
|
J:198260
|
\Rorctm1.1Zsun/\Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun)
|
abnormal T-helper 17 cell differentiation
|
J:248565
|
\Rorctm1Amj/\Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
abnormal lymph organ development
|
J:64381
|
decreased double-positive T cell number
|
J:64381
|
increased double-negative T cell number
|
J:64381
|
\Rorctm1Litt/\Rorctm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:248565
|
abnormal T cell differentiation
|
J:128344,
J:248565
|
abnormal T-helper 17 cell differentiation
|
J:248565
|
decreased double-positive T cell number
|
J:248565
|
\Rorctm1Litt/\Rorctm1Litt \Tcra-Jtm3.1Krg/\Tcra-Jtm3.1Krg
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
\Rorctm2Litt/\Rorctm2Litt
(involves: 129P2/OlaHsd)
|
abnormal lymph organ development
|
J:87395
|
decreased double-negative T cell number
|
J:91566
|
decreased double-positive T cell number
|
J:87395
|
\Rpl22Gt(GST000137)Lex/\Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:123569
|
arrested T cell differentiation
|
J:123569
|
decreased double-negative T cell number
|
J:123569
|
\Rpl22Gt(YHB332)Byg/\Rpl22Gt(YHB332)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus development
|
J:201164
|
\Rr38tm1.2Aafo/\Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased double-positive T cell number
|
J:227747
|
increased DN3 thymocyte number
|
J:227747
|
\Rr94tm3.1Litt/\Rr94+ \Tg(Cd4-cre)1Cwi/0 \Rr112tm4.1Litt/\Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
\Rr94tm3.1Litt/\Rr94tm3.1Litt \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
decreased double-positive T cell number
|
J:158962
|
\Rr94tm3.2Litt/\Rr94+ \Rr112tm4.1Litt/\Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
\Rr94tm3.2Litt/\Rr94tm3.2Litt
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
abnormal T cell differentiation
|
J:158962
|
decreased double-positive T cell number
|
J:158962
|
\Rr96tm1.1Tich/\Rr96+ \Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96+ \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96tm1.1Tich \Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96tm1.1Tich \Tg(ACTB-tTS)1Mllo/?
(involves: 129 * C57BL/6)
|
decreased double-positive T cell number
|
J:191711
|
\Rr96tm1.1Yzo/\Rr96tm1.1Yzo
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:130559
|
increased double-positive T cell number
|
J:130559
|
\Rr96tm1.1Yzo/\Rr96tm1.1Yzo \H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
\Rr96tm1Yzo/\Rr96tm1Yzo \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:130559
|
increased double-positive T cell number
|
J:130559
|
\Rr96tm1Yzo/\Rr96tm1Yzo \Tg(Cd8a-cre,-GFP)1Yzo/?
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:130559
|
\Rr96tm2Litt/\Rr96+ \Zbtb7btm1.1Tani/\Zbtb7btm1.1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Rr96tm2Litt/\Rr96+ \Zbtb7btm1Itan/\Zbtb7btm1.1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:141142
|
\Rr96tm2Litt/\Rr96tm2Litt \Tfap4tm1.1Litt/\Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
\Rr97tm3Welm/\Rr97tm3Welm
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:126027
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:126027
|
abnormal double-positive T cell morphology
|
J:126027
|
abnormal T cell differentiation
|
J:126027
|
\Rr100tm2.1Welm/\Rr100+
(involves: 129P2/OlaHsd * AKR.1 * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
\Rr100tm2.1Welm/\Rr100tm2.1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
decreased double-positive T cell number
|
J:113136
|
\Rr100tm2.1Welm/\Rr100tm2.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:158947
|
decreased double-positive T cell number
|
J:158947
|
\Rr148tm1.1Fwa/\Rr148tm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
arrested B cell differentiation
|
J:101400
|
decreased immature B cell number
|
J:101400
|
\Rr148tm1.1Fwa/\Rr148tm1.1Fwa \Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
\Rr148tm1Anbo/\Rr148tm1Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
decreased immature B cell number
|
J:136307
|
\Rr148tm1Fwa/\Rr148tm1Fwa
(129S6/SvEvTac-Rr148tm1Fwa)
|
abnormal immature B cell morphology
|
J:101400
|
arrested B cell differentiation
|
J:101400
|
\Rr148tm1Fwa/\Rr148tm1Fwa \Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
\Rr148tm2Anbo/\Rr148tm2Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
decreased immature B cell number
|
J:136307
|
\Rr152tm3.1Cog/\Rr152tm3.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:71300
|
\Rr152tm3Cog/\Rr152tm3Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:71300
|
\Rr152tm5.1Cog/\Rr152tm5.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:164513
|
abnormal somatic hypermutation frequency
|
J:164513,
J:333348
|
\Rr158tm1(Igh)Xu/\Rr158tm1(Igh)Xu
(Not Specified)
|
decreased immature B cell number
|
J:124407
|
\Rr158tm1Cgn/\Rr158tm1Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574,
J:64287
|
\Rr158tm2Cgn/\Rr158tm2Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574
|
\Rr159tm1.1Fwa/\Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
\Rr159tm1.1Fwa/\Rr159tm1.1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
\Rr159tm1Fwa/\Rr159tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
\Rr160tm1Wtg/\Rr160tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:134885
|
increased transitional stage B cell number
|
J:134885
|
\Rr161tm2.2Wtg/\Rr161tm2.2Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:167472
|
abnormal immunoglobulin V(D)J recombination
|
J:167472
|
decreased pro-B cell number
|
J:167472
|
\Rr162tm3.1Wtg/\Rr162tm3.1Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:172855
|
\Rr166tm4.1Wtg/\Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:193015
|
abnormal immunoglobulin light chain V-J recombination
|
J:193015
|
\Rr169tm2Rao/\Rr169+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
\Rr169tm2Rao/\Rr169tm2Rao
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
\Rr253em1Kmm/\Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
abnormal class switch recombination
|
J:316113
|
\Rr308tm1.1Fwa/\Rr308tm1.1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616,
J:82395
|
abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
\Rr308tm1Fwa/\Rr308tm1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616
|
abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
\Rr308tm2Fwa/\Rr308tm2Fwa
(Not Specified)
|
abnormal T cell differentiation
|
J:82395
|
\Rr338em1Jeng/\Rr338em1Jeng
(Not Specified)
|
abnormal T cell differentiation
|
J:232438
|
\Rr364tm1.1Aak/\Rr364tm1.1Aak
(129.129S2(Cg)-Rr364tm1.1Aak)
|
abnormal class switch recombination
|
J:242276
|
\Rr394em1Bhao/\Rr394em1Bhao
(Not Specified)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:333961
|
increased DN3 thymocyte number
|
J:333961
|
\Rr395em1Bhao/\Rr395em1Bhao
(Not Specified)
|
decreased double-positive T cell number
|
J:333961
|
increased DN4 thymocyte number
|
J:333961
|
\Rr149356tm1.1Pf/\Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal T cell differentiation
|
J:34311
|
arrested T cell differentiation
|
J:34311
|
decreased double-positive T cell number
|
J:34311
|
increased double-negative T cell number
|
J:34311
|
\Rr149356tm1Abnd/\Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:137580
|
arrested T cell differentiation
|
J:137580
|
decreased double-positive T cell number
|
J:137580
|
increased double-negative T cell number
|
J:137580
|
\Rr149356tm1Che/\Rr149356tm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246,
J:107306
|
abnormal double-positive T cell morphology
|
J:106246,
J:107306
|
\Rr149356tm1Che/\Rr149356tm1Che \Tcrdtm1Mom/\Tcrdtm1Mom \Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
\Rr149356tm1Che/\Rr149356tm1Che \Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
abnormal double-positive T cell morphology
|
J:106246
|
\Rr275254tm2.1Dhr/\Rr275254tm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr275254tm2Dhr/\Rr275254tm2Dhr
(involves: 129S4/SvJae)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr282726tm1Dhr/\Rr282726tm1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr282729tm1.1Iku/\Rr282729tm1.1Iku
(C57BL/6J-Rr316tm1.1Iku)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:288442
|
\Rragcem1Efe/\Rragc+
(Not Specified)
|
abnormal class switch recombination
|
J:320567
|
\Rsad2tm1Kchc/\Rsad2tm1Kchc
(B6.129-Rsad2tm1Kchc)
|
abnormal T-helper 2 cell differentiation
|
J:148305
|
\Rthyd1NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd2B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd3B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd5NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Runx1tm1(RUNX1)Gcg/\Runx1tm1(RUNX1)Gcg \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal granulocyte differentiation
|
J:106800
|
abnormal myelopoiesis
|
J:106801
|
abnormal T cell differentiation
|
J:106800
|
decreased double-positive T cell number
|
J:106800
|
\Runx1tm1(RUNX1/EVI1)Kmit/\Runx1+
(involves: C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:118892
|
\Runx1tm1Soga/\Runx1tm1.1Soga \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:88511
|
abnormal T cell differentiation
|
J:88511
|
\Runx1tm1Spe/\Runx1tm1Spe
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
impaired myelopoiesis
|
J:35115
|
\Runx1tm1Tani/\Runx1tm1Tani \Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125959
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125959
|
abnormal double-positive T cell morphology
|
J:125959
|
\Runx1tm1Tani/\Runx1tm1Tani \Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:125959
|
decreased double-positive T cell number
|
J:125959
|
increased double-negative T cell number
|
J:125959
|
\Runx1tm1Yg/\Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal leukopoiesis
|
J:125830
|
abnormal T cell differentiation
|
J:125830
|
increased double-positive T cell number
|
J:125830
|
\Runx1tm2.1Gss/\Runx1tm2.1Gss
(involves: 129S4/SvJae * C57BL/6)
|
decreased immature B cell number
|
J:214025
|
decreased pre-pro B cell number
|
J:214025
|
increased pro-B cell number
|
J:214025
|
myeloid hyperplasia
|
J:214025
|
\Runx1tm2Buch/\Runx1tm2Buch \Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:105709
|
impaired myelopoiesis
|
J:105709
|
\Runx1tm3Itan/\Runx1tm3Itan
(involves: 129P2/OlaHsd)
|
abnormal lymph organ development
|
J:168918
|
\Runx1tm3Spe/\Runx1tm3Spe \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:131217
|
decreased double-negative T cell number
|
J:131217
|
increased double-negative T cell number
|
J:131217
|
\Runx1tm3Spe/\Runx1tm3Spe \Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae)
|
decreased double-positive T cell number
|
J:145700
|
\Runx3tm1Itan/\Runx3tm1Itan \Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
\Runx3tm1Litt/\Runx3tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
abnormal double-positive T cell morphology
|
J:141144
|
\Runx3tm1Yg/\Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal dendritic cell differentiation
|
J:88424
|
\Runx3tm2Yg/\Runx3tm2Yg
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)
|
abnormal dendritic cell differentiation
|
J:109584
|
\Ruvbl1tm1.1Oxbk/\Ruvbl1tm1.1Oxbk \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA/J * SJL)
|
bone marrow failure
|
J:220926
|
\Ruvbl2M1Btlr/\Ruvbl2+
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
decreased double-positive T cell number
|
J:185495
|
\S1pr1tm1Rlp/\S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal NK cell differentiation
|
J:154069
|
\S1pr4tm1Lipp/\S1pr4tm1Lipp
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:179199
|
\S1pr5tm1Jch/\S1pr5tm1Jch
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:154069
|
\Samd3tm1.1(HBEGF)Wfkr/\Samd3+
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
abnormal NK cell differentiation
|
J:322359
|
\Samd9ltm1Homy/\Samd9l+
(involves: 129P2/OlaHsd)
|
abnormal myelopoiesis
|
J:202604
|
\Samd9ltm1Homy/\Samd9ltm1Homy
(involves: 129P2/OlaHsd)
|
abnormal myelopoiesis
|
J:202604
|
\Sash3tm1Hlz/\Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
abnormal CD4-positive T cell differentiation
|
J:102171
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:102171
|
decreased double-positive T cell number
|
J:102171
|
\Satb1tm1Kos/\Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:61085
|
arrested T cell differentiation
|
J:61085
|
\Scmh1tm1Yota/\Scmh1tm1Yota
(involves: 129X1/SvJ * C57BL/6)
|
myeloid hyperplasia
|
J:194424
|
\Seletm1Hyn/\Seletm1Hyn \Selptm1Hyn/\Selptm1Hyn
(involves: 129S2/SvPas)
|
abnormal granulocyte differentiation
|
J:31626
|
abnormal myelopoiesis
|
J:31626
|
\Sema4atm1Kik/\Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
abnormal T-helper 1 cell differentiation
|
J:97027
|
\Senp1tm1.1Wami/\Senp1tm1.1Wami
(involves: 129 * C57BL/6)
|
abnormal granulocyte differentiation
|
J:163428
|
abnormal monocyte differentiation
|
J:163428
|
\Septin9tm2.1Emfu/\Septin9tm2.1Emfu \Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:205027
|
decreased DN4 thymocyte number
|
J:205027
|
increased DN3 thymocyte number
|
J:205027
|
increased double-negative T cell number
|
J:205027
|
\Serpini2pq/\Serpini2pq
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:115744
|
abnormal pro-B cell morphology
|
J:115744
|
decreased immature B cell number
|
J:115744
|
decreased pro-B cell number
|
J:115744
|
\Sesn1tm1a(EUCOMM)Wtsi/\Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:240602
|
\Sf3b1tm1.1Mdf/\Sf3b1+ \Tet2tm1.1Iaai/\Tet2tm1.1Iaai \Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal myelopoiesis
|
J:234976
|
\Sf3b1tm1.1Mdf/\Sf3b1+ \Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal myelopoiesis
|
J:234976
|
\Sfntm1Mak/\Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:168328
|
\Sgpl1Gt(OST58278)Lex/\Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:145159
|
decreased double-positive T cell number
|
J:145159
|
\Sh2b2tm1Yeb/\Sh2b2tm1Yeb
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:88527
|
\Sh2b3tm1Paw/\Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal granulocyte differentiation
|
J:77248
|
abnormal monocyte differentiation
|
J:77248
|
\Sh2b3tm1Paw/\Sh2b3tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
myeloid hyperplasia
|
J:161643
|
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
(B6.129S4-Sh2d1atm1Cpt)
|
decreased transitional stage B cell number
|
J:97690
|
\Sh3bp2tm1Rtpl/\Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
decreased pro-B cell number
|
J:121380
|
decreased transitional stage B cell number
|
J:121380
|
\Sh3kbp1tm1Kuro/\Sh3kbp1tm1Kuro \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * NZB)
|
decreased immature B cell number
|
J:176805
|
decreased transitional stage T2 B cell number
|
J:176805
|
decreased transitional stage T3 B cell number
|
J:176805
|
\Shc1tm1Ravi/\Shc1tm1Ravi \Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
decreased double-positive T cell number
|
J:78180
|
\Shld1em1Nus/\Shld1em1Nus
(involves: C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
\Siglecftm1.2Avrk/\Siglecftm1.2Avrk
(B6.129(FVB)-Siglecftm1.2Avrk)
|
abnormal eosinophil differentiation
|
J:204811
|
\Siglecgtm1Lnit/\Siglecgtm1Lnit
(involves: BALB/c)
|
abnormal plasma cell differentiation
|
J:123353
|
\Sin3btm1.2Rdp/\Sin3btm1.2Rdp
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
abnormal granulocyte differentiation
|
J:154855
|
\Sirt6tm1Fwa/\Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112817
|
abnormal lymphopoiesis
|
J:112817
|
decreased double-positive T cell number
|
J:112817
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
abnormal T cell differentiation
|
J:100408
|
abnormal T-helper 1 cell differentiation
|
J:100408
|
increased double-positive T cell number
|
J:100408
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:100408
|
abnormal T cell differentiation
|
J:100408
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn \Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:100408
|
abnormal T cell selection
|
J:100408
|
\Skint1m1Tac/\Skint1m1Tac
(FVB/NTac)
|
abnormal T cell differentiation
|
J:139711
|
\Skp2tm1Kin/\Skp2tm1Kin
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
\Slatm1Weis/\Slatm1Weis
(involves: 129 * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:71804
|
\Slatm1Weis/\Slatm1Weis \Sla2tm1Amch/\Sla2tm1Amch
(involves: 129)
|
abnormal dendritic cell differentiation
|
J:169170
|
\Slatm1Weis/\Slatm1Weis \Tg(DO11.10)10Dlo/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:71804
|
abnormal T cell differentiation
|
J:71804
|
\Slatm1Weis/\Slatm1Weis \Zap70tm1Weis/\Zap70tm1Weis
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:71804
|
\Slc1a5tm1Tac/\Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:254980
|
abnormal T-helper 2 cell differentiation
|
J:254980
|
abnormal T-helper 17 cell differentiation
|
J:254980
|
\Slc3a2tm1.1Yait/\Slc3a2tm1.1Yait \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrSlc)
|
abnormal macrophage differentiation
|
J:188365
|
\Slc19a1tm1Gold/\Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:68666
|
\Slc19a2tm1Gelb/\Slc19a2tm1Gelb
(involves: 129X1/SvJ)
|
abnormal myelopoiesis
|
J:79974
|
\Slc29a3tm1Lex/\Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
myeloid hyperplasia
|
J:179286
|
\Slc37a4tm1Jyc/\Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelopoiesis
|
J:86005
|
\Slc39a3tm1Gka/\Slc39a3tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:99161
|
\Slc40a1Pcm/\Slc40a1+
(A.Cg-Slc40a1Pcm)
|
abnormal spleen development
|
J:98335
|
\Slc40a1Pcm/\Slc40a1Pcm
(A.Cg-Slc40a1Pcm)
|
abnormal spleen development
|
J:98335
|
\Slx4tm1a(EUCOMM)Wtsi/\Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
abnormal lymphopoiesis
|
J:168567
|
\Smad3tm1Cxd/\Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955
|
\Smad7tm1.1Ink/\Smad7tm1.1Ink \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
\Smad7tm1Rheu/\Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal class switch recombination
|
J:120714
|
\Smap1tm1.1Sata/\Smap1tm1.1Sata
(B6.Cg-Smap1tm1.1Sata)
|
abnormal myelopoiesis
|
J:196385
|
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn \Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-negative T cell number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn \Tg(Lck-cre)1Cwi/0 \Tg(LCKprBCL2L1)12Sjk/0
(Not Specified)
|
decreased double-positive T cell number
|
J:144072
|
increased double-negative T cell number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1Mag \Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:85191
|
arrested T cell differentiation
|
J:85191
|
decreased double-negative T cell number
|
J:85191
|
decreased double-positive T cell number
|
J:85191
|
\Smarca4tm1.2Pcn/\Smarca4tm1Mag \Tg(Lck-cre)1Cwi/? \Tg(LCKprBCL2)36Sjk/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:85191
|
\Smarca4tm1.2Pcn/\Smarca4tm1Tich \Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1Tich \Tg(Lck-cre)1Cwi/0 \Tg(LCKprBCL2L1)12Sjk/0
(involves: 129)
|
decreased double-positive T cell number
|
J:144072
|
increased double-negative T cell number
|
J:144072
|
\Smarca4tm1Tich/\Smarca4+ \Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
decreased double-positive T cell number
|
J:144072
|
\Smarcc1tm2.1Rhs/\Smarcc1tm2.1Rhs \Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:184060
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:184060
|
abnormal pro-B cell morphology
|
J:184060
|
arrested B cell differentiation
|
J:184060
|
decreased early pro-B cell number
|
J:184060
|
decreased late pro-B cell number
|
J:184060
|
decreased pro-B cell number
|
J:184060
|
\Snai2tm2Grid/\Snai2tm2Grid
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:78323
|
\Snai2tm2Grid/\Snai2tm2Grid \Snai3tm1.2Jhws/\Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:204710
|
\Snrnp40em1Btlr/\Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
abnormal thymus development
|
J:282417
|
decreased DN1 thymic pro-T cell number
|
J:282417
|
decreased DN4 thymocyte number
|
J:282417
|
\Socs1tm1Ayos/\Socs1tm1Ayos \Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
\Socs1tm1Jni/\Socs1tm1Jni
(Not Specified)
|
abnormal T cell differentiation
|
J:57475
|
\Socs1tm1Wehi/\Socs1tm3Wehi \Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal T cell differentiation
|
J:83009
|
\Socs3tm1Wsa/\Socs3tm2Wsa \Tg(Vav1-cre)1Awr/0
(involves: C57BL/6)
|
abnormal granulocyte differentiation
|
J:89785
|
abnormal myelopoiesis
|
J:89785
|
\Sod2tm1Leb/\Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J)
|
impaired myelopoiesis
|
J:36148
|
\Sonem1.1Bcgen/\Son+
(B6(Cg)-Sonem1.1Bcgen)
|
abnormal B cell differentiation
|
J:347709
|
abnormal transitional stage B cell morphology
|
J:347709
|
decreased transitional stage T2 B cell number
|
J:347709
|
increased transitional stage T1 B cell number
|
J:347709
|
\Sos1tm1.1Les/\Sos1tm1.1Les \Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased DN4 thymocyte number
|
J:174536
|
decreased double-negative T cell number
|
J:174536
|
decreased double-positive T cell number
|
J:174536
|
\Sox4tm1Cle/\Sox4tm1Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
decreased pro-B cell number
|
J:32741
|
\Sox4tm2Cle/\Sox4tm2Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
decreased pro-B cell number
|
J:32741
|
\Sp3tm1Sus/\Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84837
|
\Spentm1Hon/\Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:82332
|
\Sphk1tm1.1Cgh/\Sphk1tm2Cgh \Sphk2tm1.1Cgh/\Sphk2tm1.1Cgh \Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal NK cell differentiation
|
J:154069
|
abnormal T cell differentiation
|
J:120783
|
\Spi1tm1.2Nutt/\Spi1tm1.2Nutt \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal granulocyte differentiation
|
J:98188
|
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106040
|
arrested B cell differentiation
|
J:106040
|
decreased pro-B cell number
|
J:106040
|
\Spi1tm1Kast/\Spi1tm1Kast
(B6.129S2-Spi1tm1Kast)
|
failure of myelopoiesis
|
J:90543
|
\Spi1tm1Ram/\Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage differentiation
|
J:36473
|
abnormal neutrophil differentiation
|
J:36473
|
abnormal T cell differentiation
|
J:36473
|
decreased double-positive T cell number
|
J:36473
|
\Spi1tm1Rpd/\Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss)
|
abnormal myelopoiesis
|
J:123079
|
arrested B cell differentiation
|
J:123079
|
impaired myelopoiesis
|
J:123079
|
\Spi1tm1Sing/\Spi1+ \Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:88257
|
abnormal immature B cell morphology
|
J:88257
|
\Spi1tm1Sing/\Spi1tm1Sing
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:20348
|
abnormal leukopoiesis
|
J:20348
|
abnormal T cell differentiation
|
J:20348
|
\Spi1tm3Dgt/\Spi1tm3Dgt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-negative T cell number
|
J:131217
|
increased double-negative T cell number
|
J:131217
|
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immature B cell morphology
|
J:88257
|
\Spink5tm2.1Hov/\Spink5tm2.1Hov \Tg(KRT5-cre/ERT2)2Ipc/0
(involves: C57BL/6 * C57BL/6JRj * SJL)
|
arrested T cell differentiation
|
J:357366
|
decreased double-positive T cell number
|
J:357366
|
myeloid hyperplasia
|
J:357366
|
\Spns2tm1.2Nmoc/\Spns2tm1.2Nmoc
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased immature B cell number
|
J:184558
|
decreased transitional stage T1 B cell number
|
J:184558
|
\Sppl2achompB/\Sppl2achompB
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:194595
|
decreased transitional stage T2 B cell number
|
J:194595
|
\Sppl2am1Anu/\Sppl2am1Anu
(involves: C57BL/6JAnu)
|
abnormal transitional stage B cell morphology
|
J:194663
|
decreased transitional stage T2 B cell number
|
J:194663
|
decreased transitional stage T3 B cell number
|
J:194663
|
\Sppl2am1Anu/\Sppl2am1Anu \Tg(Vav-BCL2)69Jad/?
(involves: C57BL/6JAnu)
|
decreased double-negative T cell number
|
J:194663
|
\Sppl2atm1Basc/\Sppl2atm1Basc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
arrested B cell differentiation
|
J:194664
|
decreased transitional stage T2 B cell number
|
J:194664
|
\Sppl2atm1Dgen/\Sppl2atm1Dgen
(B6.129P2-Sppl2atm1Dgen)
|
decreased transitional stage T2 B cell number
|
J:194595
|
\Sppl3tm1Itl/\Sppl3em1Pomz \Ncr1tm1.1(icre)Viv/\Ncr1+
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
abnormal NK cell differentiation
|
J:280182
|
\Sppl3tm1Itl/\Sppl3tm1Itl \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell differentiation
|
J:280182
|
\Sppl3tm1Itl/\Sppl3tm1Itl \Ncr1tm1.1(icre)Viv/\Ncr1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal NK cell differentiation
|
J:280182
|
\Srsf2tm1.1Oaw/\Srsf2+ \Tg(Mx1-cre)1Cgn/?
(B6.Cg-Tg(Mx1-cre)1Cgn Srsf2tm1.1Oaw)
|
abnormal myelopoiesis
|
J:221404
|
failure of myelopoiesis
|
J:221404
|
\Srsf2tm1Xdfu/\Srsf2tm1Xdfu \Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
abnormal T cell differentiation
|
J:88668
|
decreased double-positive T cell number
|
J:88668
|
increased double-negative T cell number
|
J:88668
|
\Srsf2tm1Xdfu/\Srsf2tm1Xdfu \Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
bone marrow failure
|
J:221404
|
\Srsf3tm1Pjln/\Srsf3tm1Pjln \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased pro-B cell number
|
J:113645
|
\Srsf3tm1Pjln/\Srsf3tm1Pjln \Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA)
|
abnormal thymus development
|
J:205756
|
\Ssbtm1Rjma/\Ssbtm2.1Rjma \Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S/SvEv * BALB/c)
|
arrested B cell differentiation
|
J:207687
|
\St6gal1tm1Jlau/\St6gal1tm1Jlau
(B6.129S4-St6gal1tm1Jlau)
|
abnormal myelopoiesis
|
J:140547
|
\St6gal1tm1Jxm/\St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased transitional stage B cell number
|
J:132991
|
\St14tm1Bug/\St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased double-positive T cell number
|
J:87125
|
\Stat1m5Btlr/\Stat1m5Btlr
(C57BL/6J-Stat1m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274938
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274938
|
abnormal T cell differentiation
|
J:274938
|
\Stat2tm1Shnd/\Stat2tm1Shnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:66564
|
\Stat3tm1Dlv/\Stat3tm1Dlv \Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:124293
|
\Stat4tm1Gru/\Stat4tm1Gru
(C.129S2-Stat4tm1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
\Stat5atm1Jni/\Stat5atm1Jni \Stat5btm2Jni/\Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))
|
abnormal myelopoiesis
|
J:77412
|
\Stat5atm1Jni/\Stat5atm1Jni \Stat5btm2Jni/\Stat5btm2Jni
(involves: 129 * C57BL/6)
|
abnormal mast cell differentiation
|
J:84889
|
\Stat5atm1Mam/\Stat5atm1Mam
(C.129S6-Stat5atm1Mam)
|
abnormal mast cell differentiation
|
J:101855
|
\Stat5atm2Mam/\Stat5atm2Mam \Stat5btm1Mam/\Stat5b+
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:258967
|
\Stat5atm2Mam/\Stat5atm2Mam \Stat5btm1Mam/\Stat5btm1Mam \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:155489
|
abnormal neutrophil differentiation
|
J:155489
|
\Stat5btm1Hwd/\Stat5btm1Hwd
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112035
|
\Stat5btm1Mam/\Stat5btm1Mam \Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:155489
|
abnormal neutrophil differentiation
|
J:155489
|
\Stat6tm1Gru/\Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
\Stat6tm1Gru/\Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
abnormal T-helper 2 cell differentiation
|
J:31932
|
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal class switch recombination
|
J:32607
|
abnormal T-helper 1 cell differentiation
|
J:32607
|
abnormal T-helper 2 cell differentiation
|
J:32607
|
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:51096
|
\Stim1Sax/\Stim1+
(involves: C3HeB/FeJ * C57BL/6)
|
abnormal thrombopoiesis
|
J:127381
|
\Stim1tm1Rao/\Stim1tm1Rao \Stim2tm1Rao/\Stim2tm1Rao \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal B cell differentiation
|
J:133262
|
abnormal T cell differentiation
|
J:133262
|
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
abnormal T cell differentiation
|
J:142674
|
\Stk4m5Btlr/\Stk4m5Btlr
(C57BL/6J-Stk4m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272743
|
abnormal T cell differentiation
|
J:272743
|
\Stk17btm1Hed/\Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
decreased double-positive T cell number
|
J:94685
|
\Supv3l1tm2.1Jkl/\Supv3l1tm2.2Jkl \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:144991
|
decreased double-negative T cell number
|
J:144991
|
decreased double-positive T cell number
|
J:144991
|
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl \Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:144991
|
decreased double-negative T cell number
|
J:144991
|
decreased double-positive T cell number
|
J:144991
|
\Swap70tm1Jess/\Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
|
abnormal class switch recombination
|
J:71160
|
\SykM2Btlr/\Syk+
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
\SykM2Btlr/\SykM2Btlr
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
\Syktm1.1Tara/\Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:115080
|
\Syktm1Kuro/\Syktm1Kuro \Zap70tm1Dlo/\Zap70tm1Dlo \Cd79atm1(cre)Reth/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:134528
|
\Syktm1Paw/\Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:29797
|
decreased late pro-B cell number
|
J:29797
|
\Syktm1Tyb/\Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
arrested B cell differentiation
|
J:29796
|
\Syktm2.1(ZAP70)Fkfr/\Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
arrested B cell differentiation
|
J:188422
|
decreased DN1 thymic pro-T cell number
|
J:188422
|
decreased transitional stage B cell number
|
J:188422
|
decreased transitional stage T1 B cell number
|
J:188422
|
decreased transitional stage T2 B cell number
|
J:188422
|
increased DN3 thymocyte number
|
J:188422
|
\Tac4tm1Albe/\Tac4tm1Albe
(B6.129P2-Tac4tm1Albe)
|
increased pro-B cell number
|
J:166471
|
\Taf7tm1.1Dss/\Taf7tm1.2Dss \Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
decreased double-positive T cell number
|
J:185745
|
\Taf7tm1.1Dss/\Taf7tm1.2Dss \Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
decreased double-positive T cell number
|
J:185745
|
increased double-negative T cell number
|
J:185745
|
\Tap1tm1Arp/\Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-negative T cell number
|
J:3524
|
\Tapbptm1Luc/\Tapbptm1Luc \Tg(TcraTcrb)1100Mjb/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal negative T cell selection
|
J:64177
|
abnormal positive T cell selection
|
J:64177
|
\Tarm1tm1Yiw/\Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
abnormal dendritic cell differentiation
|
J:301164
|
\Tasp1tm1Jjdh/\Tasp1tm1Jjdh \Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:112159
|
\Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:166065
|
\Tbk1tm1Arte/\Tbk1tm1Arte \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:188560
|
\Tbk1tm1Arte/\Tbk1tm1Arte \Map3k14tm1Rds/\Map3k14tm1Rds \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:188560
|
\Tbx1tm1Pa/\Tbx1tm1Pa
(either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster))
|
abnormal thymus development
|
J:70730
|
\Tbx21duane/\Tbx21duane
(C57BL/6-Tbx21duane)
|
abnormal NK cell differentiation
|
J:154069
|
\Tbx21tm1Glm/\Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:73833
|
\Tbx21tm1Glm/\Tbx21tm1Glm
(B6.129S6-Tbx21tm1Glm)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
\Tcdel1C57BL/6/\Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
increased double-positive T cell number
|
J:97046
|
\Tcdel1NOD/ShiLtDoi/\Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
increased double-positive T cell number
|
J:97046
|
\Tcdel2C57BL/6/\Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
increased double-positive T cell number
|
J:97046
|
\Tcdel2NOD/ShiLtDoi/\Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
increased double-positive T cell number
|
J:97046
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+ \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:226241
|
abnormal pro-B cell morphology
|
J:226241
|
arrested B cell differentiation
|
J:226241
|
decreased immature B cell number
|
J:226241
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+ \Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:226241
|
decreased immature B cell number
|
J:226241
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+ \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J)
|
arrested B cell differentiation
|
J:226241
|
decreased immature B cell number
|
J:226241
|
\Tcf3tm1(TCF3/HLF)Homy/\Tcf3+ \Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:160392
|
\Tcf3tm1.1Mbu/\Tcf3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:137719
|
\Tcf3tm1Cmu/\Tcf3tm1Cmu
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:67011
|
abnormal immunoglobulin V(D)J recombination
|
J:67011
|
\Tcf3tm1Mbu/\Tcf3tm1Mbu \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
decreased pro-B cell number
|
J:137719
|
\Tcf3tm1Wein/\Tcf3tm3Zhu
(involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
\Tcf3tm1Zhu/\Tcf3tm1Zhu
(involves: 129 * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
increased double-negative T cell number
|
J:136143
|
\Tcf3tm2Cmu/\Tcf3tm2Cmu
(involves: 129P2/OlaHsd)
|
abnormal lymphopoiesis
|
J:118827
|
absent pro-B cells
|
J:118827
|
\Tcf3tm2Zhu/\Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
\Tcf3tm3.1Cmu/\Tcf3tm3.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal B cell differentiation
|
J:153423
|
abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
\Tcf3tm4.1Cmu/\Tcf3tm4.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
arrested B cell differentiation
|
J:153423
|
decreased pro-B cell number
|
J:153423
|
\Tcf3tm6(Esr1*)Zhu/\Tcf3tm6(Esr1*)Zhu
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:154788
|
arrested B cell differentiation
|
J:154788
|
\Tcf4tm1.1Hmb/\Tcf4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-negative T cell number
|
J:136143
|
\Tcf4tm1.1Hmb/\Tcf4tm1.1Hmb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell differentiation
|
J:136143
|
increased double-negative T cell number
|
J:136143
|
\Tcf4tm1Hmb/\Tcf4tm1Zhu \Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:65236
|
decreased double-positive T cell number
|
J:65236
|
\Tcf4tm1Zhu/\Tcf4+ \Tcf3tm1Wein/\Tcf3+
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:43324
|
\Tcf4tm1Zhu/\Tcf4tm1Zhu
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
\Tcf7tm1Cle/\Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:23255
|
decreased double-positive T cell number
|
J:23255
|
\Tcf7tm2Cle/\Tcf7tm2Cle
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:23255
|
\Tcf12tm1Zhu/\Tcf12+ \Tcf3tm1Wein/\Tcf3+
(involves: 129S4/SvJaeSor)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12+ \Tcf3tm4Zhu/\Tcf3tm4Zhu \Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:75746
|
increased double-negative T cell number
|
J:75746
|
\Tcf12tm1Zhu/\Tcf12+ \Tcf4tm1Zhu/\Tcf4+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129/Sv * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
increased double-negative T cell number
|
J:136143
|
\Tcf12tm1Zhu/\Tcf12tm2Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
\Tcf12tm2Zhu/\Tcf12tm2Zhu
(Not Specified)
|
abnormal B cell differentiation
|
J:120411
|
abnormal T cell differentiation
|
J:120411
|
arrested T cell differentiation
|
J:120411
|
decreased double-positive T cell number
|
J:120411
|
decreased immature B cell number
|
J:120411
|
decreased pro-B cell number
|
J:120411
|
increased double-negative T cell number
|
J:120411
|
\Tcf12tm2Zhu/\Tcf12tm2Zhu \Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
arrested T cell differentiation
|
J:120411
|
\Tcf12tm3Zhu/\Tcf12tm3Zhu \Tcf3tm4Zhu/\Tcf3tm4Zhu \Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:129171
|
\Tcf12tm3Zhu/\Tcf12tm3Zhu \Tcf3tm4Zhu/\Tcf3tm4Zhu \Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased double-positive T cell number
|
J:129570
|
increased double-negative T cell number
|
J:129570
|
\Tcf21tm1Eno/\Tcf21tm1Eno
(involves: 129 * Black Swiss)
|
abnormal spleen development
|
J:64068
|
\Tcf21tm2Eno/\Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
abnormal spleen development
|
J:64068
|
\Tcimtm1Icle/\Tcimtm1Icle
(B6.129-Tcimtm1Icle)
|
myeloid hyperplasia
|
J:217318
|
\Tcra-Jtm1Jpdv/\Tcra-Jtm1Jpdv
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77518
|
\Tcra-Jtm1Kgwa/\Tcra-Jtm1Kgwa \Tg(Tcrb2B4)1Mmd/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:50143
|
increased double-positive T cell number
|
J:50143
|
\Tcra-Jtm1Slek/\Tcra-Jtm1Slek
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:101398
|
decreased double-positive T cell number
|
J:101398
|
increased double-negative T cell number
|
J:101398
|
\Tcra-Jtm2.3Krg/\Tcra-Jtm2.3Krg
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\Tcra-Jtm3.1Krg/\Tcra-Jtm3.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
\Tcra-Jtm4.1Krg/\Tcra-Jtm4.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\Tcra-Jtm5Krg/\Tcra-Jtm5Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\TcraLn3Jae/\Tcra+
(B6.Cg-TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
decreased double-positive T cell number
|
J:143006
|
\TcraLn3Jae/\Tcra+ \TcrbLn3Jae/\Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
abnormal T cell differentiation
|
J:143006
|
decreased double-positive T cell number
|
J:143006
|
\Tcratm1Mass/\Tcra+ \Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:201417
|
increased double-negative T cell number
|
J:201417
|
\Tcratm1Mass/\Tcratm1Mass
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:201417
|
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky \H2b/\H2b \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
abnormal double-positive T cell morphology
|
J:81564
|
abnormal negative T cell selection
|
J:81564
|
abnormal T cell differentiation
|
J:81564
|
decreased double-positive T cell number
|
J:131357
|
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky \H2d/\H2d \Ptcratm1Vbo/\Ptcratm1Vbo \Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
\Tcratm1Mom/\Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
\Tcratm1Mom/\Tcratm1Mom \Tcra-Jtm1Kgwa/\Tcra-Jtm1Kgwa
(involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)
|
increased double-negative T cell number
|
J:50143
|
\Tcratm1Mom/\Tcratm1Mom \Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
decreased double-positive T cell number
|
J:3206
|
\Tcratm1Mom/\Tcratm1Mom \Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
arrested T cell differentiation
|
J:135903
|
\TcrbLn3Jae/\Tcrb+
(B6.Cg-TcrbLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
\Tcrbtm1(Tcrb)Chb/\Tcrbtm1(Tcrb)Chb
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
\Tcrbtm1(Tcrb)Chb/\Tcrbtm1Slek
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147947
|
\Tcrbtm1(Tcrb)Fwa/\Tcrbtm1(Tcrb)Fwa
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
\Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:3206
|
decreased double-positive T cell number
|
J:3206
|
\Tcrbtm1Mom/\Tcrbtm1Mom \Tcrdtm1Mom/\Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J)
|
abnormal transitional stage B cell morphology
|
J:187766
|
increased immature B cell number
|
J:187766
|
increased transitional stage T2 B cell number
|
J:187766
|
increased transitional stage T3 B cell number
|
J:187766
|
\Tcrbtm1Mom/\Tcrbtm1Mom \Tcrdtm1Mom/\Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
decreased double-positive T cell number
|
J:3206
|
\Tcrbtm1Mom/\Tcrbtm1Mom \Tcrdtm1Mom/\Tcrdtm1Mom \Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom)
|
abnormal transitional stage B cell morphology
|
J:187766
|
increased immature B cell number
|
J:187766
|
\Tcrbtm1Mom/\Tcrbtm1Mom \Tg(H2-K-Cd86)7All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:112475
|
\Tcrbtm1Slek/\Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm1Slek/\Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm2(Tcrb)Fwa/\Tcrbtm3Slek
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:132446
|
\Tcrbtm2Slek/\Tcrbtm2Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
\Tcrbtm2Slek/\Tcrbtm2Slek \Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
\Tcrbtm3Slek/\Tcrbtm3Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
\Tcrbtm5Slek/\Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm6Slek/\Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm7Slek/\Tcrbtm7Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrd-V1tm1Kjk/\Tcrd-V1tm1Kjk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:64863
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:64863
|
\Tcrd-V1tm1Kjk/\Tcrd-V1tm1Kjk
(B6.129P2-Tcrd-V1tm1Kjk)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:128525
|
\Tcrdtm1Mom/\Tcrdtm1Mom
(either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal gamma-delta T cell differentiation
|
J:3865
|
\Tcrdtm1Mom/\Tcrdtm1Mom \Tcrgtm2.1Dhr/\Tcrgtm2.1Dhr
(involves: 129 * C57BL/6)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Tcrgtm1.1Dhr/\Tcrgtm1.1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
\Tcrgtm1Dhr/\Tcrgtm1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
\Tcrgtm2.1Dhr/\Tcrgtm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Tdp2tm1.1Huy/\Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
abnormal immature B cell morphology
|
J:195301
|
abnormal lymphopoiesis
|
J:195301
|
decreased double-positive T cell number
|
J:195301
|
\Tdrd3Gt(RRK474)Byg/\Tdrd3Gt(RRK474)Byg
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:210647
|
\Ten1em1(IMPC)Hmgu/\Ten1em1(IMPC)Hmgu
(involves: C57BL/6NCrl)
|
bone marrow failure
|
J:365069
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
abnormal T cell differentiation
|
J:186446
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc \Tg(TcraTcrb)425Cbn/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)425Cbn)
|
abnormal T cell differentiation
|
J:186446
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc \Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)1100Mjb)
|
abnormal T cell differentiation
|
J:186446
|
\Tet2Gt(AN0709)Wtsi/\Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal monocyte differentiation
|
J:174052
|
\Tet2Gt(AN0709)Wtsi/\Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal monocyte differentiation
|
J:174052
|
decreased pro-B cell number
|
J:174052
|
increased DN1 thymic pro-T cell number
|
J:174052
|
increased double-negative T cell number
|
J:174052
|
\Tet2tm1.1Iaai/\Tet2tm1.1Iaai \Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:234976
|
\Tet2tm1.1Iaai/\Tet2tm1.1Iaai \Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:174053
|
\Tet2tm1.1Mjxu/\Tet2+
(involves: 129 * C57BL/6)
|
myeloid hyperplasia
|
J:178415
|
\Tet2tm1.1Mjxu/\Tet2tm1.1Mjxu
(involves: 129 * C57BL/6)
|
myeloid hyperplasia
|
J:178415
|
\Tet2tm1.2Rao/\Tet2tm1.2Rao
(involves: C57BL/6NTac)
|
abnormal myelopoiesis
|
J:175222
|
\Tet2tm1Ics/\Tet2tm1Ics \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased pro-B cell number
|
J:174052
|
increased DN1 thymic pro-T cell number
|
J:174052
|
increased double-negative T cell number
|
J:174052
|
\Tfap4tm1.1Litt/\Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
\Tg(B19-RNAi:Il3)241Ckn/?
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:107618
|
\Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:93111
|
\Tg(BCL2)25Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:131912
|
abnormal plasma cell differentiation
|
J:131912
|
\Tg(BCL2/IGH)1Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal mononuclear cell differentiation
|
J:81147
|
\Tg(BCL2/IGH)M23Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal mononuclear cell differentiation
|
J:81147
|
\Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
\Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
\Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:212571
|
\Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
increased double-negative T cell number
|
J:126456
|
\Tg(CD2-Myb/en)2Kmw/\Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased double-positive T cell number
|
J:126456
|
increased double-negative T cell number
|
J:126456
|
\Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:80066
|
\Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10)
|
abnormal positive T cell selection
|
J:113713
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 \Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 \Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(CD2-Zbtb7b)C8Rbo/? \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(CD2-Zbtb7b)C8Rbo/? \Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(CD2-Zbtb7b)C8Rbo/? \Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal T cell differentiation
|
J:151075
|
\Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J)
|
abnormal eosinophil differentiation
|
J:123440
|
\Tg(CD3E)26Cpt/\Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J)
|
arrested T cell differentiation
|
J:81711
|
decreased double-positive T cell number
|
J:54756
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal T cell clonal deletion
|
J:217939
|
decreased double-positive T cell number
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0 \Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-cre)1Cwi/0 \Trmt61aem1Hbgl/\Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
abnormal CD4-positive T cell differentiation
|
J:336736
|
\Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:158594
|
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal T cell differentiation
|
J:235890
|
increased DN3 thymocyte number
|
J:235890
|
\Tg(Cd4-NPM/ALK)N1Ingh/0 \Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal double-negative T cell morphology
|
J:235890
|
\Tg(Cd8aCd8b)3Erob/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
abnormal double-positive T cell morphology
|
J:93004
|
decreased double-negative T cell number
|
J:93004
|
\Tg(Cd8aCd8b)3Erob/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
\Tg(CD19)1Tft/\Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased immature B cell number
|
J:27236
|
\Tg(CD19-Tnfsf7)#Rvl/0
(involves: C57BL/6)
|
decreased transitional stage B cell number
|
J:88620
|
\Tg(CMV-SALL4_iB)#Chai/?
(Not Specified)
|
abnormal myelopoiesis
|
J:115037
|
myeloid hyperplasia
|
J:115037
|
\Tg(Cr2-cre)3Cgn/? \Xrcc4tm1Fwa/\Xrcc4tm2Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150339
|
\Tg(CTSG-PML/RARA)6179Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:40373
|
\Tg(CTSG-PML/RARA)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:78201,
J:40373
|
\Tg(CTSG-RARA/ZBTB16)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:65878
|
myeloid hyperplasia
|
J:65878
|
\Tg(CTSG-RARA/ZBTB16)#Ppp/0 \Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:65878
|
\Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:78201
|
\Tg(CTSG-ZBTB16/RARA)#Sjch/0
(involves: C57BL/6)
|
abnormal myelopoiesis
|
J:55196
|
myeloid hyperplasia
|
J:55196
|
\Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:70572
|
\Tg(DO11.10)10Dlo/? \Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:131287
|
\Tg(EEF1A1-SHC1*)1Ravi/? \Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
decreased double-positive T cell number
|
J:78180
|
\Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6)
|
abnormal leukopoiesis
|
J:91124
|
\Tg(Emu-Zfp521)1Homy/0
(Not Specified)
|
abnormal B cell differentiation
|
J:160392
|
\Tg(Fabp2-Arg1)1Wla/\Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
abnormal B cell differentiation
|
J:80204
|
decreased transitional stage B cell number
|
J:80204
|
\Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0
(either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))
|
abnormal thymus development
|
J:67796
|
\Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:81133
|
\Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * DBA/2)
|
increased pro-B cell number
|
J:171924
|
\Tg(H2-K-Cd86)7All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
\Tg(H2-K-Cd86)27All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
\Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
increased double-positive T cell number
|
J:138077
|
\Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:138050
|
\Tg(H2-K-MC159/EGFP)13Fkmc/\Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6)
|
increased double-negative T cell number
|
J:138050
|
\Tg(H2-K-TcrbP14)128Mak/?
(involves: C57BL/6 * C57L * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111265
|
abnormal T cell clonal deletion
|
J:111265
|
abnormal T cell differentiation
|
J:111265
|
\Tg(H2-Kb-IL21)5Wjl/0
(involves: 129)
|
abnormal B cell differentiation
|
J:93740
|
abnormal class switch recombination
|
J:93740
|
decreased transitional stage T2 B cell number
|
J:93740
|
increased immature B cell number
|
J:93740
|
increased transitional stage T1 B cell number
|
J:93740
|
\Tg(H2-Kb-Jak2*V617F)2Shmd/0
(involves: C57BL/6 * DBA/2)
|
myeloid hyperplasia
|
J:130189
|
\Tg(H2-L-IL6)1Kish/\Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
abnormal myelopoiesis
|
J:128016
|
\Tg(H2KmPCC)2939Stoe/0 \Tg(Tcra2B4)1Mmd/0 \Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:50143
|
\Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:119625
|
\Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
decreased immature B cell number
|
J:131077
|
\Tg(Igh-HOX11)11Idd/0
(CD-1)
|
abnormal immunoglobulin V(D)J recombination
|
J:52782
|
myeloid hyperplasia
|
J:52782
|
\Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
abnormal lymphopoiesis
|
J:162077
|
\Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
abnormal lymphopoiesis
|
J:109591
|
\Tg(Igh-Mir210)#aKgcs/\Tg(Igh-Mir210)#aKgcs
(B6.Cg-Tg(Igh-Mir210)#aKgcs)
|
abnormal class switch recombination
|
J:205868
|
decreased pro-B cell number
|
J:205868
|
\Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:23827
|
\Tg(IghelMD4)4Ccg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased pro-B cell number
|
J:115059
|
\Tg(IghelMD4)4Ccg/0
(involves: C57BL/6)
|
decreased pro-B cell number
|
J:115059
|
\Tg(IghelMD4)4Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg)
|
abnormal immature B cell morphology
|
J:109923
|
abnormal pro-B cell morphology
|
J:109923
|
increased immature B cell number
|
J:78308,
J:132538
|
\Tg(IghelMD4)4Ccg/? \Tg(KLK4mHEL)6Ccg/?
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:78307
|
increased immature B cell number
|
J:78307
|
\Tg(IghelMD4)4Ccg/0 \Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)
|
abnormal B cell clonal deletion
|
J:89156
|
\Tg(IghelMD4)4Ccg/0 \Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)
|
abnormal immature B cell morphology
|
J:109923
|
abnormal pro-B cell morphology
|
J:109923
|
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(involves: C57BL/6)
|
decreased pro-B cell number
|
J:171924
|
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:78177
|
\Tg(IghMyc)22Bri/0 \Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:23827
|
\Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh)
|
abnormal plasma cell differentiation
|
J:131912
|
\Tg(Igl-2MOPC315)1275Ust/?
(C57BL/6-Tg(Igl-2MOPC315)1275Ust)
|
decreased immature B cell number
|
J:134666
|
\Tg(Ins2-Ccl19)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymph organ development
|
J:77238
|
\Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymph organ development
|
J:77238
|
\Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymph organ development
|
J:110548
|
\Tg(Ins2-GP)#Psoh/0 \Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell selection
|
J:81285
|
\Tg(Ins2-TFRC/OVA)296Wehi/0 \Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:135154
|
\Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
decreased double-positive T cell number
|
J:80777
|
\Tg(ITGAL-Ptprca)FRasch/\Tg(ITGAL-Ptprca)FRasch
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
\Tg(Itgax-TGFBR2)1Flv/0
(C.Cg-Tg(Itgax-TGFBR2)1Flv)
|
abnormal NK cell differentiation
|
J:98953
|
\Tg(JAK2*V617F)FF1Rsko/0 \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal myelopoiesis
|
J:134364
|
\Tg(JAK2*V617F)FF1Rsko/0 \Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:134364
|
\Tg(KLK4mHEL)6Ccg/0 \Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
\Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:196403
|
\Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6)
|
increased double-negative T cell number
|
J:135903
|
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified)
|
abnormal T cell differentiation
|
J:144975
|
\Tg(Lck-cre)548Jxm/? \Upf2tm1Btp/\Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:134765
|
decreased double-positive T cell number
|
J:134765
|
\Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:100451
|
\Tg(Lck-FADD)1Hed/\Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:100451
|
\Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
decreased double-positive T cell number
|
J:80777
|
\Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6)
|
abnormal leukopoiesis
|
J:91124
|
\Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93003
|
\Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:63300
|
increased double-negative T cell number
|
J:63300
|
\Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
\Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:117301
|
\Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
increased double-positive T cell number
|
J:149973
|
\Tg(Lck-Stk17b)26.1Wals/? \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell differentiation
|
J:149973
|
\Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:92453
|
decreased double-positive T cell number
|
J:92453
|
increased double-negative T cell number
|
J:92453
|
\Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93005
|
\Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(LCKprBCL2)36Sjk/0 \Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(LCKprBCL2)36Sjk/0 \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Ly6a-SET/NUP214)2969Gcg/0
(involves: FVB/NJ)
|
abnormal B cell differentiation
|
J:142938
|
decreased pro-B cell number
|
J:142938
|
\Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA)
|
increased pro-B cell number
|
J:185590
|
\Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
abnormal immature B cell morphology
|
J:50604
|
abnormal mast cell differentiation
|
J:50604
|
abnormal monocyte differentiation
|
J:50604
|
\Tg(ML5sHEL)5Ccg/0 \Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
\Tg(ML5sHEL)5Ccg/0 \Tg(TcrHEL3A9)1Mmd/0 \Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
\Tg(Mx1-cre)1Cgn/0 \Thoc5tm1Tate/\Thoc5tm1Tate
(involves: C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:169944
|
\Tg(Mx1-cre)1Cgn/0 \Tnfrsf13ctm2.1Mass/\Tnfrsf13ctm2.1Mass
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:170519
|
increased pro-B cell number
|
J:170519
|
\Tg(Mx1-cre)1Cgn/0 \U2af1tm1Mohi/\U2af1tm1Mohi
(involves: C57BL/6J * CBA/J)
|
bone marrow failure
|
J:308564
|
\Tg(PF4-tTA/VP16)42Kra/0 \Tg(tetO-Aurkb,lacZ)41Kra/0
(FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)
|
abnormal thrombopoiesis
|
J:104239
|
\Tg(Pgk1-HA)1.1Vbo/? \Tg(Tcra/Tcrb)1Vbo/?
(involves: 129 * BALB/c * C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:125750
|
\Tg(PML-RARA)556Kog/?
(involves: FVB/N)
|
abnormal neutrophil differentiation
|
J:39327
|
\Tg(Rr158-H2-Ead)1Flv/0 \Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL)
|
decreased double-positive T cell number
|
J:124574
|
\Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:210877
|
\Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA)
|
increased pro-B cell number
|
J:82428
|
\Tg(SV40-Igh-64C8)H3Hon/0 \Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6)
|
abnormal B cell clonal deletion
|
J:139864
|
\Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
arrested T cell differentiation
|
J:55022
|
decreased double-positive T cell number
|
J:55022
|
\Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6)
|
decreased double-positive T cell number
|
J:92992
|
increased double-negative T cell number
|
J:92992
|
\Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
abnormal T cell differentiation
|
J:104243
|
\Tg(TcraCl4,TcrbCl4)1Shrm/?
(B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:99756
|
\Tg(TcraDN32D3)#Alhn/0
(involves: NOD)
|
increased double-negative T cell number
|
J:201417
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:79738
|
abnormal T cell differentiation
|
J:79738,
J:90776
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/? \Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
abnormal positive T cell selection
|
J:151074
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/? \Themistm1Lov/\Themistm1Lov
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151075
|
abnormal positive T cell selection
|
J:151075
|
increased double-positive T cell number
|
J:151075
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0 \Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:84536
|
\Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal positive T cell selection
|
J:85777
|
abnormal T cell differentiation
|
J:85777
|
decreased double-positive T cell number
|
J:85777
|
\Tg(TcrAND)53Hed/? \Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151074
|
increased double-positive T cell number
|
J:151074
|
\Tg(TcrAND)53Hed/? \Themistm1Lov/\Themistm1Lov
(involves: 129 * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151075
|
increased double-positive T cell number
|
J:151075
|
\Tg(TcrAND)53Hed/? \Zbtb7btm1.1Rbo/\Zbtb7btm1.1Rbo
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:141145
|
\Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal T cell clonal deletion
|
J:36815
|
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:87876
|
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867,
J:133645
|
abnormal T cell clonal deletion
|
J:92867
|
\Tg(TcraTcrb)1100Mjb/? \Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:151074
|
increased double-positive T cell number
|
J:151074
|
\Tg(Tcrb)93Vbo/0
(involves: C57BL/LiA * CBA/BrA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:93247
|
\Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:66565
|
abnormal T cell clonal deletion
|
J:66565
|
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal double-positive T cell morphology
|
J:78309
|
\Tg(TcrHEL3A9)1Mmd/0 \Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
\Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox)
|
decreased double-positive T cell number
|
J:92228
|
increased double-negative T cell number
|
J:92228
|
\Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox)
|
decreased double-positive T cell number
|
J:92228
|
increased double-negative T cell number
|
J:92228
|
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:77696
|
\Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(tetO-BCR/ABL1)2Dgt/0 \Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal lymphopoiesis
|
J:96511
|
\Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
abnormal B cell differentiation
|
J:73711
|
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell differentiation
|
J:115788
|
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
increased transitional stage B cell number
|
J:113556
|
\Tg(Tnfsf13b)1Fma/? \Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(B6.Cg-Tnfrsf13btm1Rjb Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
\Tg(Tnfsf13b)1Fma/? \Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(B6.Cg-Tnfrsf13ctm1Mass Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
\Tg(Tnfsf13b)1Fma/\Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
increased transitional stage T2 B cell number
|
J:178227
|
\Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:96759
|
abnormal B cell receptor editing
|
J:96759
|
\Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:189197
|
decreased double-positive T cell number
|
J:189197
|
\Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:88565
|
abnormal somatic hypermutation frequency
|
J:88565
|
\Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J)
|
increased double-negative T cell number
|
J:91542
|
\Themism5Btlr/\Themism5Btlr
(C57BL/6J-Themism5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274716
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274716
|
abnormal T cell differentiation
|
J:274716
|
\ThemisSpotr/\ThemisSpotr
(C57BL/6-ThemisSpotr)
|
abnormal T cell differentiation
|
J:152601
|
\Themistm1Gasc/\Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
abnormal positive T cell selection
|
J:151074
|
increased double-positive T cell number
|
J:151074
|
\Themistm1Hasu/\Themistm1Hasu
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:153235
|
\Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
abnormal T cell differentiation
|
J:151075
|
\Tinf2tm2.2Tdl/\Tinf2+
(involves: BALB/cJ * C57BL/6)
|
myeloid hyperplasia
|
J:207367
|
\Tle4tm1.2Dasw/\Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
abnormal lymphopoiesis
|
J:219243
|
decreased DN2 thymocyte number
|
J:219243
|
decreased double-positive T cell number
|
J:219243
|
decreased pre-pro B cell number
|
J:219243
|
\Tlx1tm1Sjk/\Tlx1tm1Sjk
(involves: 129S2/SvPas)
|
abnormal spleen development
|
J:17695
|
abnormal spleen mesenchyme morphology
|
J:17695
|
\Tlx1tm1Thr/\Tlx1tm1Thr
(involves: 129P2/OlaHsd * MF1)
|
abnormal spleen development
|
J:28700
|
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal myelopoiesis
|
J:108572
|
\Tnftm3Gkl/\Tnftm3Gkl \Zfp36tm1Pjb/\Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:114740
|
\Tnfaip3tm1Homy/\Tnfaip3tm1Homy \Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal myelopoiesis
|
J:212681
|
\Tnfaip3tm2Ama/\Tnfaip3tm2Ama \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased immature B cell number
|
J:163917
|
\Tnfaip3tm3.1Ama/\Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama)
|
myeloid hyperplasia
|
J:203160
|
\Tnfaip3tm4.1Ama/\Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama)
|
myeloid hyperplasia
|
J:203160
|
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx \Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymph organ development
|
J:110548
|
\Tnfrsf11atm1Imx/\Tnfrsf11atm1Imx
(involves: 129)
|
abnormal negative T cell selection
|
J:125864
|
\Tnfrsf11btm1Eac/\Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor)
|
abnormal pro-B cell differentiation
|
J:67105
|
increased immature B cell number
|
J:67105
|
increased pro-B cell number
|
J:67105
|
\Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(involves: 129X1/SvJ)
|
abnormal class switch recombination
|
J:95288
|
\Tnfrsf13btm1Vmd/\Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased transitional stage B cell number
|
J:70172
|
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(C57BL/6-Tnfrsf13ctm1Mass)
|
arrested B cell differentiation
|
J:92732
|
\Tnfrsf13ctm1Msc/\Tnfrsf13ctm1Msc
(involves: 129P2/OlaHsd * C57BL/6)
|
absent transitional stage B cells
|
J:92676
|
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal negative T cell selection
|
J:84536
|
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:52369
|
arrested T cell differentiation
|
J:52369
|
decreased immature B cell number
|
J:52369
|
\Tnfsf12tm1Ash/\Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash)
|
increased double-positive T cell number
|
J:104801
|
\Tnfsf13tm1Geha/\Tnfsf13tm1Geha
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:88910
|
\Tnfsf13bm1Anu/\Tnfsf13bm1Anu
(C57BL/6JAnu-Tnfsf13bm1Anu/AnuApb)
|
abnormal B cell differentiation
|
J:104190
|
increased immature B cell number
|
J:104190
|
\Tnfsf13btm1Cleg/\Tnfsf13btm1Cleg
(involves: 129S5/SvEvBrd)
|
abnormal B cell differentiation
|
J:71301
|
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:71681
|
arrested B cell differentiation
|
J:71681
|
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased transitional stage B cell number
|
J:138560
|
\Tnfsf15tm1Cdon/\Tnfsf15tm1Cdon
(B6.129-Tnfsf15tm1Cdon)
|
abnormal dendritic cell differentiation
|
J:136280
|
\Tox2em1Cdon/\Tox2em1Cdon
(C57BL/6J-Tox2em1Cdon)
|
abnormal T follicular helper cell differentiation
|
J:290926
|
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:131287
|
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:164687
|
\Toxtm1Kay/\Toxtm1Kay \Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:164687
|
\Tpm4Plt53/\Tpm4+
(BALB/c-Tpm4Plt53)
|
abnormal thrombopoiesis
|
J:242938
|
\Tpm4Plt53/\Tpm4Plt53
(BALB/c-Tpm4Plt53)
|
abnormal thrombopoiesis
|
J:242938
|
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased double-positive T cell number
|
J:133572
|
increased double-negative T cell number
|
J:133572
|
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:221205
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221205
|
\Tpsab1m1/\Tpsab1m1
(involves: C57BL/6J)
|
abnormal mast cell differentiation
|
J:142880
|
\Tpsab1m1/\Tpsab1m1 \Tpsb2tm1(cre)Adch/\Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1)
|
abnormal mast cell differentiation
|
J:142880
|
\Tpsb2tm1.1Mfg/\Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg)
|
abnormal mast cell differentiation
|
J:142880
|
\Traf2tm1Mak/\Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased double-positive T cell number
|
J:44360
|
decreased immature B cell number
|
J:44360
|
\Traf3tm1Bal/\Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:37065
|
decreased double-positive T cell number
|
J:37065
|
\Traf3tm1Bshp/\Traf3tm1Bshp \Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased transitional stage B cell number
|
J:124329
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix)
|
increased transitional stage B cell number
|
J:138560
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix)
|
abnormal transitional stage B cell morphology
|
J:187766
|
increased immature B cell number
|
J:187766
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix \Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c)
|
decreased transitional stage B cell number
|
J:138560
|
\Traf3ip3tm1b(KOMP)Wtsi/\Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
abnormal T cell differentiation
|
J:226431
|
increased double-positive T cell number
|
J:226431
|
\Traf6tm1Jino/\Traf6tm1Jino
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:77453
|
\Traf6tm1Ywc/\Traf6tm1Ywc
(Not Specified)
|
abnormal dendritic cell differentiation
|
J:85808
|
\Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
\Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:121608
|
\Trp53tm1.1Awbr/\Trp53tm1.1Awbr
(involves: C57BL/6)
|
increased pro-B cell number
|
J:169434
|
\Trp53tm1Tyj/\Trp53tm1Tyj \Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:61973
|
\Trp53bp1Gt(OST94324)Lex/\Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:83164
|
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:82512
|
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129)
|
abnormal class switch recombination
|
J:194603,
J:231089,
J:307190
|
\Trpm7tm1Clph/\Trpm7tm1.1Clph \Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:140630
|
\Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
decreased DN3 thymocyte number
|
J:223992
|
increased DN4 thymocyte number
|
J:223992
|
\Tshrhyt/\Tshrhyt
(CBy.RF-Tshrhyt/J)
|
increased pro-B cell number
|
J:111014
|
\TsilTg(Myc)12ALvn/\TsilTg(Myc)12ALvn
(involves: C57BL/6 * SJL/J)
|
increased double-positive T cell number
|
J:33857
|
\Tslptm1(KOMP)Vlcg/\Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 2 cell differentiation
|
J:187770
|
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
abnormal NK cell differentiation
|
J:119985
|
\Twsg1tm1Nosa/\Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:82738
|
abnormal spleen development
|
J:82738
|
abnormal thymus development
|
J:82738
|
decreased double-positive T cell number
|
J:82738
|
decreased immature B cell number
|
J:82738
|
decreased pro-B cell number
|
J:82738
|
\Tyk2tm1Shmd/\Tyk2tm1Shmd
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:65409
|
\Tyrobptm1.1Viv/\Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
abnormal myelopoiesis
|
J:95232
|
\Unc93b1tm1.1Kmiy/\Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:174308
|
abnormal T-helper 17 cell differentiation
|
J:174308
|
\Ungtm1Tld/\Ungtm1Tld
(Not Specified)
|
abnormal class switch recombination
|
J:79590
|
\Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:306598
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Vav1M4Btlr/\Vav1M4Btlr
(C57BL/6J-Vav1M4Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272528
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272528
|
abnormal T cell differentiation
|
J:272528
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
decreased double-negative T cell number
|
J:113270
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal negative T cell selection
|
J:113270
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:79323
|
decreased double-positive T cell number
|
J:79323
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(C.129S2-Vav1tm1Tyb)
|
abnormal negative T cell selection
|
J:79323
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
decreased double-positive T cell number
|
J:190087
|
increased DN2 thymocyte number
|
J:190087
|
increased DN3 thymocyte number
|
J:190087
|
increased double-negative T cell number
|
J:190087
|
\Vav1tm1Tyb/\Vav1tm1Tyb \Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased double-negative T cell number
|
J:86654
|
decreased double-positive T cell number
|
J:86654
|
\Vav1tm1Tyb/\Vav1tm1Tyb \Vav2tm1Kdf/\Vav2tm1Kdf \Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:86654
|
arrested T cell differentiation
|
J:86654
|
decreased double-positive T cell number
|
J:86654
|
decreased transitional stage T2 B cell number
|
J:86654
|
increased immature B cell number
|
J:86654
|
increased transitional stage T1 B cell number
|
J:86654
|
\Vav1tm1Tyb/\Vav1tm1Tyb \Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased immature B cell number
|
J:69807
|
\Vav1tm1Tyb/\Vav1tm1Tyb \Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased double-negative T cell number
|
J:86654
|
decreased double-positive T cell number
|
J:86654
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal T cell differentiation
|
J:47596
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:47596
|
increased double-negative T cell number
|
J:47596
|
increased transitional stage B cell number
|
J:69806
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(B6.129-Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
abnormal positive T cell selection
|
J:141390
|
decreased double-positive T cell number
|
J:141390
|
\Vav1tm2Bbd/\Vav1tm2Bbd \Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:69806
|
abnormal T cell differentiation
|
J:69806
|
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased double-negative T cell number
|
J:113270
|
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal negative T cell selection
|
J:113270
|
\Vav1tm4Tyb/\Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
increased DN2 thymocyte number
|
J:190087
|
increased DN3 thymocyte number
|
J:190087
|
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:69807
|
\Vcam1tm2Flv/\Vcam1tm3Flv \Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C3H * C57BL/6)
|
decreased immature B cell number
|
J:68147
|
increased immature B cell number
|
J:68147
|
\Vcam1tm2Roml/\Vcam1tm2Roml \Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased transitional stage B cell number
|
J:68148
|
increased immature B cell number
|
J:68148
|
increased transitional stage B cell number
|
J:68148
|
\Vdrtm1Ska/\Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
abnormal dendritic cell differentiation
|
J:127787
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:53512
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm \Vpreb1btm1Ilm/\Vpreb1btm1Ilm
(B6.129P2-Vpreb1atm1Ilm Vpreb1btm1Ilm)
|
abnormal B cell differentiation
|
J:67609
|
abnormal immature B cell morphology
|
J:67609
|
\Vtcn1tm1Lpc/\Vtcn1tm1Lpc
(B6.129S-Vtcn1tm1Lpc)
|
abnormal myelopoiesis
|
J:145712
|
\Wastm1Kas/\Wastm1Kas
(involves: 129/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:87875
|
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal double-negative T cell morphology
|
J:125309
|
abnormal double-positive T cell morphology
|
J:125309
|
\Wastm1Sbs/\Wastm1Sbs \Wasltm2Sbs/\Wasltm2Sbs \Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:125309
|
abnormal double-positive T cell morphology
|
J:125309
|
\Wbp1ltm2a(EUCOMM)Hmgu/\Wbp1ltm2a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
decreased pro-B cell number
|
J:284781
|
\Wdr1rede/\Wdr1rede
(C57BL/6-Wdr1rede)
|
abnormal myelopoiesis
|
J:134092
|
abnormal thrombopoiesis
|
J:134092
|
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lymphopoiesis
|
J:116168
|
\Wlstm1.1Arte/\Wlstm1.1Arte \Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:202499
|
decreased double-positive T cell number
|
J:202499
|
increased double-negative T cell number
|
J:202499
|
\Wt1tm1Jae/\Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6 * MF1)
|
abnormal spleen development
|
J:56651
|
\Xrcc5m1Btlr/\Xrcc5m1Btlr
(C57BL/6J-Xrcc5m1Btlr)
|
abnormal B cell differentiation
|
J:274736
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274736
|
abnormal T cell differentiation
|
J:274736
|
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:34834
|
arrested B cell differentiation
|
J:34834
|
arrested T cell differentiation
|
J:34834
|
increased double-negative T cell number
|
J:34834
|
\Xrcc5tm1Nus/\Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal class switch recombination
|
J:120658
|
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:44361
|
abnormal T cell differentiation
|
J:44361
|
absent immature B cells
|
J:44361
|
arrested B cell differentiation
|
J:44361
|
increased double-positive T cell number
|
J:44361
|
\Xrcc6tm1Gcl/\Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:108657
|
X/\Yaa
(BXSB/MpJ)
|
abnormal B cell differentiation
|
J:108760
|
\Yeats4em1Zfa/\Yeats4em1Zfa \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
\Zap70m1Btlr/\Zap70m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Zap70m1Saka/\Zap70m1Saka
(involves: BALB/c)
|
abnormal positive T cell selection
|
J:154166,
J:86607
|
abnormal T cell clonal deletion
|
J:154166
|
abnormal T cell differentiation
|
J:86607
|
abnormal T cell selection
|
J:86607
|
\Zap70m1Saka/\Zap70m1Saka \Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:86607
|
\Zap70m1Saka/\Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell clonal deletion
|
J:154166
|
\Zap70m6Hefl/\Zap70m6Hefl
(C3HeB/FeJ-Zap70m6Hefl)
|
abnormal T cell differentiation
|
J:137446
|
\Zap70mrtle/\Zap70mrtle
(C57BL/6JSfdAnu-Zap70mrtle/Apb)
|
abnormal positive T cell selection
|
J:104190
|
arrested T cell differentiation
|
J:104190
|
\Zap70mrtle/\Zap70mrtle
(involves: C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
increased double-positive T cell number
|
J:211510
|
\Zap70mrtle/\Zap70rps
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
increased double-positive T cell number
|
J:211510
|
\Zap70st/\Zap70st
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
\Zap70st/\Zap70tm1Dlo
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
\Zap70tm1Dlo/\Zap70tm1Dlo
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:97610
|
\Zap70tm1Weis/\Zap70tm1Weis
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:74974
|
arrested T cell differentiation
|
J:74974
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal positive T cell selection
|
J:154166
|
abnormal T cell clonal deletion
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis \Tg(DO11.10)10Dlo/?
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis \Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S4/SvJae * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:154166
|
abnormal T cell clonal deletion
|
J:154166
|
\Zbtb1m1Btlr/\Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J)
|
abnormal B cell differentiation
|
J:178820
|
abnormal T cell differentiation
|
J:178820
|
decreased DN2 thymocyte number
|
J:178820
|
decreased DN3 thymocyte number
|
J:178820
|
decreased DN4 thymocyte number
|
J:178820
|
decreased double-positive T cell number
|
J:178820
|
decreased transitional stage B cell number
|
J:178820
|
\Zbtb1m2Btlr/\Zbtb1m2Btlr
(C57BL/6J-Zbtb1m2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272845
|
\Zbtb7atm1Ppp/\Zbtb7atm1Ppp
(B6.129S1-Zbtb7atm1Ppp)
|
abnormal lymphopoiesis
|
J:121576
|
decreased pro-B cell number
|
J:121576
|
\Zbtb7atm1Ppp/\Zbtb7atm2Ppp \Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:121576
|
abnormal double-positive T cell morphology
|
J:121576
|
\Zbtb7bhd/\Zbtb7bhd
(involves: 129/Sv * BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:48734
|
\Zbtb7btm1.1Rbo/\Zbtb7btm1.1Rbo
(Not Specified)
|
abnormal T cell differentiation
|
J:141145
|
\Zbtb7btm1.1Tani/\Zbtb7btm1.1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Itan/\Zbtb7btm1.1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Itan/\Zbtb7btm2Itan
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Litt/\Zbtb7btm1.2Litt
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:141144
|
\Zbtb7btm2Litt/\Zbtb7btm1.2Litt \Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
\Zbtb17tm1Cksn/\Zbtb17tm1Cksn \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
decreased DN1 thymic pro-T cell number
|
J:170508
|
decreased DN2 thymocyte number
|
J:170508
|
decreased DN3 thymocyte number
|
J:170508
|
decreased double-negative T cell number
|
J:170508
|
\Zc3h12atm1Aki/\Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147868
|
\Zc3h12ctm2c(EUCOMM)Hmgu/\Zc3h12ctm2c(EUCOMM)Hmgu \Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
increased immature B cell number
|
J:277714
|
\Zc3h12ctm2d(EUCOMM)Hmgu/\Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
increased immature B cell number
|
J:277714
|
\Zeb1m1Btlr/\Zeb1m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
abnormal class switch recombination
|
J:185495
|
decreased double-positive T cell number
|
J:185495
|
\Zeb1tm1Yhi/\Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi)
|
abnormal T cell differentiation
|
J:39865
|
abnormal thymus development
|
J:39865
|
decreased double-positive T cell number
|
J:39865
|
\Zfattm2.1Sawa/\Zfattm2.1Sawa \Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:187164
|
\Zfp35tm1Naka/\Zfp35tm1Naka
(either: B6.Cg-Zfp35tm1Naka or C.Cg-Zfp35tm1Naka)
|
abnormal T-helper 2 cell differentiation
|
J:153828
|
\Zfp36l1tm1.1Tnr/\Zfp36l1tm1.1Tnr \Zfp36l2tm1.1Tnr/\Zfp36l2tm1.1Tnr \Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)
|
abnormal thymus development
|
J:162388
|
\Zfp131tm1.1Mytk/\Zfp131tm1.2Mytk \Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
abnormal double-negative T cell morphology
|
J:271921
|
abnormal T cell differentiation
|
J:271921
|
arrested T cell differentiation
|
J:271921
|
decreased DN2 thymocyte number
|
J:271921
|
decreased DN3 thymocyte number
|
J:271921
|
decreased DN4 thymocyte number
|
J:271921
|
decreased double-negative T cell number
|
J:271921
|
decreased double-positive T cell number
|
J:271921
|
\Zfp318tm1.1Jhws/\Zfp318tm1.1Jhws \Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zfp318tm1.1Jhws TgVav1-creA2Kio)
|
decreased transitional stage T2 B cell number
|
J:215815
|
\Zfp335blt/\Zfp335blt
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214793
|
abnormal T cell differentiation
|
J:214793
|
\Zfp574em1Btlr/\Zfp574em1Btlr
(C57BL/6J-Zfp574em1Btlr)
|
abnormal class switch recombination
|
J:354285
|